No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4b7qD, 1.0000, 0.00, 1.000, 387, 387, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
2, 4b7rD, 0.9992, 0.19, 1.000, 387, 387, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
3, 4b7rB, 0.9987, 0.25, 1.000, 387, 387, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
4, 5nweD, 0.9986, 0.26, 0.997, 388, 387, COMPLEX OF H275Y MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
5, 5nweB, 0.9986, 0.26, 0.997, 388, 387, COMPLEX OF H275Y MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
6, 4b7qB, 0.9986, 0.26, 1.000, 387, 387, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
7, 5nweC, 0.9985, 0.27, 0.997, 388, 387, COMPLEX OF H275Y MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
8, 5nweA, 0.9985, 0.27, 0.997, 388, 387, COMPLEX OF H275Y MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
9, 4b7rC, 0.9985, 0.27, 1.000, 387, 387, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
10, 4b7rA, 0.9985, 0.27, 1.000, 387, 387, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
11, 4b7qA, 0.9983, 0.29, 1.000, 387, 387, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
12, 4b7qC, 0.9982, 0.30, 1.000, 387, 387, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
13, 4b7jA, 0.9981, 0.31, 0.990, 387, 387, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
14, 3ti5B, 0.9963, 0.24, 1.000, 387, 386, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
15, 3ti4B, 0.9963, 0.24, 1.000, 387, 386, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
16, 3ti3B, 0.9963, 0.24, 1.000, 387, 386, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
17, 5nznD, 0.9962, 0.25, 0.995, 387, 386, COMPLEX OF H275Y/S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
18, 3ti4A, 0.9962, 0.24, 1.000, 387, 386, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
19, 3ti3A, 0.9962, 0.24, 1.000, 387, 386, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
20, 5nznB, 0.9961, 0.25, 0.995, 387, 386, COMPLEX OF H275Y/S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
21, 3ti5A, 0.9961, 0.25, 1.000, 387, 386, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
22, 5nznC, 0.9960, 0.26, 0.995, 387, 386, COMPLEX OF H275Y/S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
23, 5nznA, 0.9960, 0.26, 0.995, 387, 386, COMPLEX OF H275Y/S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
24, 5nzfB, 0.9960, 0.26, 0.995, 387, 386, COMPLEX OF H275Y/I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
25, 3ti6B, 0.9960, 0.26, 1.000, 387, 386, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH OSELTAMIVIR
26, 3nssB, 0.9960, 0.26, 1.000, 387, 386, THE 2009 PANDEMIC H1N1 NEURAMINIDASE N1 LACKS THE 150-CAVITY IN ITS ACTIVE SITES
27, 5nzfD, 0.9959, 0.27, 0.995, 387, 386, COMPLEX OF H275Y/I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
28, 5nzfC, 0.9959, 0.27, 0.995, 387, 386, COMPLEX OF H275Y/I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
29, 5nzfA, 0.9959, 0.27, 0.995, 387, 386, COMPLEX OF H275Y/I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
30, 5nz4A, 0.9959, 0.27, 0.997, 387, 386, COMPLEX OF I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
31, 5nzeB, 0.9958, 0.28, 0.997, 387, 386, COMPLEX OF S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
32, 5nzeA, 0.9958, 0.28, 0.997, 387, 386, COMPLEX OF S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
33, 5nz4B, 0.9958, 0.28, 0.997, 387, 386, COMPLEX OF I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR 
34, 3ti6A, 0.9958, 0.28, 1.000, 387, 386, CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH OSELTAMIVIR
35, 3nssA, 0.9958, 0.28, 1.000, 387, 386, THE 2009 PANDEMIC H1N1 NEURAMINIDASE N1 LACKS THE 150-CAVITY IN ITS ACTIVE SITES
36, 4b7nA, 0.9957, 0.29, 0.990, 386, 386, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
37, 5hugA, 0.9933, 0.66, 0.915, 388, 387, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/AMERICAN GREEN-WINGED TEAL/WASHINGTON/195750/2014 INFLUENZA VIRUS
38, 3ckzA, 0.9928, 0.32, 0.912, 385, 385, N1 NEURAMINIDASE H274Y + ZANAMIVIR
39, 3b7eA, 0.9928, 0.32, 0.888, 385, 385, NEURAMINIDASE OF A/BREVIG MISSION/1/1918 H1N1 STRAIN IN COMPLEX WITH ZANAMIVIR
40, 3cl0A, 0.9927, 0.33, 0.912, 385, 385, N1 NEURAMINIDASE H274Y + OSELTAMIVIR
41, 3b7eB, 0.9927, 0.33, 0.888, 385, 385, NEURAMINIDASE OF A/BREVIG MISSION/1/1918 H1N1 STRAIN IN COMPLEX WITH ZANAMIVIR
42, 3cl2F, 0.9922, 0.37, 0.912, 385, 385, N1 NEURAMINIDASE N294S + OSELTAMIVIR
43, 3cl2E, 0.9922, 0.37, 0.912, 385, 385, N1 NEURAMINIDASE N294S + OSELTAMIVIR
44, 3cl2B, 0.9922, 0.36, 0.912, 385, 385, N1 NEURAMINIDASE N294S + OSELTAMIVIR
45, 3cl2A, 0.9922, 0.36, 0.912, 385, 385, N1 NEURAMINIDASE N294S + OSELTAMIVIR
46, 2hu4G, 0.9922, 0.37, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
47, 3cl2H, 0.9921, 0.37, 0.912, 385, 385, N1 NEURAMINIDASE N294S + OSELTAMIVIR
48, 3cl2G, 0.9921, 0.37, 0.912, 385, 385, N1 NEURAMINIDASE N294S + OSELTAMIVIR
49, 3cl2D, 0.9921, 0.37, 0.912, 385, 385, N1 NEURAMINIDASE N294S + OSELTAMIVIR
50, 3cl2C, 0.9921, 0.37, 0.912, 385, 385, N1 NEURAMINIDASE N294S + OSELTAMIVIR
51, 2hu4H, 0.9920, 0.38, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
52, 2hu4F, 0.9919, 0.38, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
53, 2hu4C, 0.9919, 0.39, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
54, 2hu4B, 0.9918, 0.39, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
55, 2hu4A, 0.9918, 0.39, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
56, 2hu4E, 0.9917, 0.40, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
57, 2hu4D, 0.9916, 0.41, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 2
58, 4b7mA, 0.9913, 0.64, 0.990, 386, 386, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
59, 4b7mB, 0.9912, 0.64, 0.990, 386, 386, H1N1 2009 PANDEMIC INFLUENZA VIRUS: RESISTANCE OF THE I223R NEURAMINIDASE MUTANT EXPLAINED BY KINETIC AND STRUCTURAL ANALYSIS
60, 4qn5A, 0.9894, 0.76, 0.576, 394, 387, NEURAMINIDASE N5 BINDS LSTA AT THE SECOND SIA BINDING SITE
61, 4qn5B, 0.9893, 0.76, 0.576, 394, 387, NEURAMINIDASE N5 BINDS LSTA AT THE SECOND SIA BINDING SITE
62, 3ti8B, 0.9893, 0.76, 0.576, 394, 387, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH LANINAMIVIR
63, 3ti8A, 0.9893, 0.76, 0.576, 394, 387, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH LANINAMIVIR
64, 4qnpB, 0.9892, 0.62, 1.000, 386, 385, CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY
65, 4qnpA, 0.9891, 0.63, 1.000, 386, 385, CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY
66, 3sanB, 0.9891, 0.77, 0.576, 394, 387, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH ZANAMIVIR
67, 3sanA, 0.9891, 0.77, 0.576, 394, 387, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5 COMPLEXED WITH ZANAMIVIR
68, 3cyeB, 0.9888, 0.63, 0.888, 385, 385, CYRSTAL STRUCTURE OF THE NATIVE 1918 H1N1 NEURAMINIDASE FROM A CRYSTAL WITH LATTICE-TRANSLOCATION DEFECTS
69, 3cyeA, 0.9888, 0.63, 0.888, 385, 385, CYRSTAL STRUCTURE OF THE NATIVE 1918 H1N1 NEURAMINIDASE FROM A CRYSTAL WITH LATTICE-TRANSLOCATION DEFECTS
70, 3beqB, 0.9888, 0.63, 0.888, 385, 385, NEURAMINIDASE OF A/BREVIG MISSION/1/1918 H1N1 STRAIN
71, 3beqA, 0.9888, 0.62, 0.888, 385, 385, NEURAMINIDASE OF A/BREVIG MISSION/1/1918 H1N1 STRAIN
72, 2hu0G, 0.9885, 0.63, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
73, 2hu0H, 0.9884, 0.64, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
74, 2htyG, 0.9884, 0.64, 0.914, 385, 385, N1 NEURAMINIDASE
75, 2hu0F, 0.9883, 0.65, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
76, 2hu0C, 0.9883, 0.65, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
77, 2hu0B, 0.9883, 0.64, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
78, 2htyC, 0.9883, 0.64, 0.914, 385, 385, N1 NEURAMINIDASE
79, 2htyH, 0.9882, 0.64, 0.914, 385, 385, N1 NEURAMINIDASE
80, 2hu0E, 0.9881, 0.65, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
81, 2htyF, 0.9881, 0.65, 0.914, 385, 385, N1 NEURAMINIDASE
82, 2htyB, 0.9881, 0.65, 0.914, 385, 385, N1 NEURAMINIDASE
83, 2htyE, 0.9880, 0.66, 0.914, 385, 385, N1 NEURAMINIDASE
84, 2hu0D, 0.9879, 0.66, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
85, 2hu0A, 0.9879, 0.66, 0.914, 385, 385, N1 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR 1
86, 2htyA, 0.9878, 0.66, 0.914, 385, 385, N1 NEURAMINIDASE
87, 2htyD, 0.9877, 0.67, 0.914, 385, 385, N1 NEURAMINIDASE
88, 2htwA, 0.9874, 0.62, 0.701, 388, 385, N4 NEURAMINIDASE IN COMPLEX WITH DANA
89, 4ks1A, 0.9852, 0.92, 0.566, 389, 387, INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S4R5R)- 4-(ACETYLAMINO)-3-AMINO-5-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID
90, 3salB, 0.9851, 0.96, 0.576, 394, 387, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5
91, 2htvA, 0.9847, 0.79, 0.699, 388, 385, N4 NEURAMINIDASE
92, 4ks2A, 0.9845, 0.94, 0.566, 389, 387, INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S4R5R)- 4-(ACETYLAMINO)-3-CARBAMIMIDAMIDO-5-(PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1- CARBOXYLIC ACID
93, 2htvB, 0.9842, 0.80, 0.699, 388, 385, N4 NEURAMINIDASE
94, 3salA, 0.9836, 1.00, 0.576, 394, 387, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS NEURAMINIDASE N5
95, 4mjvA, 0.9814, 1.07, 0.563, 390, 387, INFLUENZA NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND
96, 4mjuA, 0.9809, 1.08, 0.566, 389, 387, INFLUENZA NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND
97, 4ks4A, 0.9805, 1.09, 0.566, 389, 387, INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S4R5R)- 4-(ACETYLAMINO)-3-{4-[(1R)-1-HYDROXYPROPYL]-1H-123-TRIAZOL-1-YL}-5- (PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID
98, 2htrA, 0.9804, 0.90, 0.556, 387, 385, N8 NEURAMINIDASE IN COMPLEX WITH DANA
99, 4m3mA, 0.9803, 1.09, 0.566, 390, 387, INFLUENZA NEURAMINIDASE IN COMPLEX WITH A STEREOMUTATED ANALOGUE OF OSELTAMIVIR CARBOXYLATE
100, 4ks3A, 0.9803, 0.99, 0.565, 388, 386, INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S4R5R)- 4-(ACETYLAMINO)-3-[4-(3-HYDROXYPROPYL)-1H-123-TRIAZOL-1-YL]-5- (PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID
101, 4d8sA, 0.9801, 0.99, 0.560, 388, 386, INFLUENZA NA IN COMPLEX WITH ANTIVIRAL COMPOUND
102, 4wa5A, 0.9797, 1.05, 0.580, 388, 386, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH ZANAMIVIR
103, 2htuA, 0.9795, 0.93, 0.556, 387, 385, N8 NEURAMINIDASE IN COMPLEX WITH PERAMIVIR
104, 2ht8A, 0.9792, 0.94, 0.556, 387, 385, N8 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR
105, 4wa3A, 0.9788, 1.08, 0.580, 388, 386, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS
106, 2htqA, 0.9784, 0.96, 0.556, 387, 385, N8 NEURAMINIDASE IN COMPLEX WITH ZANAMIVIR
107, 5hunA, 0.9778, 1.10, 0.554, 389, 386, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/GYRFALCON/WASHINGTON/41088-6/2014 INFLUENZA VIRUS
108, 4ks5A, 0.9775, 1.11, 0.565, 388, 386, INFLUENZA NEURAMINIDASE IN COMPLEX WITH ANTIVIRAL COMPOUND (3S4R5R)- 4-(ACETYLAMINO)-3-[4-(2-HYDROXYPROPAN-2-YL)-1H-123-TRIAZOL-1-YL]-5- (PENTAN-3-YLOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID
109, 2ht7A, 0.9764, 1.05, 0.556, 387, 385, N8 NEURAMINIDASE IN OPEN COMPLEX WITH OSELTAMIVIR
110, 4gb1A, 0.9762, 1.07, 0.558, 387, 385, SYNTHESIS AND EVALUATION OF NOVEL 3-C-ALKYLATED-NEU5AC2EN DERIVATIVES AS PROBES OF INFLUENZA VIRUS SIALIDASE 150-LOOP FLEXIBILITY
111, 3o9kA, 0.9751, 1.10, 0.558, 387, 385, INFLUENZA NA IN COMPLEX WITH COMPOUND 6
112, 3o9jA, 0.9751, 1.09, 0.558, 387, 385, INFLUENZA NA IN COMPLEX WITH COMPOUND 5
113, 2ht5A, 0.9749, 1.09, 0.556, 387, 385, N8 NEURAMINIDASE
114, 4wa4A, 0.9726, 0.91, 0.579, 384, 382, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
115, 5l17A, 0.9654, 1.24, 0.486, 388, 383, THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH ZANAMIVIR FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS
116, 5l15A, 0.9654, 1.24, 0.486, 388, 383, THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS
117, 5l14A, 0.9654, 1.24, 0.486, 388, 383, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS
118, 5l18A, 0.9652, 1.25, 0.486, 388, 383, THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH SIALIC ACID FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS
119, 4dgrA, 0.9652, 1.25, 0.488, 389, 383, INFLUENZA SUBTYPE 9 NEURAMINIDASE BENZOIC ACID INHIBITOR COMPLEX
120, 1l7hA, 0.9651, 1.25, 0.486, 388, 383, CRYSTAL STRUCTURE OF R292K MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812
121, 1l7fA, 0.9651, 1.25, 0.488, 388, 383, CRYSTAL STRUCTURE OF INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812
122, 1f8cA, 0.9651, 1.25, 0.488, 388, 383, NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 4-AMINO-2-DEOXY-23- DEHYDRO-N-NEURAMINIC ACID
123, 2qwhA, 0.9650, 1.25, 0.486, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1- ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
124, 2qwgA, 0.9650, 1.25, 0.486, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6- DIETHYLCARBOXAMIDE-45-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
125, 2qwfA, 0.9650, 1.25, 0.486, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6- METHYL(PROPYL)CARBOXAMIDE-45-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
126, 2qwcA, 0.9650, 1.25, 0.486, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
127, 2qwaA, 0.9650, 1.25, 0.486, 388, 383, THE X-RAY STRUCTURE OF A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
128, 2c4aA, 0.9650, 1.25, 0.488, 388, 383, STRUCTURE OF NEURAMINIDASE SUBTYPE N9 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 291 K.
129, 1mweA, 0.9650, 1.25, 0.488, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH SIALIC ACID AT 4 DEGREES C REVEALING A SECOND SIALIC ACID BINDING SITE
130, 1l7gA, 0.9650, 1.25, 0.486, 388, 383, CRYSTAL STRUCTURE OF E119G MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812
131, 1f8eA, 0.9650, 1.25, 0.488, 388, 383, NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 49-DIAMINO-2-DEOXY-2 3-DEHYDRO-N-ACETYL-NEURAMINIC ACID
132, 1f8bA, 0.9650, 1.25, 0.488, 388, 383, NATIVE INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH NEU5AC2EN
133, 2qwkA, 0.9649, 1.25, 0.488, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1- ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE
134, 2qwjA, 0.9649, 1.25, 0.488, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6- DIETHYLCARBOXAMIDE-45-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
135, 2qweA, 0.9649, 1.25, 0.486, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF 4-GUANIDINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
136, 2qwdA, 0.9649, 1.25, 0.486, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF 4-AMINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
137, 1f8dA, 0.9649, 1.25, 0.488, 388, 383, NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 9-AMINO-2-DEOXY-23- DEHYDRO-N-NEURAMINIC ACID
138, 7nn9A, 0.9648, 1.26, 0.488, 388, 383, NATIVE INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN)
139, 5w2yA, 0.9648, 1.26, 0.488, 388, 383, INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 9-DEOXYGENATED 23- DIFLUORO-N-ACETYLNEURAMINIC ACID
140, 5w2wA, 0.9648, 1.26, 0.488, 388, 383, INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 8-DEOXYGENATED 23- DIFLUORO-N-ACETYLNEURAMINIC ACID
141, 5w2uA, 0.9648, 1.26, 0.488, 388, 383, INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 7-DEOXYGENATED 23- DIFLUORO-N-ACETYLNEURAMINIC ACID
142, 5w26A, 0.9648, 1.25, 0.488, 388, 383, INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 4-DEOXYGENATED 23- DIFLUORO-N-ACETYLNEURAMINIC ACID
143, 4wegA, 0.9648, 1.26, 0.488, 388, 383, INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX 23-DIFLUOROSIALIC ACID
144, 2qwbA, 0.9648, 1.26, 0.486, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF SIALIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE
145, 2c4lA, 0.9648, 1.26, 0.488, 388, 383, STRUCTURE OF NEURAMINIDASE SUBTYPE N9 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 24 HOURS AT 291 K AND FINALLY BACKSOAKED FOR 30 MIN IN A CRYOPROTECTANT SOLUTION WHICH DID NOT CONTAIN NEU5AC
146, 2b8hA, 0.9648, 1.26, 0.480, 388, 383, A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE
147, 1nncA, 0.9648, 1.25, 0.488, 388, 383, INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 4- GUANIDINO-NEU5AC2EN INHIBITOR
148, 3w09A, 0.9647, 1.26, 0.488, 388, 383, INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 23-DIF GUANIDINO-NEU5AC2EN INHIBITOR
149, 1bjiA, 0.9646, 1.26, 0.488, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH THE GLAXO 6-CARBOXAMIDE SIALIC ACID ANALOGUE GR217029
150, 4mwrA, 0.9645, 1.27, 0.486, 388, 383, ANHUI N9-ZANAMIVIR
151, 4mwqA, 0.9644, 1.27, 0.486, 388, 383, ANHUI N9-OSELTAMIVIR CARBOXYLATE
152, 2qwiA, 0.9644, 1.26, 0.488, 388, 383, THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6- METHYL(PROPYL)CARBOXAMIDE-45-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE
153, 1xoeA, 0.9644, 1.27, 0.488, 387, 383, N9 TERN INFLUENZA NEURAMINIDASE COMPLEXED WITH (2R4R5R)-5-(1- ACETYLAMINO-3-METHYL-BUTYL-PYRROLIDINE-2 4-DICAROBYXYLIC ACID 4- METHYL ESTERDASE COMPLEXED WITH
154, 4qn7A, 0.9642, 1.37, 0.456, 390, 384, CRYSTAL STRUCTURE OF NEURAMNIDASE N7 COMPLEXED WITH OSELTAMIVIR
155, 4mx0A, 0.9642, 1.28, 0.483, 388, 383, SHANGHAI N9-PERAMIVIR
156, 4mwyA, 0.9642, 1.28, 0.483, 388, 383, SHANGHAI N9-LANINAMIVIR
157, 4mwxA, 0.9642, 1.28, 0.483, 388, 383, SHANGHAI N9-ZANAMIVIR
158, 4qn6A, 0.9641, 1.31, 0.486, 389, 383, CRYSTAL STRUCTURE OF NEURAMINIDASE N6 COMPLEXED WITH LANINAMIVIR
159, 4mwuA, 0.9641, 1.28, 0.486, 388, 383, ANHUI N9-LANINAMIVIR
160, 4qn6B, 0.9640, 1.32, 0.488, 389, 383, CRYSTAL STRUCTURE OF NEURAMINIDASE N6 COMPLEXED WITH LANINAMIVIR
161, 4qn4A, 0.9640, 1.32, 0.488, 389, 383, CRYSTAL STRUCTURE OF NEURAMINIDASE N6
162, 4mwwA, 0.9640, 1.28, 0.483, 388, 383, SHANGHAI N9-OSELTAMIVIR CARBOXYLATE
163, 4mwvA, 0.9640, 1.28, 0.486, 388, 383, ANHUI N9-PERAMIVIR
164, 4mwlA, 0.9640, 1.28, 0.483, 388, 383, SHANGHAI N9
165, 4mwjA, 0.9640, 1.28, 0.486, 388, 383, ANHUI N9
166, 4qn4B, 0.9639, 1.32, 0.486, 389, 383, CRYSTAL STRUCTURE OF NEURAMINIDASE N6
167, 2cmlA, 0.9639, 1.32, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM ZANAMIVIR CRYSTAL SOAKED FOR 3 HOURS AT 291 K.
168, 1nnaA, 0.9639, 1.27, 0.488, 387, 383, THREE-DIMENSIONAL STRUCTURE OF INFLUENZA A N9 NEURAMINIDASE AND ITS COMPLEX WITH THE INHIBITOR 2-DEOXY 23-DEHYDRO-N-ACETYL NEURAMINIC ACID
169, 1ncaN, 0.9639, 1.27, 0.491, 389, 383, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
170, 5jyyA, 0.9638, 1.29, 0.483, 388, 383, STRUCTURE-BASED TETRAVALENT ZANAMIVIR WITH POTENT INHIBITORY ACTIVITY AGAINST DRUG-RESISTANT INFLUENZA VIRUSES
171, 4qn7B, 0.9638, 1.38, 0.456, 390, 384, CRYSTAL STRUCTURE OF NEURAMNIDASE N7 COMPLEXED WITH OSELTAMIVIR
172, 1v0zA, 0.9638, 1.32, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6
173, 1nmbN, 0.9638, 1.28, 0.483, 388, 383, THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY
174, 1ncdN, 0.9638, 1.27, 0.483, 389, 383, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
175, 4qn3A, 0.9637, 1.38, 0.456, 390, 384, CRYSTAL STRUCTURE OF NEURAMINIDASE N7
176, 1w21A, 0.9637, 1.32, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 43 HOURS AT 291 K.
177, 1w20A, 0.9637, 1.32, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 291 K
178, 5humC, 0.9636, 1.32, 0.491, 389, 383, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SICHUAN/26221/2014 INFLUENZA VIRUS
179, 2cmlD, 0.9636, 1.32, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM ZANAMIVIR CRYSTAL SOAKED FOR 3 HOURS AT 291 K.
180, 2cmlB, 0.9636, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM ZANAMIVIR CRYSTAL SOAKED FOR 3 HOURS AT 291 K.
181, 1xogA, 0.9636, 1.28, 0.488, 387, 383, N9 TERN INFLUENZA NEURAMINIDASE COMPLEXED WITH A 25-DISUBSTITUTED TETRAHYDROFURAN-5-CARBOXYLIC ACID
182, 1w21C, 0.9636, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 43 HOURS AT 291 K.
183, 1w21B, 0.9636, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 43 HOURS AT 291 K.
184, 1w20C, 0.9636, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 291 K
185, 1w20B, 0.9636, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 291 K
186, 1a14N, 0.9636, 1.28, 0.488, 388, 383, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
187, 4qn3B, 0.9635, 1.38, 0.456, 390, 384, CRYSTAL STRUCTURE OF NEURAMINIDASE N7
188, 2cmlC, 0.9635, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM ZANAMIVIR CRYSTAL SOAKED FOR 3 HOURS AT 291 K.
189, 1nnbA, 0.9635, 1.28, 0.488, 387, 383, THREE-DIMENSIONAL STRUCTURE OF INFLUENZA A N9 NEURAMINIDASE AND ITS COMPLEX WITH THE INHIBITOR 2-DEOXY 23-DEHYDRO-N-ACETYL NEURAMINIC ACID
190, 1ncbN, 0.9635, 1.28, 0.486, 389, 383, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
191, 5humD, 0.9634, 1.33, 0.491, 389, 383, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SICHUAN/26221/2014 INFLUENZA VIRUS
192, 1w21D, 0.9634, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 43 HOURS AT 291 K.
193, 1w20D, 0.9634, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 291 K
194, 1v0zD, 0.9634, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6
195, 1v0zB, 0.9634, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6
196, 5humA, 0.9633, 1.33, 0.491, 389, 383, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SICHUAN/26221/2014 INFLUENZA VIRUS
197, 1w1xA, 0.9633, 1.33, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 277 K.
198, 5humB, 0.9632, 1.33, 0.491, 389, 383, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SICHUAN/26221/2014 INFLUENZA VIRUS
199, 1w1xB, 0.9631, 1.34, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 277 K.
200, 1v0zC, 0.9631, 1.34, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6
201, 1w1xC, 0.9630, 1.35, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 277 K.
202, 4h53C, 0.9629, 1.15, 0.457, 388, 381, INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC
203, 1w1xD, 0.9629, 1.34, 0.473, 389, 383, STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6 COMPLEXED WITH 30 MM SIALIC ACID (NANA NEU5AC) CRYSTAL SOAKED FOR 3 HOURS AT 277 K.
204, 6br6A, 0.9628, 1.16, 0.457, 387, 381, N2 NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND
205, 6br5A, 0.9627, 1.15, 0.457, 387, 381, N2 NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND
206, 3nn9A, 0.9626, 1.30, 0.486, 388, 383, REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS
207, 1nccN, 0.9626, 1.29, 0.486, 389, 383, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
208, 5nn9A, 0.9625, 1.30, 0.488, 388, 383, REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS
209, 6nn9A, 0.9624, 1.30, 0.486, 388, 383, REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS
210, 4k1jB, 0.9624, 1.16, 0.462, 388, 381, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
211, 4nn9A, 0.9623, 1.31, 0.486, 388, 383, REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS
212, 4k1jA, 0.9623, 1.17, 0.462, 388, 381, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
213, 4h53B, 0.9623, 1.17, 0.457, 388, 381, INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC
214, 3ticD, 0.9623, 1.17, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
215, 3ticB, 0.9623, 1.17, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
216, 3ticA, 0.9622, 1.17, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
217, 3tiaD, 0.9622, 1.17, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
218, 3tiaB, 0.9622, 1.17, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
219, 1nmcN, 0.9622, 1.31, 0.488, 388, 383, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
220, 1nmcA, 0.9622, 1.31, 0.488, 388, 383, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
221, 4gztA, 0.9621, 1.17, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
222, 3ticC, 0.9621, 1.17, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
223, 3tiaC, 0.9621, 1.17, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
224, 3tiaA, 0.9621, 1.17, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR
225, 2b8hC, 0.9621, 1.32, 0.480, 388, 383, A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE
226, 4k1iB, 0.9620, 1.18, 0.459, 388, 381, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
227, 4h53A, 0.9620, 1.17, 0.457, 388, 381, INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC
228, 4gztB, 0.9620, 1.18, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
229, 4gzqA, 0.9620, 1.17, 0.457, 388, 381, N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH SIALIC ACID
230, 4k1iA, 0.9619, 1.17, 0.459, 388, 381, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
231, 4k1hB, 0.9619, 1.18, 0.459, 388, 381, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
232, 4k1hA, 0.9619, 1.18, 0.459, 388, 381, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
233, 4gzpA, 0.9619, 1.18, 0.457, 388, 381, N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
234, 4gzoA, 0.9619, 1.18, 0.457, 388, 381, N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES
235, 3tibD, 0.9619, 1.18, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
236, 3tibC, 0.9619, 1.18, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
237, 3tibB, 0.9618, 1.18, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
238, 4gzxB, 0.9617, 1.18, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR
239, 4gztC, 0.9617, 1.19, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
240, 4gzsA, 0.9617, 1.18, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES
241, 3tibA, 0.9617, 1.18, 0.459, 388, 381, CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE
242, 5hukB, 0.9616, 1.17, 0.467, 388, 381, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS
243, 4gzxC, 0.9616, 1.18, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR
244, 2aepA, 0.9616, 1.18, 0.451, 388, 381, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
245, 4gzsB, 0.9615, 1.18, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES
246, 4gzxA, 0.9614, 1.19, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR
247, 4gzwC, 0.9614, 1.19, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR
248, 4gztD, 0.9614, 1.19, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
249, 4gzsC, 0.9614, 1.19, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES
250, 5hukA, 0.9612, 1.19, 0.467, 388, 381, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS
251, 4gzxD, 0.9612, 1.19, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR
252, 4gzwB, 0.9610, 1.20, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR
253, 4gzsD, 0.9610, 1.20, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES
254, 1inxA, 0.9610, 1.20, 0.449, 388, 381, A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
255, 4gzwA, 0.9609, 1.20, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR
256, 1inwA, 0.9609, 1.20, 0.449, 388, 381, A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
257, 2batA, 0.9608, 1.20, 0.449, 388, 381, THE STRUCTURE OF THE COMPLEX BETWEEN INFLUENZA VIRUS NEURAMINIDASE AND SIALIC ACID THE VIRAL RECEPTOR
258, 4h52B, 0.9606, 1.21, 0.459, 388, 381, WILD-TYPE INFLUENZA N2 NEURAMINIDASE COVALENT COMPLEX WITH 3-FLUORO- NEU5AC
259, 4k1kA, 0.9605, 1.21, 0.459, 388, 381, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
260, 4h52A, 0.9605, 1.21, 0.459, 388, 381, WILD-TYPE INFLUENZA N2 NEURAMINIDASE COVALENT COMPLEX WITH 3-FLUORO- NEU5AC
261, 4gzwD, 0.9605, 1.21, 0.454, 388, 381, N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR
262, 4k1kB, 0.9604, 1.22, 0.459, 388, 381, INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING
263, 1nn2A, 0.9604, 1.22, 0.449, 388, 381, THREE-DIMENSIONAL STRUCTURE OF THE NEURAMINIDASE OF INFLUENZA VIRUS A(SLASH)TOKYO(SLASH)3(SLASH)67 AT 2.2 ANGSTROMS RESOLUTION
264, 2aeqA, 0.9603, 1.21, 0.451, 388, 381, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
265, 1ivcB, 0.9603, 1.22, 0.449, 388, 381, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
266, 1ivcA, 0.9603, 1.22, 0.449, 388, 381, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
267, 2b8hD, 0.9602, 1.41, 0.480, 388, 383, A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE
268, 1ivfB, 0.9602, 1.22, 0.449, 388, 381, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
269, 1ivfA, 0.9602, 1.22, 0.449, 388, 381, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
270, 4hzwA, 0.9600, 1.24, 0.486, 388, 381, CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH LANINAMIVIR
271, 2b8hB, 0.9599, 1.39, 0.480, 388, 383, A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE
272, 1ingB, 0.9597, 1.23, 0.449, 388, 381, INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR
273, 1ingA, 0.9597, 1.23, 0.449, 388, 381, INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR
274, 1inyA, 0.9595, 1.36, 0.486, 388, 383, A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
275, 5hukD, 0.9594, 1.24, 0.467, 388, 381, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS
276, 4hzxA, 0.9594, 1.25, 0.486, 388, 381, CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3 COMPLEXED WITH OSELTAMIVIR
277, 4hzyA, 0.9592, 1.25, 0.483, 388, 381, CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3-H274Y
278, 4hzvA, 0.9592, 1.25, 0.486, 388, 381, THE CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3
279, 4i00A, 0.9590, 1.26, 0.483, 388, 381, CRYSTAL STRUCTURE OF INFLUENZA A NEURAMINIDASE N3-H274Y COMPLEXED WITH ZANAMIVIR
280, 1ivgB, 0.9582, 1.25, 0.451, 388, 381, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
281, 1ivgA, 0.9582, 1.25, 0.451, 388, 381, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
282, 1ivdB, 0.9582, 1.27, 0.451, 388, 381, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
283, 1ivdA, 0.9582, 1.27, 0.451, 388, 381, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
284, 1inhB, 0.9580, 1.27, 0.449, 388, 381, INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR
285, 1inhA, 0.9580, 1.27, 0.449, 388, 381, INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA111 INHIBITOR
286, 5hukC, 0.9579, 1.27, 0.467, 388, 381, THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS
287, 4hzzA, 0.9579, 1.28, 0.483, 387, 381, CRYSTAL STRUCTURE OF INFLUENZA NEURAMINIDASE N3-H274Y COMPLEXED WITH OSELTAMIVIR
288, 1iveB, 0.9579, 1.27, 0.451, 388, 381, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
289, 1iveA, 0.9579, 1.27, 0.451, 388, 381, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
290, 4h53D, 0.9577, 1.30, 0.457, 388, 381, INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC
291, 1nmaN, 0.9387, 1.25, 0.485, 378, 373, N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA
292, 4cpnA, 0.9136, 2.01, 0.335, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH ZANAMIVIR
293, 4cpmB, 0.9135, 2.01, 0.335, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH OSELTAMIVIR
294, 4cpoB, 0.9134, 2.01, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/ 2011  VIRUS
295, 1a4qB, 0.9134, 2.02, 0.335, 390, 376, INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH DIHYDROPYRAN-PHENETHYL-PROPYL-CARBOXAMIDE
296, 1a4qA, 0.9133, 2.02, 0.335, 390, 376, INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH DIHYDROPYRAN-PHENETHYL-PROPYL-CARBOXAMIDE
297, 1a4gB, 0.9133, 2.02, 0.335, 390, 376, INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
298, 3k36B, 0.9131, 2.03, 0.338, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE
299, 1a4gA, 0.9130, 2.02, 0.335, 390, 376, INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
300, 4cpyA, 0.9129, 2.02, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/ 2011 VIRUS IN COMPLEX WITH OSELTAMIVIR
301, 4cplA, 0.9129, 2.03, 0.335, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS.
302, 3k38E, 0.9129, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
303, 3k38C, 0.9129, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
304, 3k37A, 0.9129, 2.03, 0.338, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE IN COMPLEX WITH PERAMIVIR
305, 3k36A, 0.9129, 2.03, 0.338, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE
306, 1nsdA, 0.9129, 2.03, 0.335, 390, 376, INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR
307, 4cpzA, 0.9128, 2.03, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
308, 3k38O, 0.9128, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
309, 3k38M, 0.9128, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
310, 3k38A, 0.9128, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
311, 3k37B, 0.9128, 2.03, 0.338, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE IN COMPLEX WITH PERAMIVIR
312, 1nscA, 0.9128, 2.03, 0.335, 390, 376, INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR
313, 1nsbA, 0.9128, 2.03, 0.335, 390, 376, THE 2.2 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF INFLUENZA B NEURAMINIDASE AND ITS COMPLEX WITH SIALIC ACID
314, 4cpnB, 0.9127, 2.03, 0.335, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH ZANAMIVIR
315, 3k38K, 0.9127, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
316, 3k38I, 0.9127, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
317, 1nsbB, 0.9127, 2.03, 0.335, 390, 376, THE 2.2 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF INFLUENZA B NEURAMINIDASE AND ITS COMPLEX WITH SIALIC ACID
318, 4cpzF, 0.9126, 2.03, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
319, 4cpzB, 0.9126, 2.03, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
320, 3k38L, 0.9126, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
321, 3k38H, 0.9126, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
322, 3k38G, 0.9126, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
323, 3k38F, 0.9126, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
324, 3k38D, 0.9126, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
325, 3k38B, 0.9126, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
326, 1nsdB, 0.9126, 2.03, 0.335, 390, 376, INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR
327, 1nscB, 0.9126, 2.03, 0.335, 390, 376, INFLUENZA B VIRUS NEURAMINIDASE CAN SYNTHESIZE ITS OWN INHIBITOR
328, 3k38J, 0.9125, 2.03, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
329, 4cpoA, 0.9124, 2.04, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/ 2011  VIRUS
330, 4cpmA, 0.9124, 2.04, 0.335, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH OSELTAMIVIR
331, 3k3aK, 0.9124, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
332, 3k3aJ, 0.9124, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
333, 3k38P, 0.9124, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
334, 3k38N, 0.9124, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT
335, 3k3aO, 0.9123, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
336, 3k3aM, 0.9123, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
337, 3k3aL, 0.9123, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
338, 3k3aI, 0.9123, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
339, 3k3aG, 0.9123, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
340, 3k3aE, 0.9123, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
341, 3k3aC, 0.9123, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
342, 4cpzE, 0.9122, 2.04, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
343, 4cpzC, 0.9122, 2.04, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
344, 3k3aP, 0.9122, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
345, 3k3aN, 0.9122, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
346, 3k3aH, 0.9122, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
347, 3k3aF, 0.9122, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
348, 3k3aD, 0.9122, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
349, 3k3aB, 0.9122, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
350, 3k3aA, 0.9122, 2.04, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH OSELTAMIVIR
351, 4cpzD, 0.9121, 2.04, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
352, 4cplB, 0.9121, 2.05, 0.335, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS.
353, 4cpyB, 0.9120, 2.09, 0.326, 390, 377, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/ 2011 VIRUS IN COMPLEX WITH OSELTAMIVIR
354, 3k39P, 0.9119, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
355, 3k39O, 0.9119, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
356, 3k39N, 0.9119, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
357, 3k39M, 0.9119, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
358, 3k39G, 0.9119, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
359, 3k39F, 0.9119, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
360, 3k39D, 0.9119, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
361, 3k39L, 0.9118, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
362, 3k39K, 0.9118, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
363, 3k39J, 0.9118, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
364, 3k39I, 0.9118, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
365, 3k39H, 0.9118, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
366, 3k39E, 0.9118, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
367, 3k39C, 0.9118, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
368, 3k39B, 0.9118, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
369, 3k39A, 0.9118, 2.05, 0.335, 389, 376, CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR
370, 4cpzH, 0.9116, 2.05, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
371, 1ivbA, 0.9115, 2.04, 0.338, 390, 376, STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE
372, 4cpzG, 0.9114, 2.05, 0.330, 390, 376, STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/15.216/2011 VIRUS IN COMPLEX WITH ZANAMIVIR
373, 1infA, 0.9104, 2.06, 0.338, 390, 376, INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE COMPLEXED WITH BANA113 INHIBITOR
374, 1b9vA, 0.9103, 2.07, 0.338, 390, 376, NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN TEH ACTIVE SITE
375, 1vcjA, 0.9101, 2.07, 0.338, 389, 376, INFLUENZA B VIRUS NEURAMINIDASE COMPLEXED WITH 1-(4-CARBOXY-2-(3- PENTYLAMINO)PHENYL)-5-AMINOMETHYL-5-HYDROXYMETHYL-PYRROLIDIN-2-ONE
376, 1invA, 0.9101, 2.07, 0.338, 390, 376, A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
377, 1b9sA, 0.9099, 2.08, 0.338, 390, 376, NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN THE ACTIVE SITE
378, 1b9tA, 0.9098, 2.08, 0.338, 390, 376, NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN THE ACTIVE SITE
379, 4gdiF, 0.8797, 2.29, 0.287, 367, 366, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
380, 4gdiE, 0.8794, 2.28, 0.287, 367, 366, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
381, 4fvkB, 0.8794, 2.29, 0.287, 367, 366, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF NEURAMINIDASE-LIKE MOLECULE N10 DERIVED FROM BAT INFLUENZA A VIRUS
382, 4fvkA, 0.8792, 2.30, 0.287, 367, 366, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF NEURAMINIDASE-LIKE MOLECULE N10 DERIVED FROM BAT INFLUENZA A VIRUS
383, 4gezD, 0.8785, 2.25, 0.293, 365, 365, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
384, 4gezH, 0.8784, 2.26, 0.293, 365, 365, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
385, 4gdiC, 0.8776, 2.33, 0.287, 367, 366, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
386, 4gdiA, 0.8776, 2.34, 0.287, 367, 366, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
387, 4gdiB, 0.8775, 2.32, 0.287, 367, 366, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
388, 4gezI, 0.8772, 2.20, 0.294, 365, 364, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
389, 4gezF, 0.8772, 2.19, 0.294, 365, 364, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
390, 4gezE, 0.8772, 2.28, 0.293, 365, 365, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
391, 4gezB, 0.8772, 2.28, 0.293, 365, 365, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
392, 4gezC, 0.8769, 2.28, 0.293, 365, 365, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
393, 4gezG, 0.8768, 2.28, 0.293, 365, 365, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
394, 4gdiD, 0.8768, 2.34, 0.287, 367, 366, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009
395, 4gezL, 0.8764, 2.27, 0.293, 365, 365, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
396, 4gezA, 0.8764, 2.29, 0.293, 365, 365, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
397, 4gezK, 0.8731, 2.21, 0.295, 364, 363, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
398, 4mc7B, 0.8729, 2.17, 0.288, 363, 361, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
399, 4mc7C, 0.8728, 2.17, 0.288, 363, 361, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
400, 4mc7D, 0.8727, 2.18, 0.288, 363, 361, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
401, 4mc7A, 0.8727, 2.18, 0.288, 363, 361, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
402, 4gezJ, 0.8715, 2.21, 0.296, 363, 362, STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009
403, 4k3yA, 0.8560, 2.13, 0.295, 354, 352, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
404, 4k3yD, 0.8552, 2.13, 0.295, 354, 352, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
405, 4k3yB, 0.8544, 2.05, 0.296, 354, 351, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
406, 4k3yC, 0.8528, 2.05, 0.293, 355, 351, CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)
407, 4gdjB, 0.7836, 1.74, 0.324, 321, 318, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010
408, 4gdjA, 0.7816, 1.73, 0.322, 317, 317, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010
409, 4gdjD, 0.7759, 1.65, 0.325, 314, 314, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010
410, 4gdjC, 0.7736, 1.74, 0.325, 314, 314, A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/060/2010
411, 4fzhC, 0.7148, 4.33, 0.089, 486, 347, STRUCTURE OF THE ULSTER STRAIN NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE REVEALS AUTO-INHIBITORY INTERACTIONS ASSOCIATED WITH LOW VIRULENCE
412, 4fzhA, 0.7133, 4.36, 0.089, 486, 347, STRUCTURE OF THE ULSTER STRAIN NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE REVEALS AUTO-INHIBITORY INTERACTIONS ASSOCIATED WITH LOW VIRULENCE
413, 4fzhB, 0.7116, 4.38, 0.092, 486, 347, STRUCTURE OF THE ULSTER STRAIN NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE REVEALS AUTO-INHIBITORY INTERACTIONS ASSOCIATED WITH LOW VIRULENCE
414, 4fzhD, 0.7097, 4.32, 0.096, 486, 345, STRUCTURE OF THE ULSTER STRAIN NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE REVEALS AUTO-INHIBITORY INTERACTIONS ASSOCIATED WITH LOW VIRULENCE
415, 1usxA, 0.7014, 4.10, 0.087, 446, 334, CRYSTAL STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE COMPLEXED WITH THIOSIALOSIDE
416, 1usxB, 0.7013, 4.16, 0.087, 446, 335, CRYSTAL STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE COMPLEXED WITH THIOSIALOSIDE
417, 1usrA, 0.7012, 4.09, 0.087, 447, 333, NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE: EVIDENCE FOR A SECOND SIALIC ACID BINDING SITE AND IMPLICATIONS FOR FUSION
418, 1usrB, 0.7006, 4.13, 0.087, 446, 334, NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE: EVIDENCE FOR A SECOND SIALIC ACID BINDING SITE AND IMPLICATIONS FOR FUSION
419, 1usxC, 0.7005, 4.14, 0.087, 446, 334, CRYSTAL STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE COMPLEXED WITH THIOSIALOSIDE
420, 1e8vB, 0.6998, 4.16, 0.087, 446, 334, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
421, 1e8vA, 0.6998, 4.16, 0.087, 447, 334, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
422, 4jf7C, 0.6979, 4.22, 0.078, 493, 335, STRUCTURE OF THE PARAINFLUENZA VIRUS 5 (PIV5) HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN
423, 1e8tA, 0.6969, 4.14, 0.090, 446, 334, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
424, 4jf7B, 0.6968, 4.25, 0.078, 501, 335, STRUCTURE OF THE PARAINFLUENZA VIRUS 5 (PIV5) HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN
425, 1z50A, 0.6965, 4.18, 0.078, 448, 333, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH SIALIC ACID PH 8.0)
426, 1z4xA, 0.6964, 4.18, 0.078, 448, 333, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND SIALYLLACTOSE (SOAKED WITH SIALYLLACTOSE PH8.0)
427, 1z4zA, 0.6963, 4.18, 0.078, 448, 333, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA(SOAKED WITH SIALIC ACID PH7.0))
428, 1e8uA, 0.6963, 4.17, 0.090, 446, 334, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
429, 1z4wA, 0.6957, 4.19, 0.078, 448, 333, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH DANA PH8.0)
430, 1e8tB, 0.6957, 4.23, 0.087, 449, 335, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
431, 1e8uB, 0.6954, 4.30, 0.089, 449, 336, STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE
432, 4jf7D, 0.6949, 4.13, 0.078, 492, 332, STRUCTURE OF THE PARAINFLUENZA VIRUS 5 (PIV5) HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN
433, 4jf7A, 0.6932, 4.23, 0.084, 501, 334, STRUCTURE OF THE PARAINFLUENZA VIRUS 5 (PIV5) HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN
434, 5b2dA, 0.6927, 4.25, 0.075, 450, 333, CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE BOUND TO 3-SIALYLLACTOSE
435, 1v3bA, 0.6925, 4.18, 0.114, 431, 333, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III
436, 5b2dB, 0.6923, 4.26, 0.072, 450, 333, CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE BOUND TO 3-SIALYLLACTOSE
437, 5b2cA, 0.6921, 4.31, 0.075, 450, 334, CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE
438, 5b2cB, 0.6919, 4.27, 0.072, 450, 333, CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE
439, 4wefA, 0.6915, 4.19, 0.108, 431, 333, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH DIFLUOROSIALIC ACID
440, 4mzeB, 0.6914, 4.18, 0.117, 432, 333, CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE H552Q/Q559R MUTANT
441, 1v2iB, 0.6913, 4.11, 0.120, 431, 332, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III
442, 3t1eB, 0.6912, 4.13, 0.088, 445, 330, THE STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN REVEALS A 4-HELIX BUNDLE STALK
443, 1v3eA, 0.6910, 4.20, 0.114, 431, 333, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH ZANAMAVIR
444, 1v3cA, 0.6910, 4.19, 0.111, 431, 333, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC
445, 4wefB, 0.6904, 4.22, 0.114, 431, 333, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH DIFLUOROSIALIC ACID
446, 3t1eA, 0.6904, 4.17, 0.088, 447, 330, THE STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN REVEALS A 4-HELIX BUNDLE STALK
447, 4mzeA, 0.6903, 4.16, 0.108, 432, 332, CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE H552Q/Q559R MUTANT
448, 1v3bB, 0.6902, 4.22, 0.108, 431, 333, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III
449, 1v3dA, 0.6900, 4.21, 0.108, 431, 333, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC2EN
450, 1v3cB, 0.6897, 4.22, 0.108, 431, 333, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC
451, 6c0mB, 0.6894, 4.25, 0.111, 428, 334, THE SYNTHESIS; BIOLOGICAL EVALUATION AND STRUCTURAL INSIGHTS OF UNSATURATED 3-N-SUBSTITUTED SIALIC ACIDS AS PROBES OF HUMAN PARAINFLUENZA VIRUS-3 HAEMAGGLUTININ-NEURAMINIDASE 
452, 5kv8B, 0.6894, 4.29, 0.105, 424, 334, CRYSTAL STRUCTURE OF A HPIV HAEMAGGLUTININ-NEURAMINIDASE-INHIBITOR COMPLEX
453, 4xjrA, 0.6894, 4.17, 0.114, 429, 332, THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED
454, 4mzaB, 0.6893, 4.14, 0.114, 437, 332, CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE
455, 5kv8A, 0.6891, 4.24, 0.120, 430, 334, CRYSTAL STRUCTURE OF A HPIV HAEMAGGLUTININ-NEURAMINIDASE-INHIBITOR COMPLEX
456, 1v2iA, 0.6890, 4.20, 0.114, 431, 332, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III
457, 1v3dB, 0.6889, 4.29, 0.114, 431, 334, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH NEU5AC2EN
458, 4xjqB, 0.6888, 4.15, 0.111, 434, 332, THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED
459, 6c0mA, 0.6886, 4.36, 0.116, 431, 336, THE SYNTHESIS; BIOLOGICAL EVALUATION AND STRUCTURAL INSIGHTS OF UNSATURATED 3-N-SUBSTITUTED SIALIC ACIDS AS PROBES OF HUMAN PARAINFLUENZA VIRUS-3 HAEMAGGLUTININ-NEURAMINIDASE 
460, 1v3eB, 0.6886, 4.24, 0.111, 431, 333, STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH ZANAMAVIR
461, 4xjqA, 0.6885, 4.21, 0.111, 432, 332, THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED
462, 5kv9B, 0.6880, 4.19, 0.105, 430, 332, CRYSTAL STRUCTURE OF A HPIV HAEMAGGLUTININ-NEURAMINIDASE-INHIBITOR COMPLEX
463, 4mzaA, 0.6877, 4.22, 0.111, 432, 332, CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE
464, 4xjrB, 0.6872, 4.30, 0.114, 426, 334, THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED
465, 1z4vA, 0.6871, 4.19, 0.079, 444, 329, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH DANA PH 7.0)
466, 5nopA, 0.6849, 4.50, 0.056, 423, 337, STRUCTURE OF MOJIANG VIRUS ATTACHMENT GLYCOPROTEIN
467, 3d11A, 0.6846, 4.25, 0.051, 427, 334, CRYSTAL STRUCTURES OF THE NIPAH G ATTACHMENT GLYCOPROTEIN
468, 1z4yA, 0.6842, 4.31, 0.079, 443, 330, PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) (PH 8.0)
469, 5nopB, 0.6828, 4.50, 0.057, 434, 336, STRUCTURE OF MOJIANG VIRUS ATTACHMENT GLYCOPROTEIN
470, 6cmiB, 0.6820, 4.38, 0.057, 428, 334, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
471, 6cmgA, 0.6813, 4.39, 0.054, 428, 334, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
472, 3d12D, 0.6802, 4.46, 0.054, 428, 335, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
473, 3d12A, 0.6800, 4.46, 0.051, 428, 335, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
474, 4uf7A, 0.6796, 4.07, 0.088, 417, 328, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
475, 4uf7B, 0.6779, 4.09, 0.091, 412, 328, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
476, 2vwdA, 0.6721, 4.05, 0.056, 413, 324, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN
477, 2x9mA, 0.6688, 4.33, 0.052, 419, 328, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN
478, 2x9mB, 0.6671, 4.32, 0.052, 418, 327, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN
479, 2vsmA, 0.6663, 4.31, 0.052, 413, 326, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
480, 2x9mC, 0.6643, 4.38, 0.049, 417, 327, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN
481, 2x9mD, 0.6639, 4.42, 0.046, 417, 328, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN
482, 2vwdB, 0.6635, 4.17, 0.050, 410, 322, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN
483, 2vskA, 0.6592, 4.25, 0.050, 400, 321, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
484, 2vskC, 0.6586, 4.21, 0.050, 399, 320, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
485, 3h73B, 0.6549, 3.92, 0.106, 477, 310, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA) IN COMPLEX WITH DANA
486, 3h73A, 0.6548, 3.99, 0.094, 474, 310, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA) IN COMPLEX WITH DANA
487, 3h72B, 0.6548, 3.92, 0.106, 477, 310, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA) IN COMPLEX WITH NANA
488, 4xogA, 0.6547, 4.00, 0.084, 660, 308, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AND DANA
489, 3h72A, 0.6547, 4.00, 0.100, 474, 311, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA) IN COMPLEX WITH NANA
490, 2ya7C, 0.6540, 3.81, 0.092, 470, 306, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH ZANAMIVIR
491, 4xmiA, 0.6538, 4.09, 0.087, 657, 309, CRYSTAL STRUCTURE OF THE K499G MUTANT OF NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
492, 2ya5A, 0.6531, 3.90, 0.088, 471, 307, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH SIALIC ACID
493, 2ya7A, 0.6530, 3.79, 0.085, 469, 305, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH ZANAMIVIR
494, 4xioA, 0.6528, 3.97, 0.085, 658, 307, CRYSTAL STRUCTURE OF APO NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE AT PH 8.0 WITH MPD AS THE CRYOPROTECTANT
495, 2ya4A, 0.6525, 3.86, 0.088, 470, 306, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4)
496, 2ya8A, 0.6524, 3.84, 0.092, 470, 306, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
497, 4xyxA, 0.6521, 4.11, 0.087, 660, 310, NANB PLUS OPTACTAMIDE
498, 2vw1A, 0.6521, 3.98, 0.088, 658, 307, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
499, 2ya6A, 0.6520, 3.88, 0.094, 470, 307, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH DANA
500, 2ya7D, 0.6518, 3.91, 0.094, 470, 307, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH ZANAMIVIR
501, 2vw0A, 0.6518, 4.07, 0.097, 657, 309, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
502, 4xilA, 0.6515, 3.97, 0.094, 658, 307, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AT PH 7.4 IN PBS WITH MPD AS THE CRYOPROTECTANT
503, 2ya7B, 0.6515, 3.77, 0.089, 468, 304, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH ZANAMIVIR
504, 2w20A, 0.6515, 4.05, 0.097, 470, 308, STRUCTURE OF THE CATALYTIC DOMAIN OF THE NATIVE NANA SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
505, 2w20B, 0.6514, 3.83, 0.101, 469, 306, STRUCTURE OF THE CATALYTIC DOMAIN OF THE NATIVE NANA SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
506, 5kkyB, 0.6513, 3.89, 0.091, 470, 307, STRUCTURE OF STREPTOCOCCUS PNEUMONIA NANA BOUND WITH INHIBITOR 9N3NEU5AC2EN
507, 4foqA, 0.6513, 3.98, 0.088, 658, 306, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-AMINOETHANESULFONIC ACID
508, 2vvzA, 0.6513, 4.05, 0.097, 470, 308, STRUCTURE OF THE CATALYTIC DOMAIN OF STREPTOCOCCUS PNEUMONIAE SIALIDASE NANA
509, 2sliA, 0.6510, 4.19, 0.077, 679, 311, LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 27- ANHYDRO-NEU5AC THE REACTION PRODUCT
510, 4sliA, 0.6509, 4.17, 0.074, 679, 310, LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2- PROPENYL-NEU5AC AN INACTIVE SUBSTRATE ANALOGUE
511, 5kkyA, 0.6508, 3.88, 0.094, 471, 307, STRUCTURE OF STREPTOCOCCUS PNEUMONIA NANA BOUND WITH INHIBITOR 9N3NEU5AC2EN
512, 2f29A, 0.6508, 3.94, 0.105, 370, 306, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 Q116E MUTANT IN COMPLEX WITH DANA INHIBITOR
513, 3sliA, 0.6507, 4.17, 0.074, 679, 310, LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 27- ANHYDRO-NEU5AC PREPARED BY SOAKING WITH 3 -SIALYLLACTOSE
514, 2ya5B, 0.6507, 3.88, 0.088, 470, 306, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH SIALIC ACID
515, 2vvzB, 0.6507, 3.90, 0.095, 470, 306, STRUCTURE OF THE CATALYTIC DOMAIN OF STREPTOCOCCUS PNEUMONIAE SIALIDASE NANA
516, 4x49A, 0.6505, 4.11, 0.074, 489, 310, CRYSTAL STRUCTURE OF THE INTRAMOLECULAR TRANS-SIALIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
517, 2ya8B, 0.6504, 3.90, 0.092, 470, 306, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE
518, 2f27B, 0.6504, 3.94, 0.101, 373, 306, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q-Q112E DOUBLE MUTANT IN COMPLEX WITH DANA INHIBITOR
519, 1vcuA, 0.6504, 3.88, 0.108, 370, 305, STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2 IN COMPLEX WITH THE INHIBITOR DANA
520, 1sliA, 0.6503, 4.25, 0.077, 679, 312, LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH DANA
521, 2ya6B, 0.6501, 3.93, 0.094, 470, 307, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH DANA
522, 2ya4B, 0.6501, 3.90, 0.092, 471, 306, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4)
523, 1sllA, 0.6501, 4.21, 0.077, 679, 311, SIALIDASE L FROM LEECH MACROBDELLA DECORA
524, 2f25B, 0.6490, 3.91, 0.115, 370, 305, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q MUTANT IN COMPLEX WITH DANA INHIBITOR
525, 2f29B, 0.6488, 3.92, 0.108, 370, 305, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 Q116E MUTANT IN COMPLEX WITH DANA INHIBITOR
526, 2f27A, 0.6488, 3.93, 0.115, 370, 305, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q-Q112E DOUBLE MUTANT IN COMPLEX WITH DANA INHIBITOR
527, 4x47A, 0.6487, 4.34, 0.070, 489, 315, CRYSTAL STRUCTURE OF THE INTRAMOLECULAR TRANS-SIALIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH NEU5AC2EN
528, 1vcuB, 0.6487, 3.99, 0.101, 373, 306, STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2 IN COMPLEX WITH THE INHIBITOR DANA
529, 2f25A, 0.6484, 3.95, 0.105, 373, 306, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q MUTANT IN COMPLEX WITH DANA INHIBITOR
530, 4x6kA, 0.6467, 4.36, 0.070, 485, 314, CRYSTAL STRUCTURE OF THE INTRAMOLECULAR TRANS-SIALIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH SIASTATIN B
531, 2xzkA, 0.6450, 4.13, 0.091, 385, 309, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
532, 2xzjB, 0.6446, 4.13, 0.097, 384, 308, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
533, 2xzkB, 0.6445, 4.15, 0.091, 384, 309, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
534, 4x4aA, 0.6443, 4.26, 0.071, 485, 311, CRYSTAL STRUCTURE OF THE INTRAMOLECULAR TRANS-SIALIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH 27-ANHYDRO-NEU5AC
535, 4m4vA, 0.6441, 4.15, 0.091, 385, 309, STRUCTURAL EVALUATION R171L MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
536, 2xziA, 0.6441, 4.15, 0.091, 385, 309, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
537, 4m4uA, 0.6440, 4.15, 0.087, 384, 309, STRUCTURAL EVALUATION D84A MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
538, 2xzjA, 0.6440, 4.15, 0.091, 386, 309, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
539, 4m4nA, 0.6438, 4.20, 0.087, 386, 310, STRUCTURAL EVALUATION THE Y358H MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
540, 2agsA, 0.6438, 4.28, 0.122, 634, 311, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 2-KETO-3- DEOXY-D-GLYCERO-D-GALACTO-23-DIFLUORO-NONONIC ACID (23- DIFLUORO-KDN)
541, 2fhrA, 0.6432, 4.28, 0.122, 625, 311, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 23- DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)
542, 1n1tA, 0.6432, 4.29, 0.122, 628, 311, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH DANA AT 1.6 A
543, 4m4uB, 0.6431, 4.12, 0.100, 384, 309, STRUCTURAL EVALUATION D84A MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
544, 1ms3A, 0.6430, 4.20, 0.123, 623, 310, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE
545, 1ms3B, 0.6429, 4.21, 0.119, 623, 310, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE
546, 2xziB, 0.6428, 4.18, 0.087, 384, 310, THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS
547, 4m4nB, 0.6426, 4.19, 0.090, 384, 310, STRUCTURAL EVALUATION THE Y358H MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
548, 1n1vA, 0.6426, 4.30, 0.122, 628, 311, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH DANA
549, 4m4vB, 0.6423, 4.18, 0.094, 384, 310, STRUCTURAL EVALUATION R171L MUTANT OF THE ASPERGILLUS FUMIGATUS KDNASE (SIALIDASE)
550, 1n1sA, 0.6423, 4.30, 0.119, 628, 311, TRYPANOSOMA RANGELI SIALIDASE
551, 1mz5A, 0.6423, 4.30, 0.122, 622, 311, TRYPANOSOMA RANGELI SIALIDASE
552, 1wcsA, 0.6422, 4.24, 0.123, 628, 310, A MUTANT OF TRYPANOSOMA RANGELI SIALIDASE DISPLAYING TRANS- SIALIDASE ACTIVITY
553, 1mz6A, 0.6421, 4.30, 0.122, 620, 311, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH THE INHIBITOR DANA
554, 3pjqA, 0.6419, 4.22, 0.119, 626, 310, TRYPANOSOMA CRUZI TRANS-SIALIDASE-LIKE INACTIVE ISOFORM (INCLUDING THE NATURAL MUTATION TYR342HIS) IN COMPLEX WITH LACTOSE
555, 2a75A, 0.6419, 4.23, 0.123, 632, 310, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 23- DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)
556, 1s0jA, 0.6418, 4.22, 0.119, 623, 310, TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH MUNANA (MICHAELIS COMPLEX)
557, 1s0iA, 0.6416, 4.22, 0.116, 623, 310, TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH SIALYL- LACTOSE (MICHAELIS COMPLEX)
558, 1ms1A, 0.6416, 4.23, 0.123, 622, 310, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)
559, 3opzC, 0.6415, 4.24, 0.123, 625, 310, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
560, 3opzA, 0.6415, 4.25, 0.123, 625, 310, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
561, 3b69A, 0.6415, 4.23, 0.119, 626, 310, T CRUZI TRANS-SIALIDASE COMPLEX WITH BENZOYLATED NANA DERIVATIVE
562, 3opzB, 0.6414, 4.25, 0.123, 625, 310, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
563, 1ms4A, 0.6412, 4.25, 0.123, 623, 310, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE
564, 1ms1B, 0.6412, 4.24, 0.123, 622, 310, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)
565, 5f9tA, 0.6411, 4.36, 0.096, 659, 312, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COVALENT COMPLEX WITH A FLUORINATED NEU5AC DERIVATIVE
566, 5f9tB, 0.6410, 4.37, 0.096, 659, 312, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COVALENT COMPLEX WITH A FLUORINATED NEU5AC DERIVATIVE
567, 4yw5A, 0.6409, 4.42, 0.096, 659, 313, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH OSELTAMIVIR CARBOXYLATE
568, 2ah2A, 0.6409, 4.24, 0.119, 624, 310, TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 23-DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)
569, 4yw2A, 0.6408, 4.36, 0.096, 659, 312, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX 6 SL
570, 1ms9A, 0.6408, 4.25, 0.123, 622, 310, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH LACTOSE
571, 1ms4B, 0.6408, 4.25, 0.123, 623, 310, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE
572, 1ms9B, 0.6406, 4.26, 0.123, 623, 310, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH LACTOSE
573, 4yw1A, 0.6405, 4.37, 0.096, 659, 312, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH NEU5AC AND NEU5AC2EN FOLLOWING SOAKING WITH 3 SL
574, 4yw3A, 0.6404, 4.44, 0.093, 659, 313, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH NEU5AC AND NEU5AC2EN FOLLOWING SOAKING WITH NEU5AC2EN
575, 4yw4A, 0.6403, 4.44, 0.093, 659, 313, STREPTOCOCCUS PNEUMONIAE SIALIDASE NANC
576, 4yw2B, 0.6403, 4.40, 0.093, 659, 312, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX 6 SL
577, 4yw5B, 0.6402, 4.44, 0.096, 659, 313, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH OSELTAMIVIR CARBOXYLATE
578, 1ms5A, 0.6402, 4.27, 0.123, 623, 310, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE SOAKED WITH N-ACETYLNEURAMINYL-A-23-THIO-GALACTOSIDE (NA-S-GAL)
579, 4yw3B, 0.6401, 4.44, 0.093, 659, 313, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH NEU5AC AND NEU5AC2EN FOLLOWING SOAKING WITH NEU5AC2EN
580, 4yw1B, 0.6401, 4.38, 0.096, 659, 312, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC COMPLEX WITH NEU5AC AND NEU5AC2EN FOLLOWING SOAKING WITH 3 SL
581, 1ms5B, 0.6401, 4.27, 0.123, 621, 310, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE SOAKED WITH N-ACETYLNEURAMINYL-A-23-THIO-GALACTOSIDE (NA-S-GAL)
582, 4yw4B, 0.6400, 4.39, 0.096, 659, 312, STREPTOCOCCUS PNEUMONIAE SIALIDASE NANC
583, 3h71B, 0.6399, 4.16, 0.100, 465, 310, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA)
584, 1ms8A, 0.6398, 4.27, 0.119, 624, 310, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)
585, 1mr5A, 0.6391, 4.18, 0.123, 621, 308, ORTHORHOMBIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE
586, 1ms8B, 0.6389, 4.29, 0.123, 623, 310, TRICLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)
587, 1ms0B, 0.6387, 4.26, 0.126, 623, 309, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)AND LACTOSE
588, 3h71A, 0.6386, 4.13, 0.100, 462, 309, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE D39 NEURAMINIDASE A PRECURSOR (NANA)
589, 1n1yA, 0.6384, 4.33, 0.119, 628, 310, TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH SIALIC ACID
590, 1eutA, 0.6383, 3.85, 0.100, 601, 300, SIALIDASE LARGE 68KD FORM COMPLEXED WITH GALACTOSE
591, 1ms0A, 0.6382, 4.29, 0.126, 623, 310, MONOCLINIC FORM OF TRYPANOSOMA CRUZI TRANS-SIALIDASE IN COMPLEX WITH 3-DEOXY-23-DEHYDRO-N-ACETYLNEURAMINIC ACID (DANA)AND LACTOSE
592, 1euuA, 0.6381, 3.85, 0.100, 601, 300, SIALIDASE OR NEURAMINIDASE LARGE 68KD FORM
593, 2berA, 0.6378, 3.84, 0.097, 601, 300, Y370G ACTIVE SITE MUTANT OF THE SIALIDASE FROM MICROMONOSPORA VIRIDIFACIENS IN COMPLEX WITH BETA-NEU5AC (SIALIC ACID).
594, 1eusA, 0.6376, 3.85, 0.100, 358, 300, SIALIDASE COMPLEXED WITH 2-DEOXY-23-DEHYDRO-N- ACETYLNEURAMINIC ACID
595, 1w8nA, 0.6375, 3.91, 0.096, 601, 301, CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS.
596, 4hizA, 0.6374, 3.86, 0.086, 658, 302, PHAGE PHI92 ENDOSIALIDASE
597, 1wcqA, 0.6374, 3.90, 0.103, 601, 300, MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE.
598, 1eurA, 0.6374, 3.85, 0.100, 361, 300, SIALIDASE
599, 4hizC, 0.6373, 3.86, 0.083, 655, 302, PHAGE PHI92 ENDOSIALIDASE
600, 4hizB, 0.6367, 3.85, 0.086, 652, 301, PHAGE PHI92 ENDOSIALIDASE
601, 1wcqB, 0.6365, 3.83, 0.104, 601, 299, MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE.
602, 1wcqC, 0.6364, 3.73, 0.104, 599, 297, MUTAGENESIS OF THE NUCLEOPHILIC TYROSINE IN A BACTERIAL SIALIDASE TO PHENYLALANINE.
603, 1w8oA, 0.6364, 3.94, 0.096, 601, 301, CONTRIBUTION OF THE ACTIVE SITE ASPARTIC ACID TO CATALYSIS IN THE BACTERIAL NEURAMINIDASE FROM MICROMONOSPORA VIRIDIFACIENS
604, 2bzdC, 0.6361, 3.82, 0.097, 600, 299, GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE.
605, 2bzdB, 0.6359, 3.86, 0.104, 601, 299, GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE.
606, 2bzdA, 0.6352, 3.91, 0.097, 601, 300, GALACTOSE RECOGNITION BY THE CARBOHYDRATE-BINDING MODULE OF A BACTERIAL SIALIDASE.
607, 2f12A, 0.6351, 3.95, 0.110, 359, 299, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH 3- HYDROXYPROPYL ETHER MIMETIC INHIBITOR
608, 2f10A, 0.6347, 3.95, 0.110, 349, 299, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH PERAMIVIR INHIBITOR
609, 4ncsA, 0.6346, 3.89, 0.107, 350, 298, HUMAN SIALIDASE 2 IN COMPLEX WITH 23-DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)
610, 2f13A, 0.6341, 3.90, 0.111, 351, 298, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH 2 3 - DIHYDROXYPROPYL ETHER MIMETIC INHIBITOR
611, 4nc5A, 0.6340, 3.93, 0.114, 354, 298, HUMAN SIALIDASE 2 IN COMPLEX WITH 23-DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)
612, 4j9tA, 0.6332, 3.79, 0.094, 355, 297, CRYSTAL STRUCTURE OF A PUTATIVE DE NOVO DESIGNED UNNATURAL AMINO ACID DEPENDENT METALLOPROTEIN NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR61
613, 3h6jA, 0.6332, 3.92, 0.083, 438, 301, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE FROM PSEUDOMONAS AERUGINOSA
614, 2w38A, 0.6332, 3.81, 0.087, 432, 299, CRYSTAL STRUCTURE OF THE PSEUDAMINIDASE FROM PSEUDOMONAS AERUGINOSA
615, 2f0zA, 0.6329, 3.93, 0.111, 356, 297, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH ZANAMIVIR INHIBITOR
616, 6ekuA, 0.6327, 4.10, 0.103, 755, 301, VIBRIO CHOLERAE NEURAMINIDASE COMPLEXED WITH ZANAMIVIR
617, 2xcyA, 0.6324, 4.23, 0.094, 381, 307, CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS SIALIDASE
618, 2f11A, 0.6324, 3.97, 0.111, 347, 298, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH ISOBUTYL ETHER MIMETIC INHIBITOR
619, 2xcyB, 0.6319, 4.29, 0.097, 379, 308, CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS SIALIDASE
620, 1v0fA, 0.6313, 3.82, 0.074, 666, 299, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
621, 2simA, 0.6312, 4.12, 0.105, 381, 305, THE STRUCTURES OF SALMONELLA TYPHIMURIUM LT2 NEURAMINIDASE AND ITS COMPLEX WITH A TRANSITION STATE ANALOGUE AT 1.6 ANGSTROMS RESOLUTION
622, 1dilA, 0.6312, 4.12, 0.105, 381, 305, SIALIDASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH APANA AND EPANA INHIBITORS
623, 1v0fE, 0.6310, 3.82, 0.074, 666, 299, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
624, 1dimA, 0.6309, 4.13, 0.105, 381, 305, SIALIDASE FROM SALMONELLA TYPHIMURIUM COMPLEXED WITH EPANA INHIBITOR
625, 2silA, 0.6308, 4.13, 0.105, 381, 305, THE STRUCTURES OF SALMONELLA TYPHIMURIUM LT2 NEURAMINIDASE AND ITS COMPLEX WITH A TRANSITION STATE ANALOGUE AT 1.6 ANGSTROMS RESOLUTION
626, 1v0fD, 0.6308, 3.96, 0.066, 666, 302, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
627, 3gvlA, 0.6307, 3.84, 0.067, 670, 300, CRYSTAL STRUCTURE OF ENDO-NEURAMINIDASENF
628, 3gvjA, 0.6306, 3.86, 0.077, 670, 300, CRYSTAL STRUCTURE OF AN ENDO-NEURAMINIDASENF MUTANT
629, 1v0eD, 0.6306, 3.99, 0.059, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F
630, 3gvkC, 0.6305, 3.83, 0.074, 666, 299, CRYSTAL STRUCTURE OF ENDO-NEURAMINIDASE NF MUTANT
631, 1v0eE, 0.6304, 3.83, 0.074, 666, 299, ENDOSIALIDASE OF BACTERIOPHAGE K1F
632, 3ju4A, 0.6303, 4.00, 0.073, 670, 302, CRYSTAL STRUCTURE ANALYSIS OF ENDOSIALIDASENF AT 0.98 A RESOLUTION
633, 1v0eC, 0.6302, 3.84, 0.074, 666, 299, ENDOSIALIDASE OF BACTERIOPHAGE K1F
634, 1v0eF, 0.6301, 4.04, 0.059, 666, 304, ENDOSIALIDASE OF BACTERIOPHAGE K1F
635, 3gvkB, 0.6299, 4.01, 0.059, 666, 303, CRYSTAL STRUCTURE OF ENDO-NEURAMINIDASE NF MUTANT
636, 1v0eA, 0.6298, 4.01, 0.069, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F
637, 2f24A, 0.6297, 4.01, 0.107, 359, 299, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q MUTANT
638, 1v0fB, 0.6296, 4.01, 0.063, 666, 303, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
639, 1v0fF, 0.6293, 4.06, 0.059, 666, 304, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
640, 1v0fC, 0.6292, 4.06, 0.059, 666, 304, ENDOSIALIDASE OF BACTERIOPHAGE K1F IN COMPLEX WITH OLIGOMERIC ALPHA-28-SIALIC ACID
641, 1v0eB, 0.6291, 3.88, 0.063, 666, 300, ENDOSIALIDASE OF BACTERIOPHAGE K1F
642, 3gvkA, 0.6290, 3.88, 0.067, 644, 300, CRYSTAL STRUCTURE OF ENDO-NEURAMINIDASE NF MUTANT
643, 1sntA, 0.6277, 4.05, 0.100, 352, 299, STRUCTURE OF THE HUMAN CYTOSOLIC SIALIDASE NEU2
644, 3silA, 0.6274, 4.05, 0.106, 378, 302, SIALIDASE FROM SALMONELLA TYPHIMURIUM
645, 1so7A, 0.6270, 4.00, 0.101, 361, 298, MALTOSE-INDUCED STRUCTURE OF THE HUMAN CYTOLSOLIC SIALIDASE NEU2
646, 2f26A, 0.6234, 4.08, 0.104, 362, 299, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q-Q112E DOUBLE MUTANT
647, 4q6kA, 0.6227, 4.17, 0.094, 507, 299, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE (BACCAC_01090) FROM BACTEROIDES CACCAE ATCC 43185 AT 1.90 A RESOLUTION (PSI COMMUNITY TARGET)
648, 2f28A, 0.6224, 3.97, 0.108, 358, 296, CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 Q116E MUTANT
649, 4q6kC, 0.6220, 4.18, 0.094, 506, 299, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE (BACCAC_01090) FROM BACTEROIDES CACCAE ATCC 43185 AT 1.90 A RESOLUTION (PSI COMMUNITY TARGET)
650, 5hx0B, 0.6219, 4.25, 0.108, 359, 305, CRYSTAL STRUCTURE OF UNKNOWN FUNCTION PROTEIN DFER_1899 FROMDYADOBACTER FERMENTANS DSM 18053
651, 4q6kD, 0.6219, 4.14, 0.094, 506, 298, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE (BACCAC_01090) FROM BACTEROIDES CACCAE ATCC 43185 AT 1.90 A RESOLUTION (PSI COMMUNITY TARGET)
652, 4q6kB, 0.6214, 4.16, 0.097, 507, 298, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE (BACCAC_01090) FROM BACTEROIDES CACCAE ATCC 43185 AT 1.90 A RESOLUTION (PSI COMMUNITY TARGET)
653, 5hx0A, 0.6210, 4.34, 0.107, 360, 307, CRYSTAL STRUCTURE OF UNKNOWN FUNCTION PROTEIN DFER_1899 FROMDYADOBACTER FERMENTANS DSM 18053
654, 4fj6A, 0.6202, 4.14, 0.087, 502, 298, CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 33 CANDIDATE SIALIDASE (BDI_2946) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 1.90 A RESOLUTION
655, 4fj6B, 0.6201, 4.19, 0.087, 503, 299, CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 33 CANDIDATE SIALIDASE (BDI_2946) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 1.90 A RESOLUTION
656, 4fj6C, 0.6192, 4.20, 0.087, 502, 299, CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 33 CANDIDATE SIALIDASE (BDI_2946) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 1.90 A RESOLUTION
657, 4fj6D, 0.6191, 4.29, 0.096, 504, 301, CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 33 CANDIDATE SIALIDASE (BDI_2946) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 1.90 A RESOLUTION
658, 4bbwA, 0.6170, 4.14, 0.108, 502, 296, THE CRYSTAL STRUCTURE OF SIALIDASE VPI 5482 (BTSA) FROM BACTEROIDES THETAIOTAOMICRON
659, 4amfA, 0.6122, 5.24, 0.095, 581, 327, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH THE SUBSTRATE ANALOGUE APPCP
660, 4alfA, 0.6114, 5.16, 0.098, 581, 325, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH PHOSPHATE
661, 4a9vA, 0.6101, 5.02, 0.096, 581, 322, PSEUDOMONAS FLUORESCENS PHOX
662, 3zwuA, 0.6095, 4.95, 0.097, 580, 320, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH VANADATE A TRANSITION STATE ANALOGUE
663, 3zwuB, 0.6089, 5.09, 0.096, 580, 323, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH VANADATE A TRANSITION STATE ANALOGUE
664, 4amfB, 0.6086, 5.04, 0.096, 581, 322, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH THE SUBSTRATE ANALOGUE APPCP
665, 4a9xA, 0.6084, 5.05, 0.099, 581, 322, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH THE SUBSTRATE ANALOGUE APPCP
666, 4alfB, 0.6072, 5.07, 0.096, 581, 322, PSEUDOMONAS FLUORESCENS PHOX IN COMPLEX WITH PHOSPHATE
667, 2ydpB, 0.6048, 4.49, 0.073, 359, 301, STRUCTURE OF THE E242A MUTANT OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEX WITH AN IMINOSUGAR INHIBITOR
668, 2ydpC, 0.6045, 4.46, 0.067, 359, 300, STRUCTURE OF THE E242A MUTANT OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEX WITH AN IMINOSUGAR INHIBITOR
669, 2ydpA, 0.6043, 4.37, 0.064, 361, 298, STRUCTURE OF THE E242A MUTANT OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEX WITH AN IMINOSUGAR INHIBITOR
670, 5m1zA, 0.6041, 4.41, 0.067, 359, 299, STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEX WITH AN HYDROXIMOLACTONE INHIBITOR
671, 2ydtA, 0.6038, 4.51, 0.073, 359, 301, STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEXE WITH AN IMINOSUGAR INHIBITOR
672, 3a71A, 0.6034, 4.31, 0.081, 353, 296, HIGH RESOLUTION STRUCTURE OF PENICILLIUM CHRYSOGENUM ALPHA-L- ARABINANASE
673, 3a72A, 0.6032, 4.34, 0.078, 353, 296, HIGH RESOLUTION STRUCTURE OF PENICILLIUM CHRYSOGENUM ALPHA-L- ARABINANASE COMPLEXED WITH ARABINOBIOSE
674, 2w5nA, 0.6029, 4.42, 0.054, 365, 299, NATIVE STRUCTURE OF THE GH93 ALPHA-L-ARABINOFURANOSIDASE OF FUSARIUM GRAMINEARUM
675, 4irzA, 0.5950, 4.88, 0.080, 592, 311, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
676, 2w5oA, 0.5949, 4.42, 0.078, 354, 295, COMPLEX STRUCTURE OF THE GH93 ALPHA-L-ARABINOFURANOSIDASE OF FUSARIUM GRAMINEARUM WITH ARABINOBIOSE
677, 2zb6A, 0.5944, 5.05, 0.058, 427, 313, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ (OLIGO-SUGAR TYPE)
678, 3v4vA, 0.5937, 4.91, 0.080, 582, 311, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
679, 3v4pA, 0.5934, 4.91, 0.080, 582, 311, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
680, 3v4vC, 0.5933, 4.91, 0.080, 580, 311, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
681, 3v4pC, 0.5933, 4.90, 0.080, 581, 311, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
682, 5yylA, 0.5922, 4.72, 0.046, 405, 303, STRUCTURE OF MAJOR ROYAL JELLY PROTEIN 1 OLIGOMER 
683, 5mvhA, 0.5906, 4.82, 0.069, 397, 306, GLYCOSIDE HYDROLASE BACCELL_00856
684, 3alxC, 0.5901, 5.12, 0.074, 514, 312, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (MV-H(L482R)-SLAM(N102H/R108Y) FUSION)
685, 5mumA, 0.5895, 4.80, 0.069, 394, 304, GLYCOSIDE HYDROLASE BACINT_00347
686, 2zb5A, 0.5886, 5.00, 0.055, 424, 309, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ (COMPLEX-SUGAR- TYPE)
687, 3alxB, 0.5879, 5.25, 0.064, 526, 314, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (MV-H(L482R)-SLAM(N102H/R108Y) FUSION)
688, 4irtA, 0.5870, 4.86, 0.062, 387, 304, CRYSTAL STRUCTURE OF A PUTATIVE NEURAMINIDASE (BACOVA_03493) FROM BACTEROIDES OVATUS ATCC 8483 AT 1.74 A RESOLUTION
689, 5a11A, 0.5863, 4.71, 0.063, 345, 301, THE CRYSTAL STRUCTURE OF TA-TFP A THIOCYANATE-FORMING PROTEIN INVOLVED IN GLUCOSINOLATE BREAKDOWN (SPACE GROUP P21)
690, 5hrmD, 0.5858, 4.83, 0.056, 495, 306, CRYSTAL STRUCTURE OF PHOSPHOTRIESTERASE FROM SPHINGOBIUM SP. TCM1
691, 5hrmB, 0.5857, 4.93, 0.055, 495, 307, CRYSTAL STRUCTURE OF PHOSPHOTRIESTERASE FROM SPHINGOBIUM SP. TCM1
692, 3alxA, 0.5854, 5.00, 0.059, 515, 306, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (MV-H(L482R)-SLAM(N102H/R108Y) FUSION)
693, 5hrmC, 0.5853, 4.93, 0.059, 494, 307, CRYSTAL STRUCTURE OF PHOSPHOTRIESTERASE FROM SPHINGOBIUM SP. TCM1
694, 4gjtA, 0.5853, 5.04, 0.055, 411, 308, COMPLEX STRUCTURE OF NECTIN-4 BOUND TO MV-H
695, 5iojB, 0.5849, 4.94, 0.055, 495, 307, CRYSTAL STRUCTURE OF THE SPHINGOBIUM SP. TCM1 PHOSPHOTRIESTERASE WITHOUT THE BINUCLEAR MANGANESE CENTER
696, 5a11B, 0.5849, 4.60, 0.057, 345, 299, THE CRYSTAL STRUCTURE OF TA-TFP A THIOCYANATE-FORMING PROTEIN INVOLVED IN GLUCOSINOLATE BREAKDOWN (SPACE GROUP P21)
697, 3q6kA, 0.5849, 4.62, 0.084, 380, 299, SALIVARY PROTEIN FROM LUTZOMYIA LONGIPALPIS
698, 5hrmA, 0.5847, 4.91, 0.055, 494, 307, CRYSTAL STRUCTURE OF PHOSPHOTRIESTERASE FROM SPHINGOBIUM SP. TCM1
699, 3alwA, 0.5847, 5.04, 0.062, 510, 307, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (FORM I MV-H-SLAM(N102H/R108Y) FUSION)
700, 3q6kB, 0.5845, 4.65, 0.087, 381, 299, SALIVARY PROTEIN FROM LUTZOMYIA LONGIPALPIS
701, 4wjkA, 0.5842, 5.29, 0.083, 452, 314, METAL ION AND LIGAND BINDING OF INTEGRIN
702, 3q6tA, 0.5841, 4.68, 0.083, 381, 300, SALIVARY PROTEIN FROM LUTZOMYIA LONGIPALPIS LIGAND FREE
703, 4wk4A, 0.5839, 5.29, 0.073, 450, 314, METAL ION AND LIGAND BINDING OF INTEGRIN
704, 4wk0A, 0.5835, 5.25, 0.070, 449, 313, METAL ION AND LIGAND BINDING OF INTEGRIN
705, 5a10A, 0.5831, 4.66, 0.054, 352, 299, THE CRYSTAL STRUCTURE OF TA-TFP A THIOCYANATE-FORMING PROTEIN INVOLVED IN GLUCOSINOLATE BREAKDOWN (SPACE GROUP C2)
706, 3alzA, 0.5831, 5.15, 0.058, 417, 309, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (FORM I)
707, 3q6tB, 0.5828, 4.69, 0.083, 381, 300, SALIVARY PROTEIN FROM LUTZOMYIA LONGIPALPIS LIGAND FREE
708, 5iojA, 0.5825, 4.87, 0.053, 494, 304, CRYSTAL STRUCTURE OF THE SPHINGOBIUM SP. TCM1 PHOSPHOTRIESTERASE WITHOUT THE BINUCLEAR MANGANESE CENTER
709, 6avrA, 0.5822, 4.85, 0.049, 924, 304, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
710, 5neuA, 0.5822, 4.76, 0.053, 590, 301, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE B.
711, 5mukA, 0.5822, 4.71, 0.056, 375, 301, GLYCOSIDE HYDROLASE BT3686
712, 5gqtA, 0.5821, 4.64, 0.054, 470, 299, CRYSTAL STRUCTURE OF A SPECIFIER PROTEIN FROM ARABIDOPSIS THALIANA
713, 4wk2A, 0.5820, 5.26, 0.077, 448, 312, METAL ION AND LIGAND BINDING OF INTEGRIN
714, 5mulA, 0.5819, 4.65, 0.054, 378, 299, GLYCOSIDE HYDROLASE BT3686 BOUND TO GLUCURONIC ACID
715, 5gq0A, 0.5819, 4.74, 0.056, 338, 301, CRYSTAL STRUCTURE OF THE EPITHIOSPECIFIER PROTEIN ESP FROM ARABIDOPSIS THALIANA
716, 6djpA, 0.5818, 4.86, 0.046, 593, 303, INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS 8B8 AND 68 
717, 3alxD, 0.5817, 5.10, 0.065, 504, 306, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (MV-H(L482R)-SLAM(N102H/R108Y) FUSION)
718, 5tihA, 0.5815, 4.04, 0.078, 326, 282, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
719, 6avqA, 0.5813, 4.87, 0.049, 927, 304, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
720, 2rkcA, 0.5813, 4.86, 0.060, 399, 302, CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ
721, 5gq0B, 0.5810, 4.78, 0.080, 330, 300, CRYSTAL STRUCTURE OF THE EPITHIOSPECIFIER PROTEIN ESP FROM ARABIDOPSIS THALIANA
722, 5ffoE, 0.5804, 4.92, 0.039, 587, 304, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
723, 2vdkA, 0.5804, 5.31, 0.058, 452, 313, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
724, 6avuA, 0.5803, 4.89, 0.049, 923, 304, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
725, 3vi3A, 0.5802, 4.90, 0.079, 601, 303, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
726, 2vdrA, 0.5802, 5.32, 0.057, 452, 314, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
727, 2vdoA, 0.5802, 5.24, 0.058, 452, 312, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
728, 3fcsA, 0.5800, 5.26, 0.058, 913, 312, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
729, 3vi4A, 0.5799, 4.99, 0.085, 601, 305, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
730, 4um9C, 0.5798, 4.89, 0.046, 589, 303, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
731, 3vi3C, 0.5798, 5.00, 0.072, 589, 306, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
732, 3nifA, 0.5797, 5.27, 0.058, 454, 312, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
733, 2vdqA, 0.5797, 5.26, 0.058, 452, 313, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
734, 2vdpA, 0.5797, 5.31, 0.057, 452, 314, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
735, 5ffoA, 0.5796, 4.88, 0.043, 589, 303, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
736, 4g1mA, 0.5796, 4.94, 0.046, 929, 304, RE-REFINEMENT OF ALPHA V BETA 3 STRUCTURE
737, 3fcuA, 0.5796, 5.34, 0.061, 457, 313, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
738, 2vdlA, 0.5796, 5.31, 0.061, 452, 313, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
739, 4z7qC, 0.5795, 5.29, 0.058, 453, 313, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
740, 3nigC, 0.5795, 5.28, 0.058, 453, 313, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
741, 2vc2A, 0.5795, 5.27, 0.058, 452, 312, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
742, 5tikB, 0.5794, 3.98, 0.072, 324, 279, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
743, 5ffgA, 0.5793, 4.93, 0.043, 591, 304, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 6 HEAD
744, 4um9A, 0.5793, 4.91, 0.043, 594, 303, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
745, 3ze2A, 0.5791, 5.26, 0.058, 454, 312, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
746, 2vdnA, 0.5791, 5.27, 0.058, 452, 312, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
747, 1tyeA, 0.5791, 5.32, 0.058, 452, 313, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
748, 3vi4C, 0.5790, 4.97, 0.066, 589, 305, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
749, 3nidA, 0.5790, 5.26, 0.058, 454, 312, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
750, 3fcsC, 0.5790, 5.30, 0.058, 903, 313, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
751, 2vdmA, 0.5790, 5.29, 0.058, 452, 313, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
752, 3nigA, 0.5789, 5.36, 0.064, 457, 314, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
753, 1jv2A, 0.5789, 4.95, 0.046, 927, 304, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3
754, 4z7oC, 0.5788, 5.25, 0.058, 453, 312, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
755, 3ze2C, 0.5788, 5.25, 0.058, 453, 311, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
756, 3ze0C, 0.5788, 5.25, 0.058, 453, 312, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
757, 3nifC, 0.5788, 5.32, 0.064, 453, 314, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
758, 3zdzC, 0.5786, 5.26, 0.058, 453, 312, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
759, 3ijeA, 0.5786, 5.38, 0.032, 938, 314, CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT
760, 3ze1C, 0.5784, 5.26, 0.058, 453, 312, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
761, 3zdxC, 0.5784, 5.26, 0.058, 453, 312, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
762, 3t3mA, 0.5783, 5.34, 0.064, 454, 313, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
763, 3fcuC, 0.5783, 5.21, 0.058, 451, 310, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
764, 3ze0A, 0.5782, 5.34, 0.064, 455, 313, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
765, 3zdxA, 0.5782, 5.27, 0.058, 457, 312, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
766, 1m1xA, 0.5782, 5.45, 0.051, 927, 316, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+
767, 5hdbC, 0.5781, 5.31, 0.058, 453, 313, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
768, 4um8C, 0.5781, 4.92, 0.043, 588, 303, CRYSTAL STRUCTURE OF ALPHA V BETA 6
769, 5tikC, 0.5780, 4.08, 0.082, 321, 281, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
770, 5hdbA, 0.5780, 5.35, 0.064, 454, 313, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
771, 3t3mC, 0.5779, 5.27, 0.058, 453, 312, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
772, 3fcuE, 0.5779, 5.40, 0.064, 452, 314, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
773, 4z7oA, 0.5778, 5.25, 0.058, 455, 312, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
774, 5yylB, 0.5777, 4.73, 0.054, 375, 296, STRUCTURE OF MAJOR ROYAL JELLY PROTEIN 1 OLIGOMER 
775, 5netA, 0.5777, 4.90, 0.046, 589, 302, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE A.
776, 5nerA, 0.5777, 4.90, 0.046, 589, 302, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A PRIME.
777, 5nemA, 0.5777, 4.90, 0.046, 589, 302, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A.
778, 4mmyA, 0.5777, 4.96, 0.046, 924, 304, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF
779, 3ze1A, 0.5777, 5.25, 0.058, 455, 312, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
780, 3zdzA, 0.5777, 5.26, 0.058, 455, 312, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
781, 1tyeC, 0.5776, 5.24, 0.045, 452, 311, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
782, 3t3pA, 0.5775, 5.22, 0.052, 454, 310, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
783, 4z7nA, 0.5774, 5.28, 0.058, 455, 312, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
784, 1l5gA, 0.5773, 4.97, 0.049, 927, 304, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGAND
785, 4um8A, 0.5772, 4.95, 0.043, 591, 303, CRYSTAL STRUCTURE OF ALPHA V BETA 6
786, 4mmzA, 0.5772, 5.30, 0.029, 920, 312, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO AN ANTAGONISTIC TENTH DOMAIN OF FIBRONECTIN
787, 3q6pA, 0.5771, 4.78, 0.081, 374, 298, SALIVARY PROTEIN FROM LUTZOMYIA LONGIPALPIS. SELENOMETHIONINE DERIVATIVE
788, 4g1eA, 0.5770, 5.42, 0.035, 964, 314, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.
789, 3nidC, 0.5770, 5.21, 0.051, 453, 311, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
790, 4mmxA, 0.5769, 5.24, 0.039, 924, 310, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN
791, 3inbB, 0.5768, 4.92, 0.053, 403, 300, STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO THE CD46 RECEPTOR
792, 4o02A, 0.5767, 4.94, 0.050, 915, 303, ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.
793, 4z7nC, 0.5763, 5.28, 0.051, 453, 312, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
794, 3t3pC, 0.5763, 5.23, 0.051, 453, 311, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
795, 3zdyA, 0.5762, 5.33, 0.064, 454, 312, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
796, 3zdyC, 0.5759, 5.30, 0.042, 453, 311, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
797, 1u8cA, 0.5759, 5.30, 0.048, 927, 312, A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE
798, 1tyeE, 0.5757, 5.22, 0.061, 452, 311, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
799, 5e6sE, 0.5756, 5.20, 0.071, 580, 309, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
800, 4z7qA, 0.5756, 5.30, 0.054, 454, 313, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
801, 5e6uA, 0.5752, 5.26, 0.065, 583, 310, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
802, 3q6pB, 0.5752, 4.76, 0.081, 374, 297, SALIVARY PROTEIN FROM LUTZOMYIA LONGIPALPIS. SELENOMETHIONINE DERIVATIVE
803, 1ofzA, 0.5750, 4.09, 0.058, 312, 276, CRYSTAL STRUCTURE OF FUNGAL LECTIN: SIX-BLADED BETA-PROPELLER FOLD AND NOVEL FUCOSE RECOGNITION MODE FOR ALEURIA AURANTIA LECTIN
804, 1ofzB, 0.5749, 4.07, 0.055, 312, 275, CRYSTAL STRUCTURE OF FUNGAL LECTIN: SIX-BLADED BETA-PROPELLER FOLD AND NOVEL FUCOSE RECOGNITION MODE FOR ALEURIA AURANTIA LECTIN
805, 5e6sA, 0.5745, 5.28, 0.068, 578, 310, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
806, 4ftdA, 0.5745, 4.70, 0.064, 433, 297, CRYSTAL STRUCTURE OF A DUF4623 FAMILY PROTEIN (BACEGG_03550) FROM BACTEROIDES EGGERTHII DSM 20697 AT 1.91 A RESOLUTION
807, 5es4A, 0.5734, 4.93, 0.073, 1080, 302, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
808, 4a7zA, 0.5733, 5.38, 0.078, 881, 308, COMPLEX OF BIFUNCTIONAL ALDOS-2-ULOSE DEHYDRATASE WITH THE REACTION INTERMEDIATE ASCOPYRONE M
809, 4a7kA, 0.5732, 5.44, 0.074, 879, 310, BIFUNCTIONAL ALDOS-2-ULOSE DEHYDRATASE
810, 4nenA, 0.5730, 5.03, 0.072, 1063, 305, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
811, 5es4G, 0.5726, 5.25, 0.045, 883, 308, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
812, 4a7yA, 0.5725, 5.41, 0.078, 880, 309, ACTIVE SITE METAL DEPLETED ALDOS-2-ULOSE DEHYDRATASE
813, 5mqrA, 0.5723, 4.53, 0.066, 1046, 286, SIALIDASE BT_1020
814, 5es4C, 0.5723, 4.98, 0.076, 884, 303, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
815, 5tikD, 0.5715, 3.98, 0.076, 318, 275, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
816, 3k6sG, 0.5715, 5.08, 0.069, 885, 304, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
817, 4cakA, 0.5713, 5.03, 0.059, 912, 303, THREE-DIMENSIONAL RECONSTRUCTION OF INTACT HUMAN INTEGRIN ALPHAIIBBETA3 IN A PHOSPHOLIPID BILAYER NANODISC
818, 3k71E, 0.5712, 5.09, 0.069, 882, 304, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
819, 3k71C, 0.5712, 5.09, 0.069, 884, 304, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
820, 3k71A, 0.5712, 5.09, 0.069, 880, 304, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
821, 1iubA, 0.5712, 4.16, 0.043, 312, 277, FUCOSE-SPECIFIC LECTIN FROM ALEURIA AURANTIA (HG-DERIVATIVE FORM)
822, 5es4E, 0.5711, 5.25, 0.049, 884, 308, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
823, 1iucA, 0.5711, 4.19, 0.043, 312, 278, FUCOSE-SPECIFIC LECTIN FROM ALEURIA AURANTIA WITH THREE LIGANDS
824, 5ezoA, 0.5710, 4.15, 0.068, 321, 280, CRYSTAL STRUCTURE OF PFCYRPA IN COMPLEX WITH AN INVASION-INHIBITORY ANTIBODY FAB.
825, 3k72C, 0.5710, 5.09, 0.072, 882, 304, STRUCTURE OF INTEGRIN ALPHAX BETA2
826, 3k72A, 0.5710, 5.09, 0.069, 884, 304, STRUCTURE OF INTEGRIN ALPHAX BETA2
827, 3k71G, 0.5710, 5.09, 0.069, 1082, 304, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
828, 3k6sE, 0.5710, 5.09, 0.069, 884, 304, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
829, 4nehA, 0.5706, 5.04, 0.066, 1084, 304, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
830, 3k6sA, 0.5703, 5.06, 0.069, 1082, 303, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
831, 5mxcA, 0.5700, 4.16, 0.058, 313, 278, ALEURIA AURANTIA LECTIN (AAL) N224Q MUTANT IN COMPLEX WITH ALPHA- METHYL-L-FUCOSIDE
832, 3k6sC, 0.5699, 5.07, 0.069, 885, 303, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
833, 6byxB, 0.5694, 4.84, 0.065, 481, 293, COMPLEX STRUCTURE OF LOR107 MUTANT (R259N) WITH TETRASACCHARIDE SUBSTRATE
834, 6byxA, 0.5683, 4.92, 0.061, 481, 294, COMPLEX STRUCTURE OF LOR107 MUTANT (R259N) WITH TETRASACCHARIDE SUBSTRATE
835, 6bypA, 0.5682, 4.93, 0.061, 481, 294, STRUCTURE OF PL24 FAMILY POLYSACCHARIDE LYASE-LOR107
836, 3fw0A, 0.5681, 4.31, 0.056, 329, 284, STRUCTURE OF PEPTIDYL-ALPHA-HYDROXYGLYCINE ALPHA-AMIDATING LYASE (PAL) BOUND TO ALPHA-HYDROXYHIPPURIC ACID (NON- PEPTIDIC SUBSTRATE)
837, 6bypB, 0.5679, 4.87, 0.065, 482, 293, STRUCTURE OF PL24 FAMILY POLYSACCHARIDE LYASE-LOR107
838, 3fvzA, 0.5678, 4.32, 0.060, 329, 284, STRUCTURE OF PEPTIDYL-ALPHA-HYDROXYGLYCINE ALPHA-AMIDATING LYASE (PAL)
839, 5tikA, 0.5677, 4.04, 0.080, 310, 275, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
840, 5e6rA, 0.5676, 5.04, 0.066, 581, 301, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
841, 3inbA, 0.5671, 4.95, 0.051, 389, 295, STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO THE CD46 RECEPTOR
842, 4c1yB, 0.5670, 4.44, 0.074, 314, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH B-METHYLFUCOSIDE
843, 2pooA, 0.5667, 4.59, 0.060, 353, 283, THERMOSTABLE PHYTASE IN FULLY CALCIUM LOADED STATE
844, 5e6sC, 0.5665, 5.11, 0.070, 578, 302, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
845, 1pooA, 0.5665, 4.63, 0.056, 353, 284, THERMOSTABLE PHYTASE FROM BACILLUS SP
846, 3amrA, 0.5662, 4.59, 0.067, 352, 283, CRYSTAL STRUCTURES OF BACILLUS SUBTILIS ALKALINE PHYTASE IN COMPLEX WITH CA2+ CO2+ NI2+ MG2+ AND MYO-INOSITOL HEXASULFATE
847, 1cvmA, 0.5662, 4.62, 0.060, 353, 284, CADMIUM INHIBITED CRYSTAL STRUCTURE OF PHYTASE FROM BACILLUS AMYLOLIQUEFACIENS
848, 1qlgA, 0.5661, 4.62, 0.060, 353, 284, CRYSTAL STRUCTURE OF PHYTASE WITH MAGNESIUM FROM BACILLUS AMYLOLIQUEFACIENS
849, 6bytA, 0.5657, 4.93, 0.061, 480, 293, COMPLEX STRUCTURE OF LOR107 MUTANT (R320) WITH TETRASACCHARIDE SUBSTRATE
850, 4agtA, 0.5656, 4.46, 0.074, 314, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH FUC1-6GLCNAC.
851, 6bytB, 0.5654, 4.95, 0.068, 482, 294, COMPLEX STRUCTURE OF LOR107 MUTANT (R320) WITH TETRASACCHARIDE SUBSTRATE
852, 4uouA, 0.5654, 4.46, 0.077, 313, 285, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) - APO-FORM
853, 4agtB, 0.5654, 4.52, 0.070, 314, 286, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH FUC1-6GLCNAC.
854, 1h6lA, 0.5654, 4.57, 0.060, 353, 283, BETA-PROPELLER PHYTASE IN COMPLEX WITH PHOSPHATE AND CALCIUM IONS
855, 4c1yD, 0.5653, 4.45, 0.074, 314, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH B-METHYLFUCOSIDE
856, 4d52B, 0.5652, 4.42, 0.070, 313, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH L-GALACTOPYRANOSE.
857, 4d52A, 0.5652, 4.48, 0.074, 314, 285, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH L-GALACTOPYRANOSE.
858, 4ah4A, 0.5652, 4.47, 0.067, 313, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.
859, 4uouC, 0.5649, 4.44, 0.063, 313, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) - APO-FORM
860, 4d4uA, 0.5646, 4.52, 0.067, 313, 285, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH LEWISY TETRASACCHARIDE.
861, 3amsA, 0.5646, 4.61, 0.070, 352, 284, CRYSTAL STRUCTURES OF BACILLUS SUBTILIS ALKALINE PHYTASE IN COMPLEX WITH CA2+ CD2+ CO2+ NI2+ MG2+ AND MYO-INOSITOL HEXASULFATE
862, 4agiD, 0.5643, 4.47, 0.070, 312, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH SELENO FUCOSIDE.
863, 4agiA, 0.5643, 4.48, 0.060, 312, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH SELENO FUCOSIDE.
864, 4agiB, 0.5642, 4.48, 0.063, 312, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH SELENO FUCOSIDE.
865, 4uouD, 0.5641, 4.40, 0.067, 313, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) - APO-FORM
866, 4ahaA, 0.5640, 4.46, 0.070, 314, 284, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH FUCOSYLATED MONOSACCHARIDES (FUC1-2GAL FUC1-3GLCNAC FUC1-4GLCNAC AND FUC1-6GLCNAC)
867, 4agiC, 0.5639, 4.40, 0.074, 312, 282, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH SELENO FUCOSIDE.
868, 2dsoD, 0.5639, 4.17, 0.061, 321, 277, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
869, 4uouB, 0.5638, 4.48, 0.070, 313, 286, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) - APO-FORM
870, 4ahaB, 0.5638, 4.53, 0.077, 314, 287, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH FUCOSYLATED MONOSACCHARIDES (FUC1-2GAL FUC1-3GLCNAC FUC1-4GLCNAC AND FUC1-6GLCNAC)
871, 5eo8A, 0.5636, 4.30, 0.085, 311, 281, CRYSTAL STRUCTURE OF AOL(868)
872, 4d52C, 0.5633, 4.37, 0.067, 310, 283, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH L-GALACTOPYRANOSE.
873, 4ah4B, 0.5633, 4.51, 0.066, 313, 286, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.
874, 2dsoF, 0.5633, 4.18, 0.061, 320, 277, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
875, 2dsoE, 0.5633, 4.18, 0.061, 321, 277, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
876, 4c1yC, 0.5632, 4.51, 0.077, 314, 286, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH B-METHYLFUCOSIDE
877, 2dsoB, 0.5632, 4.18, 0.061, 321, 277, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
878, 4c1yA, 0.5631, 4.50, 0.070, 313, 286, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH B-METHYLFUCOSIDE
879, 2dsoC, 0.5631, 4.18, 0.061, 323, 277, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
880, 2dg1D, 0.5631, 4.18, 0.061, 322, 277, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
881, 2dg1F, 0.5630, 4.18, 0.061, 321, 277, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
882, 2dg1C, 0.5630, 4.18, 0.061, 320, 277, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
883, 2dsoA, 0.5627, 4.20, 0.058, 322, 277, CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
884, 2dg1E, 0.5626, 4.19, 0.058, 321, 277, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
885, 2dg1B, 0.5626, 4.19, 0.061, 322, 277, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
886, 4d4uB, 0.5624, 4.53, 0.070, 313, 286, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH LEWISY TETRASACCHARIDE.
887, 5h47L, 0.5623, 4.32, 0.092, 310, 282, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
888, 2dg1A, 0.5621, 4.20, 0.058, 321, 277, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS COMPLEXED WITH CA2+
889, 5h47C, 0.5612, 4.34, 0.096, 310, 282, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
890, 5eo7B, 0.5611, 4.34, 0.092, 310, 282, CRYSTAL STRUCTURE OF AOL
891, 5h47B, 0.5610, 4.33, 0.092, 310, 282, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
892, 4d52D, 0.5610, 4.54, 0.073, 313, 286, CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH L-GALACTOPYRANOSE.
893, 5h47I, 0.5608, 4.35, 0.092, 310, 282, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
894, 5h47G, 0.5607, 4.34, 0.089, 310, 282, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
895, 5eo7A, 0.5607, 4.34, 0.092, 310, 282, CRYSTAL STRUCTURE OF AOL
896, 5h47F, 0.5606, 4.37, 0.088, 310, 283, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
897, 5h47A, 0.5606, 4.34, 0.089, 310, 282, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
898, 5h47E, 0.5604, 4.34, 0.092, 310, 282, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
899, 5eo7C, 0.5604, 4.35, 0.089, 310, 282, CRYSTAL STRUCTURE OF AOL
900, 5h47H, 0.5603, 4.32, 0.089, 310, 281, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
901, 5h47K, 0.5602, 4.34, 0.092, 310, 282, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
902, 5h47D, 0.5601, 4.35, 0.089, 310, 282, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
903, 5h47J, 0.5599, 4.29, 0.093, 310, 280, CRYSTAL STRUCTURE OF AOL COMPLEXED WITH 2-MESE-FUC
904, 2uvkB, 0.5593, 4.31, 0.065, 346, 277, STRUCTURE OF YJHT
905, 1c9uB, 0.5590, 4.80, 0.073, 452, 287, CRYSTAL STRUCTURE OF THE SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE IN COMPLEX WITH PQQ
906, 1cq1B, 0.5583, 4.81, 0.073, 446, 287, SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS IN COMPLEX WITH PQQH2 AND GLUCOSE
907, 5minB, 0.5582, 4.71, 0.060, 453, 285, APO FORM OF THE SOLUBLE PQQ-DEPENDENT GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS
908, 1cruB, 0.5582, 4.79, 0.073, 452, 287, SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS IN COMPLEX WITH PQQ AND METHYLHYDRAZINE
909, 1qbiB, 0.5578, 4.78, 0.073, 436, 287, SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS
910, 2qe8A, 0.5571, 4.10, 0.048, 333, 273, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE (AVA_4197) FROM ANABAENA VARIABILIS ATCC 29413 AT 1.35 A RESOLUTION
911, 5minA, 0.5567, 4.72, 0.060, 452, 284, APO FORM OF THE SOLUBLE PQQ-DEPENDENT GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS
912, 4fp3A, 0.5557, 4.72, 0.054, 658, 280, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(FURAN-2-YLMETHYL)AMMONIO]SULFONATE
913, 2dg0F, 0.5557, 4.20, 0.073, 316, 274, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
914, 2dg0C, 0.5557, 4.19, 0.069, 315, 274, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
915, 2dg0J, 0.5556, 4.20, 0.073, 316, 274, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
916, 1q47B, 0.5556, 5.34, 0.043, 495, 302, STRUCTURE OF THE SEMAPHORIN 3A RECEPTOR-BINDING MODULE
917, 2jkbA, 0.5555, 4.66, 0.050, 661, 279, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANB IN COMPLEX WITH 27-ANHYDRO-NEU5AC
918, 2dg0L, 0.5555, 4.20, 0.073, 316, 274, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
919, 2dg0E, 0.5555, 4.20, 0.073, 316, 274, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
920, 4fpcA, 0.5554, 4.69, 0.054, 658, 280, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(4-CHLOROBENZYL)AMMONIO]ETHANESULFONATE
921, 2dg0I, 0.5554, 4.18, 0.073, 314, 273, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
922, 2dg0H, 0.5554, 4.20, 0.073, 316, 274, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
923, 2dg0G, 0.5554, 4.20, 0.073, 315, 274, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
924, 4xhbA, 0.5553, 4.81, 0.053, 658, 282, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH PENTANEDIOL AND CHES
925, 2dg0K, 0.5553, 4.21, 0.073, 316, 274, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
926, 2dg0D, 0.5553, 4.20, 0.069, 315, 274, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
927, 1c9uA, 0.5553, 4.81, 0.081, 444, 285, CRYSTAL STRUCTURE OF THE SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE IN COMPLEX WITH PQQ
928, 2dg0B, 0.5552, 4.18, 0.073, 315, 273, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
929, 2dg0A, 0.5552, 4.21, 0.073, 317, 274, CRYSTAL STRUCTURE OF DRP35 A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS
930, 2vw2A, 0.5551, 4.77, 0.053, 658, 281, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE
931, 1cruA, 0.5551, 4.82, 0.074, 448, 285, SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS IN COMPLEX WITH PQQ AND METHYLHYDRAZINE
932, 6fptA, 0.5550, 4.33, 0.095, 391, 273, CRYSTAL STRUCTURE OF DANIO RERIO LIN41 FILAMIN-NHL DOMAINS 
933, 2qe8B, 0.5550, 4.07, 0.048, 332, 272, CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE (AVA_4197) FROM ANABAENA VARIABILIS ATCC 29413 AT 1.35 A RESOLUTION
934, 4fp2A, 0.5548, 4.66, 0.050, 658, 279, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2[(CYCLOHEXYLMETHYL)AMMONIO]SULFONATE
935, 1qbiA, 0.5546, 4.76, 0.074, 434, 283, SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS
936, 4xe9A, 0.5544, 4.82, 0.057, 658, 282, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN
937, 4xj9A, 0.5543, 4.74, 0.050, 658, 280, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AT PH 5.0 IN 50MM SODIUM ACETATE WITH DMSO AS THE CRYOPROTECTANT
938, 4fovA, 0.5542, 4.71, 0.054, 658, 280, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID
939, 1cq1A, 0.5542, 4.79, 0.070, 444, 284, SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE FROM ACINETOBACTER CALCOACETICUS IN COMPLEX WITH PQQH2 AND GLUCOSE
940, 4xhxA, 0.5540, 4.71, 0.050, 658, 280, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AND 2-[(3-CHLOROBENZYL) AMMONIO]ETHANESULFONATE
941, 4fpjA, 0.5540, 4.78, 0.057, 658, 281, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-METHOXYBENZYL)AMMONIO]ETHANESULFONATE
942, 2uvkA, 0.5540, 4.13, 0.052, 339, 270, STRUCTURE OF YJHT
943, 4foyA, 0.5539, 4.72, 0.054, 658, 280, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-(BENZYLAMMONIO)ETHANESULFONATE
944, 3dasA, 0.5539, 4.29, 0.043, 329, 277, STRUCTURE OF THE PQQ-BOUND FORM OF ALDOSE SUGAR DEHYDROGENASE (ADH) FROM STREPTOMYCES COELICOLOR
945, 4xjzA, 0.5538, 4.84, 0.053, 658, 282, CRYSTAL STRUCTURE OF APO NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE AT PH 7.4 IN PBS WITH DMSO
946, 4fpfA, 0.5538, 4.84, 0.060, 658, 282, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-CHLOROBENZYL)AMMONIO]ETHANESULFONATE
947, 4fpgA, 0.5536, 4.85, 0.060, 658, 282, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-HYDROXYBENZYL)AMMONIO]ETHANESULFONATE
948, 4fphA, 0.5535, 4.72, 0.054, 658, 280, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-FLUOROBENZYL)AMMONIO]ETHANESULFONATE
949, 6fqlA, 0.5533, 4.20, 0.093, 390, 270, CRYSTAL STRUCTURE OF DANIO RERIO LIN41 FILAMIN-NHL DOMAINS IN COMPLEX WITH MAB-10 3 UTR 13MER RNA 
950, 4fplA, 0.5533, 4.73, 0.057, 658, 280, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(34-DICHLOROBENZYL)AMMONIO]ETHANESULFONATE
951, 4xj8A, 0.5532, 4.73, 0.050, 658, 280, CRYSTAL STRUCTURE OF APO NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE AT PH 5.0 IN 50MM SODIUM ACETATE WITH DMSO
952, 4fpkA, 0.5532, 4.79, 0.057, 658, 281, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-METHYLBENZYL)AMMONIO]ETHANESULFONATE
953, 6fptB, 0.5528, 4.27, 0.100, 388, 271, CRYSTAL STRUCTURE OF DANIO RERIO LIN41 FILAMIN-NHL DOMAINS 
954, 4gz8B, 0.5527, 5.33, 0.047, 555, 301, MOUSE SEMAPHORIN 3A DOMAINS SEMA-PSI-IG
955, 4gn7A, 0.5523, 4.27, 0.073, 297, 273, MOUSE SMP30/GNL
956, 3a9hA, 0.5522, 4.58, 0.068, 338, 280, CRYSTAL STRUCTURE OF PQQ-DEPENDENT SUGAR DEHYDROGENASE HOLO-FORM
957, 6fq3A, 0.5520, 4.34, 0.092, 390, 272, CRYSTAL STRUCTURE OF DANIO RERIO LIN41 FILAMIN-NHL DOMAINS IN COMPLEX WITH LIN-29A 5 UTR 13MER RNA 
958, 4gnaA, 0.5520, 4.28, 0.073, 297, 273, MOUSE SMP30/GNL-XYLITOL COMPLEX
959, 4fpeA, 0.5517, 4.87, 0.060, 658, 282, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(4-METHOXYBENZYL)AMMONIO]ETHANESULFONATE
960, 4gn9A, 0.5516, 4.29, 0.073, 297, 273, MOUSE SMP30/GNL-GLUCOSE COMPLEX
961, 4gn8A, 0.5515, 4.26, 0.073, 297, 273, MOUSE SMP30/GNL-15-AG COMPLEX
962, 4fpyA, 0.5512, 4.79, 0.061, 658, 280, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-BROMOBENZYL)AMMONIO]ETHANESULFONATE
963, 3a9gA, 0.5511, 4.56, 0.072, 338, 279, CRYSTAL STRUCTURE OF PQQ-DEPENDENT SUGAR DEHYDROGENASE APO-FORM
964, 5d9cA, 0.5510, 4.42, 0.062, 307, 275, LUCIFERIN-REGENERATING ENZYME SOLVED BY SIRAS USING XFEL (REFINED AGAINST HG DERIVATIVE DATA)
965, 4o5tA, 0.5508, 4.40, 0.062, 319, 276, CRYSTAL STRUCTURE OF DIELS-ALDERASE CE20 IN COMPLEX WITH A PRODUCT ANALOG
966, 3g4eA, 0.5507, 4.31, 0.073, 297, 273, CRYSTAL STRUCTURE OF HUMAN SENESCENCE MARKER PROTEIN-30(SMP30)(CALCIUM BOUND)
967, 5tspA, 0.5505, 4.62, 0.076, 448, 275, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF CLOSTRIDIUM PERFRINGENS NEURAMINIDASE (NANI) IN COMPLEX WITH A CHES
968, 5d9bA, 0.5505, 4.43, 0.055, 307, 275, LUCIFERIN-REGENERATING ENZYME SOLVED BY SIRAS USING XFEL (REFINED AGAINST NATIVE DATA)
969, 4gz8A, 0.5505, 5.29, 0.043, 557, 299, MOUSE SEMAPHORIN 3A DOMAINS SEMA-PSI-IG
970, 4gnaB, 0.5505, 4.31, 0.073, 297, 273, MOUSE SMP30/GNL-XYLITOL COMPLEX
971, 2vk5A, 0.5505, 4.64, 0.069, 448, 275, THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES
972, 4gnbA, 0.5503, 4.25, 0.074, 297, 272, HUMAN SMP30/GNL
973, 2vk6A, 0.5503, 4.59, 0.069, 448, 275, THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES
974, 4o5sA, 0.5502, 4.41, 0.072, 323, 276, CRYSTAL STRUCTURE OF DIELS-ALDERASE CE11
975, 4gncA, 0.5502, 4.33, 0.070, 298, 273, HUMAN SMP30/GNL-15-AG COMPLEX
976, 4gn7B, 0.5501, 4.33, 0.073, 297, 274, MOUSE SMP30/GNL
977, 4gn9B, 0.5500, 4.34, 0.073, 297, 274, MOUSE SMP30/GNL-GLUCOSE COMPLEX
978, 2vk7A, 0.5499, 4.57, 0.066, 448, 274, THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES
979, 5xfeA, 0.5496, 4.35, 0.055, 306, 274, LUCIFERIN-REGENERATING ENZYME SOLVED BY SAD USING XFEL (REFINED AGAINST 11000 PATTERNS)
980, 2bf6A, 0.5496, 4.65, 0.072, 448, 276, ATOMIC RESOLUTION STRUCTURE OF THE BACTERIAL SIALIDASE NANI FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH ALPHA-SIALIC ACID (NEU5AC).
981, 5gx5A, 0.5495, 4.46, 0.058, 307, 275, LUCIFERIN-REGENERATING ENZYME COLLECTED WITH SERIAL SYNCHROTRON ROTATIONAL CRYSTALLOGRAPHY WITH ACCUMULATED DOSE OF 26 MGY (23RD MEASUREMENT)
982, 5gx4A, 0.5495, 4.45, 0.065, 307, 275, LUCIFERIN-REGENERATING ENZYME COLLECTED WITH SERIAL SYNCHROTRON ROTATIONAL CRYSTALLOGRAPHY WITH ACCUMULATED DOSE OF 14 MGY (12TH MEASUREMENT)
983, 5gx3A, 0.5494, 4.44, 0.062, 307, 275, LUCIFERIN-REGENERATING ENZYME COLLECTED WITH SERIAL SYNCHROTRON ROTATIONAL CRYSTALLOGRAPHY WITH ACCUMULATED DOSE OF 6.9 MGY (6TH MEASUREMENT)
984, 5gx2A, 0.5494, 4.44, 0.062, 307, 275, LUCIFERIN-REGENERATING ENZYME COLLECTED WITH SERIAL SYNCHROTRON ROTATIONAL CRYSTALLOGRAPHY WITH ACCUMULATED DOSE OF 3.4 MGY (3RD MEASUREMENT)
985, 5gx1A, 0.5494, 4.44, 0.062, 307, 275, LUCIFERIN-REGENERATING ENZYME COLLECTED WITH SERIAL SYNCHROTRON ROTATIONAL CRYSTALLOGRAPHY WITH ACCUMULATED DOSE OF 1.1 MGY (1ST MEASUREMENT)
986, 3g4hB, 0.5494, 4.34, 0.070, 297, 273, CRYSTAL STRUCTURE OF HUMAN SENESCENCE MARKER PROTEIN-30 (ZINC BOUND)
987, 4gn8B, 0.5493, 4.29, 0.070, 297, 273, MOUSE SMP30/GNL-15-AG COMPLEX
988, 5tspB, 0.5492, 4.59, 0.069, 448, 274, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF CLOSTRIDIUM PERFRINGENS NEURAMINIDASE (NANI) IN COMPLEX WITH A CHES
989, 5gtqA, 0.5492, 4.45, 0.062, 307, 275, LUCIFERIN-REGENERATING ENZYME AT CRYOGENIC TEMPERATURE
990, 4gnbB, 0.5491, 4.37, 0.070, 297, 273, HUMAN SMP30/GNL
991, 1w0oA, 0.5490, 5.05, 0.035, 753, 284, VIBRIO CHOLERAE SIALIDASE
992, 3u0sB, 0.5489, 4.33, 0.066, 327, 273, CRYSTAL STRUCTURE OF AN ENZYME REDESIGNED THROUGH MULTIPLAYER ONLINE GAMING: CE6
993, 3wpzA, 0.5488, 4.78, 0.046, 538, 281, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE MUTANT T47S/S200T/F447P/F470Y/P500S
994, 3vh0D, 0.5487, 4.62, 0.075, 322, 280, CRYSTAL STRUCTURE OF E. COLI YNCE COMPLEXED WITH DNA
995, 3vh0A, 0.5487, 4.62, 0.075, 322, 280, CRYSTAL STRUCTURE OF E. COLI YNCE COMPLEXED WITH DNA
996, 3u0sA, 0.5487, 4.32, 0.062, 327, 273, CRYSTAL STRUCTURE OF AN ENZYME REDESIGNED THROUGH MULTIPLAYER ONLINE GAMING: CE6
997, 4yz2A, 0.5486, 4.79, 0.057, 655, 280, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH 2- DEOXY-23-DIDEHYDRO-N-ACETYLNEURAMINIC ACID.
998, 4yz1A, 0.5486, 4.92, 0.057, 656, 283, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC APO STRUCTURE.
999, 4yz3A, 0.5484, 4.80, 0.054, 654, 280, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH OSELTAMIVIR.
1000, 4yz2B, 0.5484, 4.80, 0.057, 656, 280, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH 2- DEOXY-23-DIDEHYDRO-N-ACETYLNEURAMINIC ACID.
1001, 4gncB, 0.5484, 4.32, 0.066, 297, 272, HUMAN SMP30/GNL-15-AG COMPLEX
1002, 3wpzB, 0.5484, 4.72, 0.046, 538, 280, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE MUTANT T47S/S200T/F447P/F470Y/P500S
1003, 3g4eB, 0.5483, 4.33, 0.077, 297, 272, CRYSTAL STRUCTURE OF HUMAN SENESCENCE MARKER PROTEIN-30(SMP30)(CALCIUM BOUND)
1004, 1kitA, 0.5483, 4.87, 0.043, 757, 280, VIBRIO CHOLERAE NEURAMINIDASE
1005, 5d9dA, 0.5482, 4.36, 0.059, 306, 273, LUCIFERIN-REGENERATING ENZYME SOLVED BY SAD USING SYNCHROTRON RADIATION AT ROOM TEMPERATURE
1006, 4yz5A, 0.5481, 4.78, 0.050, 656, 280, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH 3- SIALYLLACTOSE
1007, 4yz4B, 0.5480, 5.00, 0.056, 656, 284, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH N- ACETYLNEURAMINIC ACID.
1008, 4yz1B, 0.5479, 4.87, 0.057, 656, 282, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC APO STRUCTURE.
1009, 4yz5B, 0.5478, 4.81, 0.054, 654, 280, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH 3- SIALYLLACTOSE
1010, 4yz3B, 0.5478, 4.76, 0.057, 656, 279, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH OSELTAMIVIR.
1011, 3g4hA, 0.5477, 4.30, 0.066, 297, 272, CRYSTAL STRUCTURE OF HUMAN SENESCENCE MARKER PROTEIN-30 (ZINC BOUND)
1012, 3wpyC, 0.5476, 4.75, 0.046, 538, 280, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE MUTANT T47S/S200T/F447V/P500S
1013, 3vh0C, 0.5476, 4.55, 0.076, 321, 278, CRYSTAL STRUCTURE OF E. COLI YNCE COMPLEXED WITH DNA
1014, 3vh0B, 0.5476, 4.55, 0.076, 321, 278, CRYSTAL STRUCTURE OF E. COLI YNCE COMPLEXED WITH DNA
1015, 2p4oA, 0.5476, 4.24, 0.086, 299, 269, CRYSTAL STRUCTURE OF A PUTATIVE LACTONASE OF THE SMP- 30/GLUCONOLACTONASE/LRE-LIKE REGION FAMILY (NPUN_F0524) FROM NOSTOC PUNCTIFORME PCC 73102 AT 1.90 A RESOLUTION
1016, 4yz4A, 0.5475, 4.76, 0.054, 655, 279, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC IN COMPLEX WITH N- ACETYLNEURAMINIC ACID.
1017, 4o5tB, 0.5471, 4.48, 0.054, 326, 276, CRYSTAL STRUCTURE OF DIELS-ALDERASE CE20 IN COMPLEX WITH A PRODUCT ANALOG
1018, 3wpvB, 0.5470, 4.77, 0.050, 538, 281, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE MUTANT T47S/F447V/F470Y/P500S
1019, 6eksA, 0.5468, 4.92, 0.032, 749, 282, VIBRIO CHOLERAE NEURAMINIDASE COMPLEXED WITH OSELTAMIVIR CARBOXYLATE
1020, 4o5sB, 0.5468, 4.35, 0.055, 312, 273, CRYSTAL STRUCTURE OF DIELS-ALDERASE CE11
1021, 3wpyA, 0.5467, 4.75, 0.046, 538, 280, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE MUTANT T47S/S200T/F447V/P500S
1022, 1w0pA, 0.5464, 4.91, 0.032, 753, 281, VIBRIO CHOLERAE SIALIDASE WITH ALPHA-26-SIALYLLACTOSE
1023, 3hlhD, 0.5461, 4.17, 0.074, 312, 269, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
1024, 2iawA, 0.5461, 4.21, 0.085, 312, 270, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE N175D MUTANT
1025, 2iapA, 0.5461, 4.22, 0.081, 312, 270, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE E21Q MUTANT
1026, 2iaoA, 0.5461, 4.23, 0.074, 312, 271, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE E37Q MUTANT
1027, 2iaqA, 0.5460, 4.22, 0.074, 312, 270, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE S271A MUTANT
1028, 2gvuA, 0.5459, 4.23, 0.070, 312, 270, CRYSTAL STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) MUTANT D229N / N120D
1029, 3vgzB, 0.5458, 4.50, 0.091, 318, 275, CRYSTAL STRUCTURE OF E. COLI YNCE
1030, 2iaxA, 0.5458, 4.18, 0.082, 312, 269, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE D232S MUTANT
1031, 2iasA, 0.5458, 4.23, 0.078, 312, 270, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244F MUTANT
1032, 3hliD, 0.5457, 4.18, 0.074, 312, 269, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
1033, 2iavA, 0.5457, 4.22, 0.085, 312, 270, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE H287A MUTANT
1034, 2gvxA, 0.5456, 4.23, 0.078, 312, 270, STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) MUTANT D229N / N175D
1035, 2iauA, 0.5455, 4.22, 0.081, 312, 270, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244Y MUTANT
1036, 3li5A, 0.5454, 4.22, 0.063, 312, 271, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) E21QN120DN175DD229N MUTANT
1037, 3li4A, 0.5454, 4.23, 0.085, 312, 270, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) N120DN175DD229N MUTANT
1038, 3hlhA, 0.5454, 4.17, 0.074, 312, 269, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
1039, 3hlhC, 0.5453, 4.23, 0.078, 312, 270, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
1040, 1e1aA, 0.5451, 4.19, 0.078, 312, 269, CRYSTAL STRUCTURE OF DFPASE FROM LOLIGO VULGARIS
1041, 3hliB, 0.5450, 4.24, 0.078, 312, 270, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
1042, 2iatA, 0.5450, 4.33, 0.059, 312, 273, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244L MUTANT
1043, 3bycA, 0.5449, 4.16, 0.067, 312, 268, JOINT NEUTRON AND X-RAY STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE. DEUTERIUM OCCUPANCIES ARE 1-Q WHERE Q IS OCCUPANCY OF H
1044, 2iarA, 0.5449, 4.19, 0.078, 312, 269, CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244H MUTANT
1045, 2gvvA, 0.5449, 4.16, 0.067, 309, 268, STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) IN COMPLEX WITH DICYCLOPENTYLPHOSPHOROAMIDATE (DCPPA)
1046, 3hliC, 0.5448, 4.21, 0.082, 312, 269, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
1047, 2gvwA, 0.5448, 4.17, 0.067, 312, 268, STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) HOLOENZYME (RT)
1048, 3hliA, 0.5447, 4.20, 0.063, 313, 270, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
1049, 3hlhB, 0.5447, 4.24, 0.074, 312, 270, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) ACTIVE SITE MUTANTS
1050, 3kggA, 0.5446, 4.23, 0.066, 313, 271, X-RAY STRUCTURE OF PERDEUTERATED DIISOPROPYL FLUOROPHOSPHATASE (DFPASE): PERDEUTERATION OF PROTEINS FOR NEUTRON DIFFRACTION
1051, 4jxmA, 0.5445, 4.71, 0.054, 330, 279, CRYSTAL STRUCTURE OF RRP9 WD40 REPEATS
1052, 3vgzC, 0.5445, 4.56, 0.083, 320, 276, CRYSTAL STRUCTURE OF E. COLI YNCE
1053, 3li3A, 0.5445, 4.34, 0.066, 313, 272, DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) D121E MUTANT
1054, 4qqsB, 0.5442, 4.83, 0.064, 313, 282, CRYSTAL STRUCTURE OF A THERMOSTABLE FAMILY-43 GLYCOSIDE HYDROLASE
1055, 3o4pA, 0.5442, 4.34, 0.070, 314, 273, DFPASE AT 0.85 ANGSTROM RESOLUTION (H ATOMS INCLUDED)
1056, 1pjxA, 0.5441, 4.34, 0.070, 314, 273, 0.85 ANGSTROM STRUCTURE OF SQUID GANGLION DFPASE
1057, 3i1cA, 0.5440, 4.24, 0.070, 314, 271, CRYSTAL STRUCTURE OF A NOVEL ENGINEERED DIELS-ALDERASE: DA_20_00_A74I
1058, 3vsrA, 0.5432, 5.12, 0.068, 493, 293, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE CATALYTIC DOMAIN
1059, 3vssA, 0.5426, 5.12, 0.068, 494, 293, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE CATALYTIC DOMAIN COMPLEXED WITH FRUCTOSE
1060, 1q7fB, 0.5426, 4.11, 0.069, 282, 262, BRAIN TUMOR NHL DOMAIN
1061, 3wpuB, 0.5424, 5.16, 0.065, 535, 293, FULL-LENGTH BETA-FRUCTOFURANOSIDASE FROM MICROBACTERIUM SACCHAROPHILUM K-1
1062, 3vgzD, 0.5422, 4.50, 0.080, 318, 274, CRYSTAL STRUCTURE OF E. COLI YNCE
1063, 3wpuA, 0.5421, 5.21, 0.071, 535, 294, FULL-LENGTH BETA-FRUCTOFURANOSIDASE FROM MICROBACTERIUM SACCHAROPHILUM K-1
1064, 5flwA, 0.5417, 4.80, 0.070, 302, 284, CRYSTAL STRUCTURE OF PUTATIVE EXO-BETA-13-GALACTANASE FROM BIFIDOBACTERIUM BIFIDUM S17
1065, 3wpyB, 0.5417, 5.20, 0.061, 538, 294, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE MUTANT T47S/S200T/F447V/P500S
1066, 1w18B, 0.5415, 5.20, 0.068, 493, 292, CRYSTAL STRUCTURE OF LEVANSUCRASE FROM GLUCONACETOBACTER DIAZOTROPHICUS
1067, 5flwB, 0.5412, 4.84, 0.067, 302, 284, CRYSTAL STRUCTURE OF PUTATIVE EXO-BETA-13-GALACTANASE FROM BIFIDOBACTERIUM BIFIDUM S17
1068, 4j0wA, 0.5411, 4.76, 0.058, 327, 277, STRUCTURE OF U3-55K
1069, 4qqsA, 0.5409, 4.83, 0.071, 312, 281, CRYSTAL STRUCTURE OF A THERMOSTABLE FAMILY-43 GLYCOSIDE HYDROLASE
1070, 1w18A, 0.5409, 5.11, 0.069, 492, 291, CRYSTAL STRUCTURE OF LEVANSUCRASE FROM GLUCONACETOBACTER DIAZOTROPHICUS
1071, 6b3xA, 0.5408, 4.51, 0.044, 327, 275, CRYSTAL STRUCTURE OF CSTF-50 IN COMPLEX WITH CSTF-77
1072, 3wpvA, 0.5402, 5.15, 0.075, 538, 293, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE MUTANT T47S/F447V/F470Y/P500S
1073, 3vgzA, 0.5398, 4.55, 0.088, 318, 274, CRYSTAL STRUCTURE OF E. COLI YNCE
1074, 4zlrB, 0.5394, 4.11, 0.073, 278, 261, STRUCTURE OF THE BRAT-NHL DOMAIN BOUND TO CONSENSUS RNA MOTIF
1075, 4zlrA, 0.5387, 4.08, 0.081, 278, 260, STRUCTURE OF THE BRAT-NHL DOMAIN BOUND TO CONSENSUS RNA MOTIF
1076, 3wpzC, 0.5385, 5.23, 0.054, 538, 294, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE MUTANT T47S/S200T/F447P/F470Y/P500S
1077, 3wpvC, 0.5381, 5.19, 0.068, 538, 292, MICROBACTERIUM SACCHAROPHILUM K-1 BETA-FRUCTOFURANOSIDASE MUTANT T47S/F447V/F470Y/P500S
1078, 1q7fA, 0.5381, 4.13, 0.073, 279, 260, BRAIN TUMOR NHL DOMAIN
1079, 4gzaG, 0.5377, 5.16, 0.042, 484, 289, COMPLEX OF MOUSE PLEXIN A2 - SEMAPHORIN 3A - NEUROPILIN-1
1080, 1q47A, 0.5377, 5.16, 0.042, 484, 289, STRUCTURE OF THE SEMAPHORIN 3A RECEPTOR-BINDING MODULE
1081, 5ex7A, 0.5371, 3.93, 0.078, 274, 256, CRYSTAL STRUCTURE OF BRAT NHL DOMAIN IN COMPLEX WITH AN 8-NT HUNCHBACK MRNA
1082, 2p9wA, 0.5365, 4.97, 0.075, 333, 279, CRYSTAL STRUCTURE OF THE MAJOR MALASSEZIA SYMPODIALIS ALLERGEN MALA S 2 1
1083, 4csdB, 0.5349, 3.93, 0.066, 267, 259, STRUCTURE OF MONOMERIC RALSTONIA SOLANACEARUM LECTIN
1084, 2g8sA, 0.5333, 4.31, 0.053, 342, 266, CRYSTAL STRUCTURE OF THE SOLUBLE ALDOSE SUGAR DEHYDROGENASE (ASD) FROM ESCHERICHIA COLI IN THE APO-FORM
1085, 6cvzA, 0.5331, 4.63, 0.048, 337, 270, CRYSTAL STRUCTURE OF THE WD40-REPEAT OF RFWD3 
1086, 2g8sB, 0.5327, 4.34, 0.056, 341, 266, CRYSTAL STRUCTURE OF THE SOLUBLE ALDOSE SUGAR DEHYDROGENASE (ASD) FROM ESCHERICHIA COLI IN THE APO-FORM
1087, 2ghsA, 0.5322, 4.36, 0.098, 289, 265, CRYSTAL STRUCTURE OF A CALCIUM-BINDING PROTEIN REGUCALCIN (AGR_C_1268) FROM AGROBACTERIUM TUMEFACIENS STR. C58 AT 1.55 A RESOLUTION
1088, 5fvmD, 0.5319, 4.59, 0.059, 299, 269, CRYO ELECTRON MICROSCOPY OF A COMPLEX OF TOR AND LST8
1089, 5fvmC, 0.5319, 4.59, 0.059, 299, 269, CRYO ELECTRON MICROSCOPY OF A COMPLEX OF TOR AND LST8
1090, 4csdA, 0.5315, 3.88, 0.066, 266, 256, STRUCTURE OF MONOMERIC RALSTONIA SOLANACEARUM LECTIN
1091, 3qz4A, 0.5314, 4.73, 0.098, 302, 275, CRYSTAL STRUCTURE OF AN ENDO-14-BETA-XYLANASE D (BT_3675) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.74 A RESOLUTION
1092, 5a9qY, 0.5313, 4.78, 0.059, 322, 273, HUMAN NUCLEAR PORE COMPLEX
1093, 5a9qP, 0.5313, 4.78, 0.059, 322, 273, HUMAN NUCLEAR PORE COMPLEX
1094, 5a9qG, 0.5313, 4.78, 0.059, 322, 273, HUMAN NUCLEAR PORE COMPLEX
1095, 5a9q7, 0.5313, 4.78, 0.059, 322, 273, HUMAN NUCLEAR PORE COMPLEX
1096, 3qz4B, 0.5310, 4.74, 0.098, 302, 275, CRYSTAL STRUCTURE OF AN ENDO-14-BETA-XYLANASE D (BT_3675) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.74 A RESOLUTION
1097, 5gvaA, 0.5309, 4.20, 0.049, 305, 263, WD40 DOMAIN OF HUMAN AND-1
1098, 4jt6D, 0.5307, 4.67, 0.055, 317, 271, STRUCTURE OF MTORDELTAN-MLST8-PI-103 COMPLEX
1099, 3j77SA, 0.5307, 4.57, 0.071, 318, 269, 
1100, 2vpjA, 0.5307, 4.23, 0.065, 289, 262, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KLHL12
1101, 4jt6C, 0.5306, 4.67, 0.055, 317, 271, STRUCTURE OF MTORDELTAN-MLST8-PI-103 COMPLEX
1102, 3srgA, 0.5306, 4.53, 0.056, 337, 268, SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION AT PH 6.5 IN COMPLEX WITH 2- HYDROXYQUINOLINE
1103, 6bcuB, 0.5304, 4.70, 0.052, 317, 271, struct.pdbx_descriptor              
1104, 6bcuG, 0.5303, 4.70, 0.052, 317, 271, struct.pdbx_descriptor              
1105, 5ndvYE, 0.5303, 4.64, 0.086, 318, 269, struct.pdbx_descriptor              
1106, 6cvzC, 0.5302, 4.65, 0.052, 334, 269, CRYSTAL STRUCTURE OF THE WD40-REPEAT OF RFWD3 
1107, 4jsxD, 0.5301, 4.68, 0.055, 317, 271, STRUCTURE OF MTORDELTAN-MLST8-TORIN2 COMPLEX
1108, 4jsxC, 0.5301, 4.68, 0.055, 317, 271, STRUCTURE OF MTORDELTAN-MLST8-TORIN2 COMPLEX
1109, 4jsnD, 0.5299, 4.68, 0.055, 317, 271, STRUCTURE OF MTORDELTAN-MLST8 COMPLEX
1110, 4jsnC, 0.5299, 4.69, 0.055, 317, 271, STRUCTURE OF MTORDELTAN-MLST8 COMPLEX
1111, 6gq1AC, 0.5297, 4.80, 0.077, 318, 271, Cryo-EM reconstruction of yeast 80S ribosome in complex with mRNA; tRNA and eEF2 (GMPPCP/sordarin)  
1112, 3u4yA, 0.5295, 4.94, 0.076, 316, 276, THE CRYSTAL STRUCTURE OF A FUNCTIONALLY UNKNOWN PROTEIN (DTOX_1751) FROM DESULFOTOMACULUM ACETOXIDANS DSM 771.
1113, 5wbuD, 0.5294, 4.70, 0.052, 317, 271, CRYSTAL STRUCTURE OF MTOR(DELTAN)-MLST8-PRAS40(ALPHA-HELIX & BETA- STRAND) COMPLEX
1114, 5wbuC, 0.5294, 4.70, 0.052, 317, 271, CRYSTAL STRUCTURE OF MTOR(DELTAN)-MLST8-PRAS40(ALPHA-HELIX & BETA- STRAND) COMPLEX
1115, 5k0yT, 0.5292, 4.86, 0.069, 329, 274, M48S LATE-STAGE INITIATION COMPLEX PURIFIED FROM RABBIT RETICULOCYTES LYSATES DISPLAYING EIF2 TERNARY COMPLEX AND EIF3 I AND G SUBUNITS RELOCATED TO THE INTERSUBUNIT FACE
1116, 4jt5C, 0.5292, 4.67, 0.059, 317, 270, MTORDELTAN-MLST8-PP242 COMPLEX
1117, 4n1iA, 0.5291, 4.75, 0.078, 312, 270, CRYSTAL STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE UMABF62A FROM USTILAGO MAIDYS
1118, 5dgeID, 0.5290, 4.59, 0.071, 318, 269, 
1119, 4jt5D, 0.5290, 4.71, 0.059, 317, 271, MTORDELTAN-MLST8-PP242 COMPLEX
1120, 3f3gF, 0.5289, 4.70, 0.052, 300, 270, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P212121
1121, 3f3gE, 0.5289, 4.70, 0.048, 300, 270, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P212121
1122, 3f3gB, 0.5289, 4.70, 0.048, 300, 270, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P212121
1123, 3f3gA, 0.5289, 4.70, 0.048, 300, 270, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P212121
1124, 6cvzB, 0.5288, 4.67, 0.041, 330, 269, CRYSTAL STRUCTURE OF THE WD40-REPEAT OF RFWD3 
1125, 4v88ID, 0.5288, 4.59, 0.090, 318, 268, 
1126, 4u4zID, 0.5287, 4.59, 0.082, 318, 268, 
1127, 2dyhA, 0.5286, 4.34, 0.068, 296, 263, CRYSTAL STRUCTURE OF THE KEAP1 PROTEIN IN COMPLEXED WITH THE N-TERMINAL REGION OF THE NRF2 TRANSCRIPTION FACTOR
1128, 5meiCF, 0.5285, 4.59, 0.082, 318, 268, 
1129, 4v5oAA, 0.5285, 4.69, 0.089, 338, 270, 
1130, 4u51ID, 0.5285, 4.60, 0.090, 318, 268, 
1131, 4jspD, 0.5285, 4.71, 0.059, 317, 271, STRUCTURE OF MTORDELTAN-MLST8-ATPGAMMAS-MG COMPLEX
1132, 4jspC, 0.5285, 4.71, 0.055, 317, 271, STRUCTURE OF MTORDELTAN-MLST8-ATPGAMMAS-MG COMPLEX
1133, 5wbyD, 0.5284, 4.69, 0.056, 317, 270, CRYSTAL STRUCTURE OF MTOR(DELTAN)-MLST8-PRAS40(BETA-STRAND) COMPLEX
1134, 5wbyC, 0.5284, 4.69, 0.056, 317, 270, CRYSTAL STRUCTURE OF MTOR(DELTAN)-MLST8-PRAS40(BETA-STRAND) COMPLEX
1135, 5lybID, 0.5284, 4.59, 0.086, 318, 268, 
1136, 4v5oJB, 0.5284, 4.75, 0.107, 338, 271, 
1137, 4u50ID, 0.5284, 4.67, 0.089, 318, 269, 
1138, 4btsVC, 0.5284, 4.66, 0.093, 338, 269, 
1139, 4btsLB, 0.5284, 4.66, 0.093, 338, 269, 
1140, 4btsFE, 0.5284, 4.66, 0.093, 338, 269, 
1141, 4btsBA, 0.5284, 4.66, 0.093, 338, 269, 
1142, 5fcjID, 0.5283, 4.62, 0.074, 318, 270, 
1143, 5obmDF, 0.5282, 4.66, 0.086, 318, 269, struct.pdbx_descriptor              
1144, 4u4qID, 0.5282, 4.60, 0.082, 318, 268, 
1145, 3f3fE, 0.5282, 4.61, 0.045, 306, 269, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21
1146, 5tgaID, 0.5281, 4.59, 0.090, 318, 268, 
1147, 4u4nID, 0.5281, 4.60, 0.090, 318, 268, 
1148, 3wdzA, 0.5281, 4.37, 0.065, 285, 262, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH PHOSPHORYLATED P62
1149, 4u4yID, 0.5280, 4.61, 0.078, 318, 268, 
1150, 3f3fF, 0.5280, 4.64, 0.045, 306, 269, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21
1151, 2i3tG, 0.5280, 4.84, 0.066, 334, 273, BUB3 COMPLEX WITH MAD3 (BUBR1) GLEBS MOTIF
1152, 5fznA, 0.5279, 4.39, 0.064, 290, 264, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1153, 5cgjA, 0.5279, 4.22, 0.069, 290, 259, CRYSTAL STRUCTURE OF MURINE KEAP1 IN COMPLEX WITH RA839 A NON- COVALENT SMALL-MOLECULE BINDER TO KEAP1 AND SELECTIVE ACTIVATOR OF NRF2 SIGNALLING.
1154, 4u55ID, 0.5279, 4.64, 0.089, 318, 269, 
1155, 3u4yB, 0.5279, 4.96, 0.069, 314, 275, THE CRYSTAL STRUCTURE OF A FUNCTIONALLY UNKNOWN PROTEIN (DTOX_1751) FROM DESULFOTOMACULUM ACETOXIDANS DSM 771.
1156, 5fciID, 0.5278, 4.61, 0.082, 318, 268, 
1157, 4u4uID, 0.5278, 4.61, 0.082, 318, 268, 
1158, 4l7bB, 0.5278, 4.42, 0.064, 292, 264, STRUCTURE OF KEAP1 KELCH DOMAIN WITH (1S2R)-2-{[(1S)-1-[(13-DIOXO-1 3-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-34-DIHYDROISOQUINOLIN-2(1H)- YL]CARBONYL}CYCLOHEXANECARBOXYLIC ACID
1159, 6bcxB, 0.5277, 4.71, 0.056, 317, 270, struct.pdbx_descriptor              
1160, 5igoD, 0.5277, 4.83, 0.062, 322, 274, WD40 DOMAIN OF ARABIDOPSIS THALIANA E3 UBIQUITIN LIGASE COP1 IN COMPLEX WITH PEPTIDE FROM TRIB1
1161, 5i4lID, 0.5277, 4.61, 0.093, 318, 268, 
1162, 5dgvID, 0.5277, 4.61, 0.086, 318, 268, 
1163, 4u56ID, 0.5277, 4.63, 0.078, 318, 270, 
1164, 4u3nID, 0.5277, 4.61, 0.090, 318, 268, 
1165, 4l7bA, 0.5277, 4.44, 0.068, 291, 264, STRUCTURE OF KEAP1 KELCH DOMAIN WITH (1S2R)-2-{[(1S)-1-[(13-DIOXO-1 3-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-34-DIHYDROISOQUINOLIN-2(1H)- YL]CARBONYL}CYCLOHEXANECARBOXYLIC ACID
1166, 4u6fID, 0.5276, 4.63, 0.078, 318, 270, 
1167, 4u4oID, 0.5276, 4.72, 0.096, 318, 270, 
1168, 5tgmID, 0.5275, 4.55, 0.090, 318, 267, 
1169, 4u52ID, 0.5275, 4.66, 0.089, 318, 269, 
1170, 5optp, 0.5274, 4.37, 0.053, 310, 262, STRUCTURE OF KSRP IN CONTEXT OF TRYPANOSOMA CRUZI 40S
1171, 5juoWA, 0.5273, 4.69, 0.070, 318, 270, 
1172, 4novA, 0.5273, 4.78, 0.070, 298, 272, XSA43E A GH43 FAMILY ENZYME FROM BUTYRIVIBRIO PROTEOCLASTICUS
1173, 4u3uID, 0.5272, 4.64, 0.074, 318, 270, 
1174, 3d5zA, 0.5272, 4.65, 0.066, 314, 271, CRYSTAL STRUCTURE ANALYSIS OF 15-ALPHA-ARABINANASE CATALYTIC MUTANT (ABNBE201A) COMPLEXED TO ARABINOTRIOSE
1175, 3cu9A, 0.5272, 4.65, 0.063, 314, 271, HIGH RESOLUTION CRYSTAL STRUCTURE OF 15-ALPHA-L-ARABINANASE FROM GEOBACILLUS STEAROTHERMOPHILUS
1176, 5on6DF, 0.5271, 4.62, 0.086, 318, 269, struct.pdbx_descriptor              
1177, 3fm0A, 0.5271, 4.83, 0.055, 328, 272, CRYSTAL STRUCTURE OF WD40 PROTEIN CIAO1
1178, 5fnqA, 0.5270, 4.38, 0.064, 290, 264, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1179, 4xmbA, 0.5270, 4.25, 0.069, 286, 259, CRYSTAL STRUCTURE OF 22 -(NAPHTHALENE-14-DIYLBIS(((4-METHOXYPHENYL) SULFONYL)AZANEDIYL))DIACETAMIDE BOUND TO HUMAN KEAP1 KELCH DOMAIN
1180, 5jusWA, 0.5269, 4.63, 0.078, 318, 269, 
1181, 3j80g, 0.5269, 4.73, 0.086, 318, 268, CRYOEM STRUCTURE OF 40S-EIF1-EIF1A PREINITIATION COMPLEX
1182, 1x2rA, 0.5269, 4.40, 0.068, 290, 264, STRUCTURAL BASIS FOR THE DEFECTS OF HUMAN LUNG CANCER SOMATIC MUTATIONS IN THE REPRESSION ACTIVITY OF KEAP1 ON NRF2
1183, 6fmqB, 0.5267, 4.39, 0.065, 285, 262, KEAP1 - PEPTIDE COMPLEX 
1184, 5a2qg, 0.5267, 4.48, 0.075, 314, 265, STRUCTURE OF THE HCV IRES BOUND TO THE HUMAN RIBOSOME
1185, 4u4rID, 0.5267, 4.64, 0.090, 318, 268, 
1186, 5tbwWD, 0.5265, 4.63, 0.086, 318, 268, struct.pdbx_descriptor              ? 
1187, 5f72C, 0.5265, 4.36, 0.065, 285, 262, DE NOVO DESIGN AND CRYSTALLOGRAPHIC VALIDATION OF ANTIBODIES TARGETING A PRE-SELECTED EPITOPE
1188, 3wn7A, 0.5265, 4.41, 0.065, 286, 263, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH THE N-TERMINAL REGION OF THE NRF2 TRANSCRIPTION FACTOR
1189, 3d61A, 0.5265, 4.67, 0.074, 314, 271, CRYSTAL STRUCTURE ANALYSIS OF 15-ALPHA-ARABINANASE CATALYTIC MUTANT (ABNBD147A) COMPLEXED TO ARABINOBIOSE
1190, 3d5yA, 0.5265, 4.67, 0.066, 314, 271, HIGH RESOLUTION CRYSTAL STRUCTURE OF 15-ALPHA-ARABINANASE CATALYTIC MUTANT (ABNBE201A)
1191, 2z32A, 0.5265, 4.22, 0.073, 290, 261, CRYSTAL STRUCTURE OF KEAP1 COMPLEXED WITH PROTHYMOSIN ALPHA
1192, 4u53ID, 0.5264, 4.62, 0.090, 318, 268, 
1193, 4bl0D, 0.5264, 4.87, 0.074, 331, 272, CRYSTAL STRUCTURE OF YEAST BUB3-BUB1 BOUND TO PHOSPHO-SPC105
1194, 3wn7L, 0.5264, 4.41, 0.065, 286, 263, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH THE N-TERMINAL REGION OF THE NRF2 TRANSCRIPTION FACTOR
1195, 3j6yAC, 0.5264, 4.71, 0.074, 318, 270, 
1196, 2i3sE, 0.5264, 4.82, 0.062, 332, 272, BUB3 COMPLEX WITH BUB1 GLEBS MOTIF
1197, 2hesX, 0.5264, 4.62, 0.060, 308, 268, CYTOSOLIC IRON-SULPHUR ASSEMBLY PROTEIN- 1
1198, 5oa3g, 0.5263, 4.49, 0.075, 314, 265, HUMAN 40S-EIF2D-RE-INITIATION COMPLEX
1199, 6fmqA, 0.5262, 4.29, 0.069, 285, 259, KEAP1 - PEPTIDE COMPLEX 
1200, 6fecOA, 0.5262, 4.64, 0.086, 313, 268, struct.pdbx_descriptor              
1201, 4in4A, 0.5262, 4.46, 0.065, 288, 263, CRYSTAL STRUCTURE OF CPD 15 BOUND TO KEAP1 KELCH DOMAIN
1202, 1yfqA, 0.5262, 4.99, 0.047, 342, 278, HIGH RESOLUTION S. CEREVISIAE BUB3 MITOTIC CHECKPOINT PROTEIN
1203, 1x2jA, 0.5262, 4.23, 0.073, 290, 261, STRUCTURAL BASIS FOR THE DEFECTS OF HUMAN LUNG CANCER SOMATIC MUTATIONS IN THE REPRESSION ACTIVITY OF KEAP1 ON NRF2
1204, 1uv4A, 0.5262, 4.35, 0.080, 291, 263, NATIVE BACILLUS SUBTILIS ARABINANASE ARB43A
1205, 5igoC, 0.5261, 4.64, 0.044, 323, 271, WD40 DOMAIN OF ARABIDOPSIS THALIANA E3 UBIQUITIN LIGASE COP1 IN COMPLEX WITH PEPTIDE FROM TRIB1
1206, 5fnsA, 0.5261, 4.40, 0.072, 289, 263, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1207, 5f72K, 0.5261, 4.36, 0.065, 285, 262, DE NOVO DESIGN AND CRYSTALLOGRAPHIC VALIDATION OF ANTIBODIES TARGETING A PRE-SELECTED EPITOPE
1208, 5dgvHA, 0.5261, 4.70, 0.086, 318, 269, 
1209, 5dc3ID, 0.5261, 4.66, 0.074, 318, 270, 
1210, 5tbwUD, 0.5260, 4.64, 0.082, 318, 268, struct.pdbx_descriptor              ? 
1211, 3f3fB, 0.5260, 4.64, 0.041, 307, 268, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21
1212, 3d60A, 0.5260, 4.69, 0.066, 314, 272, CRYSTAL STRUCTURE ANALYSIS OF 15-ALPHA-ARABINANASE CATALYTIC MUTANT (D27A)
1213, 5on6WD, 0.5259, 4.65, 0.082, 318, 269, struct.pdbx_descriptor              
1214, 5mc6P, 0.5259, 4.70, 0.071, 318, 269, 
1215, 4v6xB, 0.5259, 4.65, 0.071, 313, 268, 
1216, 4u4rHA, 0.5259, 4.64, 0.078, 318, 268, 
1217, 4u3mID, 0.5259, 4.66, 0.086, 318, 268, 
1218, 4kzzg, 0.5259, 4.65, 0.071, 313, 268, RABBIT 40S RIBOSOMAL SUBUNIT IN COMPLEX WITH MRNA INITIATOR TRNA AND EIF1A
1219, 4kzyg, 0.5259, 4.65, 0.071, 313, 268, RABBIT 40S RIBOSOMAL SUBUNIT IN COMPLEX WITH EIF1 AND EIF1A.
1220, 4kzxg, 0.5259, 4.65, 0.071, 313, 268, RABBIT 40S RIBOSOMAL SUBUNIT IN COMPLEX WITH EIF1.
1221, 3f3fA, 0.5258, 4.65, 0.045, 308, 268, CRYSTAL STRUCTURE OF THE NUCLEOPORIN PAIR NUP85-SEH1 SPACE GROUP P21
1222, 6emkB, 0.5257, 4.62, 0.052, 300, 269, CRYO-EM STRUCTURE OF SACCHAROMYCES CEREVISIAE TARGET OF RAPAMYCIN COMPLEX 2
1223, 5ndgHA, 0.5257, 4.65, 0.082, 318, 268, struct.pdbx_descriptor              
1224, 4l7dA, 0.5257, 4.25, 0.074, 286, 258, STRUCTURE OF KEAP1 KELCH DOMAIN WITH (1S2R)-2-{[(1S)-5-METHYL-1-[(1- OXO-13-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-34-DIHYDROISOQUINOLIN- 2(1H)-YL]CARBONYL}CYCLOHEXANECARBOXYLIC ACID
1225, 4ifjA, 0.5257, 4.43, 0.061, 288, 264, CRYSTAL STRUCTURES OF APO KEAP1 KEAP1-PEPTIDE AND KEAP1-COMPOUND COMPLEXES
1226, 5fntA, 0.5256, 4.39, 0.065, 289, 263, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1227, 4n1bA, 0.5256, 4.28, 0.070, 286, 258, STRUCTURE OF KEAP1 KELCH DOMAIN WITH(1S2R)-2-[(1S)-1-[(1-OXO-23- DIHYDRO-1H-ISOINDOL-2-YL)METHYL]-1234-TETRAHYDROISOQUINOLINE-2- CARBONYL]CYCLOHEXANE-1-CARBOXYLIC ACID
1228, 3janHC, 0.5256, 4.61, 0.075, 313, 267, 
1229, 3jajIC, 0.5256, 4.61, 0.075, 313, 267, 
1230, 1u6dX, 0.5256, 4.35, 0.065, 288, 262, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KEAP1
1231, 5datID, 0.5255, 4.67, 0.074, 318, 270, 
1232, 4u6fHA, 0.5255, 4.65, 0.078, 318, 268, 
1233, 4u55HA, 0.5255, 4.63, 0.082, 318, 268, 
1234, 4o8oA, 0.5255, 4.55, 0.072, 303, 265, CRYSTAL STRUCTURE OF STHARAF62A A GH62 FAMILY ALPHA-L- ARABINOFURANOSIDASE FROM STREPTOMYCES THERMOVIOLACEUS BOUND TO ALPHA-L-ARABINOSE
1235, 4d6vA, 0.5255, 4.68, 0.059, 313, 270, CRYSTAL STRUCTURE OF SIGNAL TRANSDUCING PROTEIN
1236, 2xl3A, 0.5255, 4.44, 0.065, 303, 263, WDR5 IN COMPLEX WITH AN RBBP5 PEPTIDE AND HISTONE H3 PEPTIDE
1237, 2fluX, 0.5255, 4.41, 0.065, 285, 262, CRYSTAL STRUCTURE OF THE KELCH-NEH2 COMPLEX
1238, 6fmpB, 0.5254, 4.36, 0.065, 285, 261, KEAP1 - PEPTIDE COMPLEX 
1239, 5m1jN, 0.5254, 4.73, 0.089, 318, 269, 
1240, 4v8zG, 0.5254, 4.59, 0.079, 318, 267, 
1241, 4v8yG, 0.5254, 4.59, 0.079, 318, 267, 
1242, 4iflX, 0.5254, 4.41, 0.065, 285, 262, CRYSTAL STRUCTURES OF APO KEAP1 KEAP1-PEPTIDE AND KEAP1-COMPOUND COMPLEXES
1243, 3adeA, 0.5254, 4.37, 0.069, 289, 262, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH SEQUESTOSOME- 1/P62
1244, 5fcjHA, 0.5253, 4.69, 0.082, 318, 269, 
1245, 4v88HA, 0.5253, 4.67, 0.078, 318, 270, 
1246, 4uerR, 0.5253, 4.67, 0.078, 318, 270, 40S-EIF1-EIF1A-EIF3-EIF3J TRANSLATION INITIATION COMPLEX FROM LACHANCEA KLUYVERI
1247, 4u4uHA, 0.5253, 4.58, 0.082, 318, 267, 
1248, 4iqkA, 0.5253, 4.41, 0.065, 285, 262, CRYSTAL STRUCTURE OF CPD 16 BOUND TO KEAP1 KELCH DOMAIN
1249, 4ifnX, 0.5253, 4.31, 0.069, 285, 259, CRYSTAL STRUCTURES OF APO KEAP1 KEAP1-PEPTIDE AND KEAP1-COMPOUND COMPLEXES
1250, 2i3sC, 0.5253, 4.80, 0.059, 328, 272, BUB3 COMPLEX WITH BUB1 GLEBS MOTIF
1251, 5igqA, 0.5252, 4.94, 0.058, 324, 275, WD40 DOMAIN OF HUMAN E3 UBIQUITIN LIGASE COP1 (RFWD2) BOUND TO PEPTIDE FROM TRIB1
1252, 5igoA, 0.5252, 4.88, 0.066, 321, 274, WD40 DOMAIN OF ARABIDOPSIS THALIANA E3 UBIQUITIN LIGASE COP1 IN COMPLEX WITH PEPTIDE FROM TRIB1
1253, 5dgfID, 0.5252, 4.65, 0.082, 318, 268, 
1254, 5dgfHA, 0.5252, 4.71, 0.081, 318, 271, 
1255, 4u4zHA, 0.5252, 4.58, 0.079, 318, 267, 
1256, 4n1bC, 0.5252, 4.33, 0.069, 287, 259, STRUCTURE OF KEAP1 KELCH DOMAIN WITH(1S2R)-2-[(1S)-1-[(1-OXO-23- DIHYDRO-1H-ISOINDOL-2-YL)METHYL]-1234-TETRAHYDROISOQUINOLINE-2- CARBONYL]CYCLOHEXANE-1-CARBOXYLIC ACID
1257, 3zgcA, 0.5252, 4.39, 0.069, 285, 262, CRYSTAL STRUCTURE OF THE KEAP1-NEH2 COMPLEX
1258, 5x54B, 0.5251, 4.38, 0.069, 285, 262, CRYSTAL STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A TETRAPEPTIDE
1259, 5x54A, 0.5251, 4.42, 0.065, 285, 262, CRYSTAL STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A TETRAPEPTIDE
1260, 5meiVD, 0.5251, 4.60, 0.082, 318, 267, 
1261, 5ealA, 0.5251, 4.43, 0.065, 304, 263, CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH COMPOUND 9H
1262, 4u4yHA, 0.5251, 4.69, 0.078, 318, 270, 
1263, 6faig, 0.5250, 4.60, 0.086, 317, 267, STRUCTURE OF A EUKARYOTIC CYTOPLASMIC PRE-40S RIBOSOMAL SUBUNIT
1264, 5igqC, 0.5250, 4.97, 0.054, 324, 276, WD40 DOMAIN OF HUMAN E3 UBIQUITIN LIGASE COP1 (RFWD2) BOUND TO PEPTIDE FROM TRIB1
1265, 5datHA, 0.5250, 4.70, 0.093, 318, 269, 
1266, 4xmmC, 0.5250, 4.60, 0.045, 307, 267, STRUCTURE OF THE YEAST COAT NUCLEOPORIN COMPLEX SPACE GROUP C2
1267, 4u3uHA, 0.5250, 4.60, 0.079, 318, 267, 
1268, 4u3mHA, 0.5250, 4.67, 0.078, 318, 270, 
1269, 5hqgA, 0.5249, 4.98, 0.058, 324, 276, WD40 DOMAIN OF HUMAN E3 UBIQUITIN LIGASE COP1 (RFWD2)
1270, 4bl0A, 0.5249, 4.84, 0.066, 331, 271, CRYSTAL STRUCTURE OF YEAST BUB3-BUB1 BOUND TO PHOSPHO-SPC105
1271, 3zgdB, 0.5249, 4.44, 0.065, 285, 262, CRYSTAL STRUCTURE OF A KEAP1 MUTANT
1272, 6g5hg, 0.5248, 4.55, 0.075, 314, 266, CRYO-EM STRUCTURE OF A LATE HUMAN PRE-40S RIBOSOMAL SUBUNIT - MATURE 
1273, 6g53g, 0.5248, 4.55, 0.075, 314, 266, CRYO-EM STRUCTURE OF A LATE HUMAN PRE-40S RIBOSOMAL SUBUNIT - STATE E 
1274, 6g51g, 0.5248, 4.55, 0.075, 314, 266, CRYO-EM STRUCTURE OF A LATE HUMAN PRE-40S RIBOSOMAL SUBUNIT - STATE D 
1275, 4u52HA, 0.5248, 4.68, 0.078, 318, 270, 
1276, 3j78SA, 0.5248, 4.75, 0.077, 318, 271, 
1277, 5igqE, 0.5247, 4.92, 0.055, 324, 274, WD40 DOMAIN OF HUMAN E3 UBIQUITIN LIGASE COP1 (RFWD2) BOUND TO PEPTIDE FROM TRIB1
1278, 5igqB, 0.5247, 4.98, 0.054, 324, 276, WD40 DOMAIN OF HUMAN E3 UBIQUITIN LIGASE COP1 (RFWD2) BOUND TO PEPTIDE FROM TRIB1
1279, 5i4lHA, 0.5247, 4.59, 0.082, 318, 267, 
1280, 4l7dC, 0.5247, 4.32, 0.069, 287, 259, STRUCTURE OF KEAP1 KELCH DOMAIN WITH (1S2R)-2-{[(1S)-5-METHYL-1-[(1- OXO-13-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-34-DIHYDROISOQUINOLIN- 2(1H)-YL]CARBONYL}CYCLOHEXANECARBOXYLIC ACID
1281, 3zgdA, 0.5247, 4.33, 0.069, 285, 259, CRYSTAL STRUCTURE OF A KEAP1 MUTANT
1282, 1u4cA, 0.5247, 4.92, 0.086, 319, 269, STRUCTURE OF SPINDLE CHECKPOINT PROTEIN BUB3
1283, 5tgmHA, 0.5246, 4.60, 0.086, 318, 267, 
1284, 5igqD, 0.5246, 4.98, 0.058, 324, 276, WD40 DOMAIN OF HUMAN E3 UBIQUITIN LIGASE COP1 (RFWD2) BOUND TO PEPTIDE FROM TRIB1
1285, 4zy3A, 0.5246, 4.41, 0.068, 285, 263, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH A SMALL CHEMICAL COMPOUND K67
1286, 4u51HA, 0.5246, 4.69, 0.078, 318, 270, 
1287, 4u4qHA, 0.5246, 4.68, 0.078, 318, 270, 
1288, 4in4C, 0.5246, 4.47, 0.064, 289, 264, CRYSTAL STRUCTURE OF CPD 15 BOUND TO KEAP1 KELCH DOMAIN
1289, 3wn0A, 0.5246, 4.62, 0.079, 302, 266, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR ALPHA-L- ARABINOFURANOSIDASE IN COMPLEX WITH L-ARABINOSE
1290, 1wl7A, 0.5246, 4.66, 0.067, 312, 270, STRUCTURE OF THE THERMOSTABLE ARABINANASE
1291, 6gy5A, 0.5245, 4.24, 0.096, 285, 260, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KLHL20 IN COMPLEX WITH DAPK1 PEPTIDE 
1292, 5lzwFC, 0.5245, 4.74, 0.063, 313, 270, 
1293, 5fciHA, 0.5244, 4.65, 0.090, 318, 268, 
1294, 3wmzA, 0.5244, 4.59, 0.072, 302, 265, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR ALPHA-L- ARABINOFURANOSIDASE ETHYLMERCURY DERIVATIVE
1295, 3vnhA, 0.5244, 4.38, 0.061, 288, 263, CRYSTAL STRUCTURE OF KEAP1 SOAKED WITH SYNTHETIC SMALL MOLECULAR
1296, 3jamg, 0.5244, 4.87, 0.086, 318, 269, CRYOEM STRUCTURE OF 40S-EIF1A-EIF1 COMPLEX FROM YEAST
1297, 2h9mA, 0.5244, 4.39, 0.065, 304, 262, WDR5 IN COMPLEX WITH UNMODIFIED H3K4 PEPTIDE
1298, 5fnrA, 0.5243, 4.23, 0.069, 289, 260, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1299, 5dc3HA, 0.5243, 4.79, 0.085, 318, 270, 
1300, 5a9qR, 0.5243, 4.60, 0.059, 316, 269, HUMAN NUCLEAR PORE COMPLEX
1301, 5a9qI, 0.5243, 4.60, 0.059, 316, 269, HUMAN NUCLEAR PORE COMPLEX
1302, 5a9q9, 0.5243, 4.60, 0.059, 316, 269, HUMAN NUCLEAR PORE COMPLEX
1303, 5a9q0, 0.5243, 4.60, 0.059, 316, 269, HUMAN NUCLEAR PORE COMPLEX
1304, 4u53HA, 0.5243, 4.61, 0.086, 318, 267, 
1305, 4u50HA, 0.5243, 4.67, 0.086, 318, 268, 
1306, 4o8nA, 0.5243, 4.60, 0.072, 302, 265, CRYSTAL STRUCTURE OF STHARAF62A A GH62 FAMILY ALPHA-L- ARABINOFURANOSIDASE FROM STREPTOMYCES THERMOVIOLACEUS IN THE APOPROTEIN FORM
1307, 4i79A, 0.5243, 4.56, 0.052, 316, 269, CRYSTAL STRUCTURE OF HUMAN NUP43
1308, 5obmZB, 0.5242, 4.66, 0.082, 318, 268, struct.pdbx_descriptor              
1309, 5igqF, 0.5242, 4.99, 0.058, 324, 276, WD40 DOMAIN OF HUMAN E3 UBIQUITIN LIGASE COP1 (RFWD2) BOUND TO PEPTIDE FROM TRIB1
1310, 5fzjA, 0.5242, 4.24, 0.073, 289, 260, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1311, 3vngA, 0.5242, 4.40, 0.073, 288, 262, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH SYNTHETIC SMALL MOLECULAR BASED ON A CO-CRYSTALLIZATION
1312, 2i3sA, 0.5242, 4.73, 0.063, 334, 269, BUB3 COMPLEX WITH BUB1 GLEBS MOTIF
1313, 6emkD, 0.5241, 4.68, 0.059, 300, 269, CRYO-EM STRUCTURE OF SACCHAROMYCES CEREVISIAE TARGET OF RAPAMYCIN COMPLEX 2
1314, 5lzyEC, 0.5241, 4.75, 0.063, 313, 269, 
1315, 5lzvFC, 0.5241, 4.72, 0.071, 313, 269, 
1316, 5jupWA, 0.5241, 4.67, 0.059, 318, 270, 
1317, 4l7cA, 0.5241, 4.30, 0.070, 286, 258, STRUCTURE OF KEAP1 KELCH DOMAIN WITH 2-{[(1S)-2-{[(1R2S)-2-(1H- TETRAZOL-5-YL)CYCLOHEXYL]CARBONYL}-1234-TETRAHYDROISOQUINOLIN-1- YL]METHYL}-1H-ISOINDOLE-13(2H)-DIONE
1318, 5yy8A, 0.5240, 4.29, 0.081, 272, 260, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN NS1-BP
1319, 3j6xAC, 0.5240, 4.71, 0.086, 318, 269, 
1320, 2g9aA, 0.5240, 4.46, 0.068, 310, 263, STRUCTURAL BASIS FOR THE SPECIFIC RECOGNITION OF METHYLATED HISTONE H3 LYSINE 4 BY THE WD-40 PROTEIN WDR5
1321, 1rwiA, 0.5240, 3.67, 0.056, 256, 248, EXTRACELLULAR DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKND
1322, 5dgeHA, 0.5239, 4.71, 0.078, 318, 269, 
1323, 4u4nHA, 0.5239, 4.69, 0.078, 318, 270, 
1324, 4u3nHA, 0.5239, 4.70, 0.078, 318, 270, 
1325, 3zgcB, 0.5238, 4.41, 0.065, 285, 262, CRYSTAL STRUCTURE OF THE KEAP1-NEH2 COMPLEX
1326, 6f0tB, 0.5237, 3.61, 0.061, 251, 246, CRYSTAL STRUCTURE OF PIZZA6-SFW
1327, 6f0tA, 0.5237, 3.49, 0.065, 251, 245, CRYSTAL STRUCTURE OF PIZZA6-SFW
1328, 4g56D, 0.5237, 4.32, 0.061, 302, 262, CRYSTAL STRUCTURE OF FULL LENGTH PRMT5/MEP50 COMPLEXES FROM XENOPUS LAEVIS
1329, 5ndvYB, 0.5236, 4.68, 0.086, 317, 268, struct.pdbx_descriptor              
1330, 5lzsEC, 0.5236, 4.77, 0.074, 313, 270, 
1331, 4zy3B, 0.5236, 4.29, 0.085, 285, 260, CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH A SMALL CHEMICAL COMPOUND K67
1332, 5lztFC, 0.5235, 4.77, 0.070, 313, 270, 
1333, 5k0ym, 0.5235, 4.65, 0.079, 313, 267, M48S LATE-STAGE INITIATION COMPLEX PURIFIED FROM RABBIT RETICULOCYTES LYSATES DISPLAYING EIF2 TERNARY COMPLEX AND EIF3 I AND G SUBUNITS RELOCATED TO THE INTERSUBUNIT FACE
1334, 4u4oHA, 0.5235, 4.63, 0.086, 318, 267, 
1335, 4o8pA, 0.5235, 4.58, 0.075, 303, 265, CRYSTAL STRUCTURE OF STHARAF62A A GH62 FAMILY ALPHA-L- ARABINOFURANOSIDASE FROM STREPTOMYCES THERMOVIOLACEUS BOUND TO XYLOTETRAOSE
1336, 3wwaA, 0.5235, 3.53, 0.065, 251, 245, CRYSTAL STRUCTURE OF THE COMPUTATIONALLY DESIGNED PIZZA7 PROTEIN AFTER HEAT TREATMENT
1337, 3wmyA, 0.5235, 4.54, 0.076, 302, 264, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR ALPHA-L- ARABINOFURANOSIDASE
1338, 1v04A, 0.5235, 4.41, 0.065, 332, 262, SERUM PARAOXONASE BY DIRECTED EVOLUTION
1339, 5lzzFC, 0.5234, 4.77, 0.078, 313, 270, 
1340, 5it7BC, 0.5234, 4.93, 0.085, 318, 270, 
1341, 5igoB, 0.5234, 4.67, 0.048, 321, 270, WD40 DOMAIN OF ARABIDOPSIS THALIANA E3 UBIQUITIN LIGASE COP1 IN COMPLEX WITH PEPTIDE FROM TRIB1
1342, 4in4B, 0.5234, 4.22, 0.070, 284, 257, CRYSTAL STRUCTURE OF CPD 15 BOUND TO KEAP1 KELCH DOMAIN
1343, 6fmpA, 0.5233, 4.36, 0.073, 285, 261, KEAP1 - PEPTIDE COMPLEX 
1344, 6ek0QB, 0.5233, 4.74, 0.078, 313, 268, struct.pdbx_descriptor              
1345, 5lzxFC, 0.5233, 4.59, 0.075, 313, 266, 
1346, 2h6nB, 0.5233, 4.57, 0.079, 305, 265, HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX
1347, 5fnuA, 0.5232, 4.40, 0.069, 288, 262, STRUCTURE OF THE KEAP1 KELCH DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR.
1348, 4n2rA, 0.5232, 4.62, 0.083, 306, 266, CRYSTAL STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE UMABF62A FROM USTILAGO MAYDIS IN COMPLEX WITH L-ARABINOFURANOSE
1349, 3sreA, 0.5232, 4.41, 0.061, 329, 262, SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION AT PH 6.5
1350, 5vycSE, 0.5231, 4.79, 0.070, 313, 270, 
1351, 5vycRA, 0.5231, 4.79, 0.070, 313, 270, 
1352, 5vycJD, 0.5231, 4.79, 0.070, 313, 270, 
1353, 5vycI, 0.5231, 4.79, 0.070, 313, 270, 
1354, 5vycBG, 0.5231, 4.79, 0.070, 313, 270, 
1355, 5vycAC, 0.5231, 4.79, 0.070, 313, 270, 
1356, 5t2cZB, 0.5231, 4.73, 0.071, 313, 269, 
1357, 4v6iA, 0.5231, 4.76, 0.085, 319, 270, 
1358, 4ug0RB, 0.5231, 4.79, 0.070, 313, 270, 
1359, 4l7dB, 0.5231, 4.32, 0.070, 285, 258, STRUCTURE OF KEAP1 KELCH DOMAIN WITH (1S2R)-2-{[(1S)-5-METHYL-1-[(1- OXO-13-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-34-DIHYDROISOQUINOLIN- 2(1H)-YL]CARBONYL}CYCLOHEXANECARBOXYLIC ACID
1360, 4l7cC, 0.5231, 4.38, 0.065, 286, 261, STRUCTURE OF KEAP1 KELCH DOMAIN WITH 2-{[(1S)-2-{[(1R2S)-2-(1H- TETRAZOL-5-YL)CYCLOHEXYL]CARBONYL}-1234-TETRAHYDROISOQUINOLIN-1- YL]METHYL}-1H-ISOINDOLE-13(2H)-DIONE
1361, 5it9g, 0.5230, 4.88, 0.086, 318, 269, STRUCTURE OF THE YEAST KLUYVEROMYCES LACTIS SMALL RIBOSOMAL SUBUNIT IN COMPLEX WITH THE CRICKET PARALYSIS VIRUS IRES.
1362, 3dr2A, 0.5230, 4.12, 0.070, 299, 257, STRUCTURAL AND FUNCTIONAL ANALYSES OF XC5397 FROM XANTHOMONAS CAMPESTRIS: A GLUCONOLACTONASE IMPORTANT IN GLUCOSE SECONDARY METABOLIC PATHWAYS
1363, 2h6kB, 0.5230, 4.48, 0.061, 306, 263, HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX
1364, 2h6kA, 0.5230, 4.57, 0.079, 305, 265, HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX
1365, 5tgaHA, 0.5229, 4.77, 0.081, 318, 270, 
1366, 5sxmB, 0.5229, 4.46, 0.065, 303, 263, WDR5 IN COMPLEX WITH MLL WIN MOTIF PEPTIDOMIMETIC
1367, 5nkpB, 0.5229, 4.52, 0.098, 289, 265, CRYSTAL STRUCTURE OF THE HUMAN KLHL3 KELCH DOMAIN IN COMPLEX WITH A WNK3 PEPTIDE
1368, 4xjuA, 0.5229, 4.32, 0.070, 658, 257, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 4-ACETAMIDO-2-FLUORO-3-HYDROXY-6-[12- DIHYDROXYETHYL]-78-DIOXABICYCLO[3.2.1]OCTANE-1-CARBOXYLIC ACID
1369, 4ql1A, 0.5229, 4.48, 0.065, 304, 263, CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH COMPOUND OICR-9429
1370, 3wn2A, 0.5229, 4.55, 0.080, 302, 264, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR ALPHA-L- ARABINOFURANOSIDASE IN COMPLEX WITH XYLOHEXAOSE
1371, 3jagFC, 0.5229, 4.85, 0.063, 313, 271, 
1372, 2co0A, 0.5229, 4.49, 0.061, 304, 263, WDR5 AND UNMODIFIED HISTONE H3 COMPLEX AT 2.25 ANGSTROM
1373, 5lzuEC, 0.5228, 4.78, 0.063, 313, 270, 
1374, 3wn1A, 0.5228, 4.55, 0.080, 302, 264, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR ALPHA-L- ARABINOFURANOSIDASE IN COMPLEX WITH XYLOTRIOSE
1375, 5ndwAF, 0.5227, 4.64, 0.086, 316, 268, struct.pdbx_descriptor              
1376, 4xjaA, 0.5227, 4.32, 0.070, 658, 257, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 5-ACETAMIDO-23-DIFLUORO-3-HYDROXY-6-[123- TRIHYDROXYPROPYL]OXANE-2-CARBOXYLIC ACID
1377, 3jaiFC, 0.5227, 4.78, 0.078, 313, 269, 
1378, 3ww9A, 0.5226, 3.59, 0.057, 251, 245, CRYSTAL STRUCTURE OF THE COMPUTATIONALLY DESIGNED PIZZA6 PROTEIN
1379, 3japJA, 0.5226, 4.86, 0.082, 318, 269, 
1380, 4hhoA, 0.5225, 4.45, 0.057, 326, 262, SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION WITH THE H115W MUTATION
1381, 4a7jA, 0.5225, 4.44, 0.076, 303, 262, SYMMETRIC DIMETHYLATION OF H3 ARGININE 2 IS A NOVEL HISTONE MARK THAT SUPPORTS EUCHROMATIN MAINTENANCE
1382, 2g99A, 0.5224, 4.73, 0.086, 304, 268, STRUCTURAL BASIS FOR THE SPECIFIC RECOGNITION OF METHYLATED HISTONE H3 LYSINE 4 BY THE WD-40 PROTEIN WDR5
1383, 5ubjA, 0.5223, 4.49, 0.061, 303, 263, STRUCTURE OF AN ALPHA-L-ARABINOFURANOSIDASE (GH62) FROM ASPERGILLUS NIDULANS
1384, 3jahFC, 0.5223, 4.66, 0.082, 313, 267, 
1385, 4o45A, 0.5222, 4.71, 0.082, 305, 268, WDR5 IN COMPLEX WITH INFLUENZA NS1 C-TERMINAL TAIL
1386, 4esgA, 0.5222, 4.65, 0.064, 304, 266, X-RAY STRUCTURE OF WDR5-MLL1 WIN MOTIF PEPTIDE BINARY COMPLEX
1387, 2h68B, 0.5222, 4.44, 0.065, 306, 262, HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX
1388, 6b7kD, 0.5221, 4.29, 0.081, 290, 259, GH43 ENDO-ARABINANASE FROM BACILLUS LICHENIFORMIS 
1389, 5m25A, 0.5221, 4.36, 0.085, 300, 260, MODULATION OF MLL1 METHYLTRANSFERASE ACTIVITY
1390, 5m23A, 0.5221, 4.36, 0.081, 300, 260, MODULATION OF MLL1 METHYLTRANSFERASE ACTIVITY
1391, 4esgB, 0.5221, 4.65, 0.064, 304, 266, X-RAY STRUCTURE OF WDR5-MLL1 WIN MOTIF PEPTIDE BINARY COMPLEX
1392, 5eamB, 0.5220, 4.67, 0.064, 304, 266, CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH COMPOUND 9O
1393, 4cy3A, 0.5220, 4.47, 0.069, 303, 262, CRYSTAL STRUCTURE OF THE NSL1-WDS COMPLEX.
1394, 3ii7A, 0.5220, 4.16, 0.098, 288, 254, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KLHL7
1395, 2g99B, 0.5220, 4.66, 0.082, 304, 267, STRUCTURAL BASIS FOR THE SPECIFIC RECOGNITION OF METHYLATED HISTONE H3 LYSINE 4 BY THE WD-40 PROTEIN WDR5
1396, 4xikA, 0.5219, 4.38, 0.070, 658, 258, CRYSTAL STRUCTURE OF NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH DMSO
1397, 4gm9B, 0.5219, 4.72, 0.090, 310, 268, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-401
1398, 4q1uA, 0.5218, 4.43, 0.038, 328, 262, SERUM PARAOXONASE-1 BY DIRECTED EVOLUTION WITH THE K192Q MUTATION
1399, 4fowA, 0.5218, 4.34, 0.070, 658, 257, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 3-AMMONIOPROPANE-1-SULFONATE
1400, 3dr2B, 0.5218, 4.11, 0.078, 297, 256, STRUCTURAL AND FUNCTIONAL ANALYSES OF XC5397 FROM XANTHOMONAS CAMPESTRIS: A GLUCONOLACTONASE IMPORTANT IN GLUCOSE SECONDARY METABOLIC PATHWAYS
1401, 1vyhK, 0.5218, 4.68, 0.064, 310, 266, PAF-AH HOLOENZYME: LIS1/ALFA2
1402, 6f0qB, 0.5217, 3.59, 0.073, 251, 246, CRYSTAL STRUCTURE OF PIZZA6-AYW
1403, 5ndwBF, 0.5217, 4.71, 0.078, 318, 269, struct.pdbx_descriptor              
1404, 4xjwA, 0.5217, 4.37, 0.070, 658, 258, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AT PH 7.4 IN PBS WITH DMSO AS THE CRYOPROTECTANT
1405, 4xmaA, 0.5216, 4.34, 0.070, 658, 257, CRYSTAL STRUCTURE OF THE K499G MUTANT OF NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN
1406, 2h9nA, 0.5216, 4.64, 0.067, 304, 267, WDR5 IN COMPLEX WITH MONOMETHYLATED H3K4 PEPTIDE
1407, 2cnxA, 0.5215, 4.69, 0.090, 306, 267, WDR5 AND HISTONE H3 LYSINE 4 DIMETHYL COMPLEX AT 2.1 ANGSTROM
1408, 5vfcA, 0.5214, 4.67, 0.079, 304, 267, WDR5 BOUND TO INHIBITOR MM-589
1409, 4erqB, 0.5214, 4.71, 0.056, 304, 266, X-RAY STRUCTURE OF WDR5-MLL2 WIN MOTIF PEPTIDE BINARY COMPLEX
1410, 3j81g, 0.5214, 4.95, 0.092, 318, 271, CRYOEM STRUCTURE OF A PARTIAL YEAST 48S PREINITIATION COMPLEX
1411, 2h9nC, 0.5214, 4.66, 0.075, 304, 267, WDR5 IN COMPLEX WITH MONOMETHYLATED H3K4 PEPTIDE
1412, 1vyhT, 0.5214, 4.68, 0.064, 310, 266, PAF-AH HOLOENZYME: LIS1/ALFA2
1413, 5lybHA, 0.5213, 4.78, 0.085, 318, 270, 
1414, 4fq4A, 0.5213, 4.39, 0.070, 658, 258, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(4-FLUORO-3-METHYLBENZYL)AMMONIO]ETHANESULFONATE
1415, 4ch9B, 0.5213, 4.43, 0.095, 286, 262, CRYSTAL STRUCTURE OF THE HUMAN KLHL3 KELCH DOMAIN IN COMPLEX WITH A WNK4 PEPTIDE
1416, 5jutWA, 0.5212, 4.77, 0.093, 318, 268, 
1417, 5aj0DC, 0.5212, 4.82, 0.074, 314, 269, 
1418, 4gmbA, 0.5212, 4.83, 0.056, 307, 268, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-402
1419, 3qeeB, 0.5211, 4.58, 0.060, 299, 265, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1420, 2o9kA, 0.5211, 4.66, 0.086, 304, 267, WDR5 IN COMPLEX WITH DIMETHYLATED H3K4 PEPTIDE
1421, 2h13A, 0.5211, 4.47, 0.076, 303, 262, CRYSTAL STRUCTURE OF WDR5/HISTONE H3 COMPLEX
1422, 1vyhD, 0.5211, 4.63, 0.064, 310, 265, PAF-AH HOLOENZYME: LIS1/ALFA2
1423, 6f0sA, 0.5210, 3.60, 0.065, 251, 246, CRYSTAL STRUCTURE OF PIZZA6-SYW
1424, 6d90EC, 0.5210, 4.77, 0.082, 313, 268, struct.pdbx_descriptor              Ribosome 
1425, 5sxmA, 0.5210, 4.65, 0.057, 304, 265, WDR5 IN COMPLEX WITH MLL WIN MOTIF PEPTIDOMIMETIC
1426, 5ealB, 0.5210, 4.64, 0.064, 304, 265, CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH COMPOUND 9H
1427, 4erqC, 0.5210, 4.66, 0.060, 304, 265, X-RAY STRUCTURE OF WDR5-MLL2 WIN MOTIF PEPTIDE BINARY COMPLEX
1428, 1u4cB, 0.5210, 4.86, 0.070, 328, 271, STRUCTURE OF SPINDLE CHECKPOINT PROTEIN BUB3
1429, 5h64C, 0.5209, 4.90, 0.070, 317, 273, CRYO-EM STRUCTURE OF MTORC1
1430, 5h64c, 0.5209, 4.90, 0.070, 317, 273, CRYO-EM STRUCTURE OF MTORC1
1431, 4gm3G, 0.5209, 4.78, 0.056, 304, 269, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-101
1432, 4gm3A, 0.5209, 4.78, 0.056, 304, 269, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-101
1433, 4erzC, 0.5209, 4.67, 0.060, 304, 267, X-RAY STRUCTURE OF WDR5-MLL4 WIN MOTIF PEPTIDE BINARY COMPLEX
1434, 4erzA, 0.5209, 4.68, 0.075, 304, 267, X-RAY STRUCTURE OF WDR5-MLL4 WIN MOTIF PEPTIDE BINARY COMPLEX
1435, 4cy1B, 0.5209, 4.50, 0.080, 301, 262, CRYSTAL STRUCTURE OF THE KANSL1-WDR5 COMPLEX.
1436, 2fp9B, 0.5209, 4.35, 0.062, 305, 259, CRYSTAL STRUCTURE OF NATIVE STRICTOSIDINE SYNTHASE
1437, 6d9jDC, 0.5208, 4.76, 0.074, 313, 269, struct.pdbx_descriptor              Ribosome 
1438, 4l7cB, 0.5208, 4.26, 0.069, 286, 259, STRUCTURE OF KEAP1 KELCH DOMAIN WITH 2-{[(1S)-2-{[(1R2S)-2-(1H- TETRAZOL-5-YL)CYCLOHEXYL]CARBONYL}-1234-TETRAHYDROISOQUINOLIN-1- YL]METHYL}-1H-ISOINDOLE-13(2H)-DIONE
1439, 4erqA, 0.5208, 4.67, 0.060, 304, 265, X-RAY STRUCTURE OF WDR5-MLL2 WIN MOTIF PEPTIDE BINARY COMPLEX
1440, 1vyhG, 0.5208, 4.70, 0.064, 310, 266, PAF-AH HOLOENZYME: LIS1/ALFA2
1441, 4erzB, 0.5207, 4.69, 0.075, 304, 267, X-RAY STRUCTURE OF WDR5-MLL4 WIN MOTIF PEPTIDE BINARY COMPLEX
1442, 4ia9A, 0.5206, 4.74, 0.060, 305, 267, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 IN COMPLEX WITH 2- CHLORO-4-FLUORO-3-METHYL-N-[2-(4-METHYLPIPERAZIN-1-YL)-5- NITROPHENYL]BENZAMIDE
1443, 4gm3D, 0.5206, 4.80, 0.052, 304, 269, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-101
1444, 2h9lA, 0.5206, 4.73, 0.093, 321, 268, WDR5DELTA23
1445, 6b7kA, 0.5205, 4.42, 0.084, 290, 262, GH43 ENDO-ARABINANASE FROM BACILLUS LICHENIFORMIS 
1446, 4n1bB, 0.5205, 4.27, 0.074, 284, 257, STRUCTURE OF KEAP1 KELCH DOMAIN WITH(1S2R)-2-[(1S)-1-[(1-OXO-23- DIHYDRO-1H-ISOINDOL-2-YL)METHYL]-1234-TETRAHYDROISOQUINOLINE-2- CARBONYL]CYCLOHEXANE-1-CARBOXYLIC ACID
1447, 4gm3E, 0.5205, 4.80, 0.052, 304, 269, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-101
1448, 5flxg, 0.5204, 4.84, 0.074, 314, 269, MAMMALIAN 40S HCV-IRES COMPLEX
1449, 4x60B, 0.5204, 4.57, 0.064, 310, 264, CRYSTAL STRUCTURE OF PRMT5:MEP50 WITH EPZ015666 AND SINEFUNGIN
1450, 3n0eA, 0.5204, 4.69, 0.064, 315, 266, CRYSTAL STRUCTURE OF WDR5 MUTANT (W330Y)
1451, 3n0dA, 0.5204, 4.68, 0.060, 315, 266, CRYSTAL STRUCTURE OF WDR5 MUTANT (W330F)
1452, 2i3tC, 0.5204, 4.88, 0.052, 334, 271, BUB3 COMPLEX WITH MAD3 (BUBR1) GLEBS MOTIF
1453, 2h9pA, 0.5204, 4.67, 0.086, 304, 267, WDR5 IN COMPLEX WITH TRIMETHYLATED H3K4 PEPTIDE
1454, 5eapA, 0.5203, 4.73, 0.064, 310, 266, CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH COMPOUND 9E
1455, 4y7rA, 0.5203, 4.69, 0.064, 304, 266, CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH MYC MBIIIB PEPTIDE
1456, 4cy1A, 0.5203, 4.70, 0.064, 303, 266, CRYSTAL STRUCTURE OF THE KANSL1-WDR5 COMPLEX.
1457, 2co0C, 0.5203, 4.70, 0.060, 304, 266, WDR5 AND UNMODIFIED HISTONE H3 COMPLEX AT 2.25 ANGSTROM
1458, 6f0tC, 0.5202, 3.62, 0.061, 251, 245, CRYSTAL STRUCTURE OF PIZZA6-SFW
1459, 5eamA, 0.5202, 4.71, 0.064, 304, 266, CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH COMPOUND 9O
1460, 4ewrA, 0.5202, 4.67, 0.086, 304, 267, X-RAY STRUCTURE OF WDR5-SETD1A WIN MOTIF PEPTIDE BINARY COMPLEX
1461, 2h6qA, 0.5202, 4.68, 0.057, 304, 265, HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX
1462, 5nkpA, 0.5201, 4.45, 0.095, 286, 262, CRYSTAL STRUCTURE OF THE HUMAN KLHL3 KELCH DOMAIN IN COMPLEX WITH A WNK3 PEPTIDE
1463, 4u56HA, 0.5201, 4.73, 0.086, 318, 269, 
1464, 2xn4B, 0.5201, 4.37, 0.085, 286, 260, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KLHL2 (MAYVEN)
1465, 5o9zD, 0.5200, 4.64, 0.075, 302, 266, CRYO-EM STRUCTURE OF A PRE-CATALYTIC HUMAN SPLICEOSOME PRIMED FOR ACTIVATION (B COMPLEX)
1466, 3smrB, 0.5200, 4.69, 0.057, 303, 265, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND
1467, 3jcrD, 0.5200, 4.64, 0.075, 302, 266, 3D STRUCTURE DETERMINATION OF THE HUMAN*U4/U6.U5* TRI-SNRNP COMPLEX
1468, 2gnqA, 0.5200, 4.79, 0.060, 316, 267, STRUCTURE OF WDR5
1469, 5a8cA, 0.5199, 4.20, 0.063, 299, 253, THE ULTRA HIGH RESOLUTION STRUCTURE OF A NOVEL ALPHA-L- ARABINOFURANOSIDASE (CTGH43) FROM CLOSTRIDIUM THERMOCELLUM ATCC 27405 WITH BOUND TRIMETHYL N-OXIDE (TRS)
1470, 3qeeA, 0.5199, 4.58, 0.061, 297, 264, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1471, 3p4fA, 0.5199, 4.70, 0.079, 304, 267, STRUCTURAL AND BIOCHEMICAL INSIGHTS INTO MLL1 CORE COMPLEX ASSEMBLY AND REGULATION.
1472, 5emmB, 0.5198, 4.51, 0.065, 313, 263, CRYSTAL STRUCTURE OF PRMT5:MEP50 WITH COMPOUND 15 AND SINEFUNGIN
1473, 4i79B, 0.5198, 4.71, 0.067, 316, 268, CRYSTAL STRUCTURE OF HUMAN NUP43
1474, 4chbB, 0.5198, 4.39, 0.085, 286, 260, CRYSTAL STRUCTURE OF THE HUMAN KLHL2 KELCH DOMAIN IN COMPLEX WITH A WNK4 PEPTIDE
1475, 3eg6A, 0.5198, 4.67, 0.086, 304, 267, STRUCTURE OF WDR5 BOUND TO MLL1 PEPTIDE
1476, 4ql1B, 0.5197, 4.69, 0.060, 302, 265, CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH COMPOUND OICR-9429
1477, 4lg8A, 0.5197, 4.54, 0.068, 310, 264, CRYSTAL STRUCTURE OF PRPF19 WD40 REPEATS
1478, 4gm3F, 0.5197, 4.78, 0.060, 304, 267, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-101
1479, 4cy5A, 0.5197, 4.66, 0.086, 303, 266, CRYSTAL STRUCTURE OF THE NSL1-WDS-NSL2 COMPLEX.
1480, 3j7rEC, 0.5197, 4.80, 0.067, 313, 268, 
1481, 3j7pDC, 0.5197, 4.80, 0.067, 313, 268, 
1482, 2xn4A, 0.5197, 4.37, 0.085, 286, 260, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KLHL2 (MAYVEN)
1483, 5c9zB, 0.5196, 4.50, 0.068, 313, 263, CRYSTAL STRUCTURE OF PRMT5:MEP50 WITH EPZ015866 AND SINEFUNGIN
1484, 4qqeA, 0.5196, 4.72, 0.075, 304, 267, CRYSTAL STRUCTURE OF WDR5 WD REPEAT DOMAIN 5 IN COMPLEX WITH COMPOUND SGC-DS-MT-0345
1485, 4gm3H, 0.5196, 4.79, 0.060, 304, 267, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-101
1486, 4gm3C, 0.5196, 4.79, 0.060, 304, 267, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-101
1487, 2xl3B, 0.5196, 4.71, 0.075, 304, 267, WDR5 IN COMPLEX WITH AN RBBP5 PEPTIDE AND HISTONE H3 PEPTIDE
1488, 2h6nA, 0.5196, 4.69, 0.060, 304, 265, HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX
1489, 5xyig, 0.5195, 4.73, 0.064, 305, 264, SMALL SUBUNIT OF TRICHOMONAS VAGINALIS RIBOSOME
1490, 4gm3B, 0.5195, 4.76, 0.064, 304, 267, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-101
1491, 3v1sA, 0.5195, 4.30, 0.062, 302, 257, SCAFFOLD TAILORING BY A NEWLY DETECTED PICTET-SPENGLERASE AC-TIVITY OF STRICTOSIDINE SYNTHASE (STR1): FROM THE COMMON TRYP-TOLINE SKELETON TO THE RARE PIPERAZINO-INDOLE FRAMEWORK
1492, 3qefB, 0.5195, 4.58, 0.076, 297, 264, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1493, 6g5ig, 0.5194, 4.81, 0.078, 314, 268, CRYO-EM STRUCTURE OF A LATE HUMAN PRE-40S RIBOSOMAL SUBUNIT - STATE R 
1494, 3jaqJA, 0.5194, 4.94, 0.074, 318, 270, 
1495, 3smrC, 0.5193, 4.75, 0.064, 303, 266, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND
1496, 2xl2B, 0.5193, 4.72, 0.060, 304, 266, WDR5 IN COMPLEX WITH AN RBBP5 PEPTIDE RECRUITED TO NOVEL SITE
1497, 1rwiB, 0.5193, 3.66, 0.053, 254, 246, EXTRACELLULAR DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKND
1498, 6dasB, 0.5192, 4.49, 0.092, 304, 261, DISCOVERY OF POTENT 2-ARYL-6;7-DIHYDRO-5HPYRROLO[ 1;2-A]IMIDAZOLES AS WDR5 WIN-SITE INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE- BASED DESIGN 
1499, 6b7kB, 0.5192, 4.35, 0.077, 290, 259, GH43 ENDO-ARABINANASE FROM BACILLUS LICHENIFORMIS 
1500, 5emlB, 0.5192, 4.58, 0.072, 310, 264, CRYSTAL STRUCTURE OF PRMT5:MEP50 WITH COMPOUND 10 AND SAM
1501, 3mxxA, 0.5192, 4.72, 0.060, 315, 267, CRYSTAL STRUCTURE OF WDR5 MUTANT (S62A)
1502, 2i3tA, 0.5192, 4.90, 0.062, 334, 273, BUB3 COMPLEX WITH MAD3 (BUBR1) GLEBS MOTIF
1503, 2xl2A, 0.5191, 4.72, 0.060, 304, 266, WDR5 IN COMPLEX WITH AN RBBP5 PEPTIDE RECRUITED TO NOVEL SITE
1504, 2i3tE, 0.5191, 4.90, 0.062, 334, 273, BUB3 COMPLEX WITH MAD3 (BUBR1) GLEBS MOTIF
1505, 6gqvAC, 0.5190, 4.90, 0.067, 318, 270, struct.pdbx_descriptor              
1506, 6b7kC, 0.5190, 4.49, 0.080, 290, 263, GH43 ENDO-ARABINANASE FROM BACILLUS LICHENIFORMIS 
1507, 5emkB, 0.5190, 4.50, 0.068, 313, 263, CRYSTAL STRUCTURE OF PRMT5:MEP50 WITH COMPOUND 9 AND SINEFUNGIN
1508, 4ascA, 0.5190, 4.29, 0.066, 307, 257, CRYSTAL STRUCTURE OF THE KELCH DOMAIN OF HUMAN KBTBD5
1509, 3ur4A, 0.5190, 4.71, 0.057, 303, 265, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND
1510, 3emhA, 0.5190, 4.38, 0.081, 300, 259, STRUCTURAL BASIS OF WDR5-MLL INTERACTION
1511, 2h14A, 0.5190, 4.53, 0.076, 303, 262, CRYSTAL OF WDR5 (APO-FORM)
1512, 6f0qA, 0.5189, 3.69, 0.077, 251, 246, CRYSTAL STRUCTURE OF PIZZA6-AYW
1513, 3uvnA, 0.5189, 4.73, 0.064, 304, 266, CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF SET1A
1514, 5juuWA, 0.5188, 4.87, 0.086, 318, 269, 
1515, 3uvlA, 0.5188, 4.71, 0.060, 303, 265, CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF MLL3
1516, 2h9mC, 0.5188, 4.64, 0.061, 304, 264, WDR5 IN COMPLEX WITH UNMODIFIED H3K4 PEPTIDE
1517, 6bynW, 0.5187, 4.69, 0.064, 305, 265, CRYSTAL STRUCTURE OF WDR5-MB(S4) MONOBODY COMPLEX 
1518, 4gm8D, 0.5187, 4.70, 0.057, 300, 265, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-102
1519, 4gm8B, 0.5187, 4.43, 0.081, 300, 260, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-102
1520, 6dasA, 0.5186, 4.77, 0.056, 305, 266, DISCOVERY OF POTENT 2-ARYL-6;7-DIHYDRO-5HPYRROLO[ 1;2-A]IMIDAZOLES AS WDR5 WIN-SITE INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE- BASED DESIGN 
1521, 4chbA, 0.5186, 4.43, 0.092, 286, 261, CRYSTAL STRUCTURE OF THE HUMAN KLHL2 KELCH DOMAIN IN COMPLEX WITH A WNK4 PEPTIDE
1522, 3pslA, 0.5185, 4.62, 0.061, 298, 263, FINE-TUNING THE STIMULATION OF MLL1 METHYLTRANSFERASE ACTIVITY BY A HISTONE H3 BASED PEPTIDE MIMETIC
1523, 1rwlA, 0.5185, 3.77, 0.048, 254, 248, EXTRACELLULAR DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKND
1524, 4v7rPC, 0.5184, 4.74, 0.086, 313, 267, 
1525, 4kcbB, 0.5184, 4.54, 0.076, 307, 263, CRYSTAL STRUCTURE OF EXO-15-ALPHA-L-ARABINANASE FROM BOVINE RUMINAL METAGENOMIC LIBRARY
1526, 4gm8A, 0.5184, 4.74, 0.064, 302, 266, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-102
1527, 2o9kC, 0.5184, 4.66, 0.053, 303, 264, WDR5 IN COMPLEX WITH DIMETHYLATED H3K4 PEPTIDE
1528, 2h6qB, 0.5184, 4.69, 0.064, 304, 265, HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX
1529, 5earB, 0.5183, 4.55, 0.057, 301, 262, CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH COMPOUND 9D
1530, 4v7rU, 0.5183, 4.74, 0.086, 313, 267, 
1531, 3v1sB, 0.5183, 4.24, 0.063, 302, 255, SCAFFOLD TAILORING BY A NEWLY DETECTED PICTET-SPENGLERASE AC-TIVITY OF STRICTOSIDINE SYNTHASE (STR1): FROM THE COMMON TRYP-TOLINE SKELETON TO THE RARE PIPERAZINO-INDOLE FRAMEWORK
1532, 2h68A, 0.5183, 4.69, 0.060, 304, 265, HISTONE H3 RECOGNITION AND PRESENTATION BY THE WDR5 MODULE OF THE MLL1 COMPLEX
1533, 4gm8C, 0.5182, 4.74, 0.064, 302, 266, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-102
1534, 4d61g, 0.5182, 4.86, 0.078, 314, 268, CRYO-EM STRUCTURES OF RIBOSOMAL 80S COMPLEXES WITH TERMINATION FACTORS AND CRICKET PARALYSIS VIRUS IRES REVEAL THE IRES IN THE TRANSLOCATED STATE
1535, 4d5lg, 0.5182, 4.86, 0.078, 314, 268, CRYO-EM STRUCTURES OF RIBOSOMAL 80S COMPLEXES WITH TERMINATION FACTORS AND CRICKET PARALYSIS VIRUS IRES REVEAL THE IRES IN THE TRANSLOCATED STATE
1536, 2wozA, 0.5182, 4.46, 0.062, 307, 259, THE NOVEL BETA-PROPELLER OF THE BTB-KELCH PROTEIN KRP1 PROVIDES THE BINDING SITE FOR LASP-1 THAT IS NECESSARY FOR PSEUDOPODIA EXTENSION
1537, 4ujeKA, 0.5181, 4.87, 0.078, 314, 268, 
1538, 4ujdEC, 0.5181, 4.87, 0.078, 314, 268, 
1539, 4ujcEC, 0.5181, 4.87, 0.078, 314, 268, 
1540, 3pslB, 0.5181, 4.48, 0.061, 298, 261, FINE-TUNING THE STIMULATION OF MLL1 METHYLTRANSFERASE ACTIVITY BY A HISTONE H3 BASED PEPTIDE MIMETIC
1541, 3smrD, 0.5180, 4.63, 0.087, 303, 265, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND
1542, 5emjB, 0.5179, 4.43, 0.061, 303, 262, CRYSTAL STRUCTURE OF PRMT5:MEP50 WITH COMPOUND 8 AND SINEFUNGIN
1543, 4cy2A, 0.5179, 4.73, 0.064, 304, 266, CRYSTAL STRUCTURE OF THE KANSL1-WDR5-KANSL2 COMPLEX.
1544, 5earA, 0.5178, 4.58, 0.084, 301, 263, CRYSTAL STRUCTURE OF HUMAN WDR5 IN COMPLEX WITH COMPOUND 9D
1545, 4eryA, 0.5178, 4.63, 0.079, 304, 265, X-RAY STRUCTURE OF WDR5-MLL3 WIN MOTIF PEPTIDE BINARY COMPLEX
1546, 3qefA, 0.5178, 4.57, 0.076, 296, 263, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1547, 6gqbAC, 0.5177, 4.66, 0.094, 318, 265, Cryo-EM reconstruction of yeast 80S ribosome in complex with mRNA; tRNA and eEF2 (GDP+AlF4/sordarin)  
1548, 2fpcB, 0.5177, 4.33, 0.062, 302, 257, STRUCTURE OF STRICTOSIDINE SYNTHASE THE BIOSYNTHETIC ENTRY TO THE MONOTERPENOID INDOLE ALKALOID FAMILY
1549, 3smrA, 0.5176, 4.64, 0.053, 302, 263, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND
1550, 3uvnC, 0.5174, 4.68, 0.057, 304, 264, CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF SET1A
1551, 5t2aEB, 0.5173, 4.67, 0.061, 308, 262, 
1552, 4x63B, 0.5171, 4.39, 0.065, 309, 261, CRYSTAL STRUCTURE OF PRMT5:MEP50 WITH EPZ015666 AND SAH
1553, 4fpoB, 0.5171, 4.53, 0.062, 658, 259, CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH 2-[(3-CHLORO-4-METHOXYBENZYL)AMMONIO]ETHANESULFONATE
1554, 2z2oA, 0.5171, 4.60, 0.065, 298, 262, CRYSTAL STRUCTURE OF APO VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS
1555, 4es0A, 0.5170, 4.54, 0.084, 304, 261, X-RAY STRUCTURE OF WDR5-SETD1B WIN MOTIF PEPTIDE BINARY COMPLEX
1556, 3uvoA, 0.5167, 4.44, 0.066, 300, 259, CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF SET1B
1557, 3ur4B, 0.5167, 4.54, 0.073, 301, 261, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND
1558, 2v91B, 0.5166, 4.28, 0.062, 302, 256, STRUCTURE OF STRICTOSIDINE SYNTHASE IN COMPLEX WITH STRICTOSIDINE
1559, 2z2oB, 0.5165, 4.63, 0.057, 293, 263, CRYSTAL STRUCTURE OF APO VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS
1560, 2fpcA, 0.5163, 4.34, 0.062, 302, 257, STRUCTURE OF STRICTOSIDINE SYNTHASE THE BIOSYNTHETIC ENTRY TO THE MONOTERPENOID INDOLE ALKALOID FAMILY
1561, 5wlcDA, 0.5158, 5.20, 0.065, 362, 276, struct.pdbx_descriptor              
1562, 3uvmA, 0.5158, 4.75, 0.060, 304, 265, CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF MLL4
1563, 4gm9A, 0.5157, 4.77, 0.057, 309, 265, CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-401
1564, 4v7hQ, 0.5155, 4.74, 0.095, 313, 264, 
1565, 4aowA, 0.5155, 4.80, 0.071, 305, 267, CRYSTAL STRUCTURE OF THE HUMAN RACK1 PROTEIN AT A RESOLUTION OF 2.45 ANGSTROM
1566, 2qc5A, 0.5154, 4.59, 0.076, 298, 262, STREPTOGRAMIN B LYASE STRUCTURE
1567, 1zgkA, 0.5154, 4.32, 0.070, 281, 256, 1.35 ANGSTROM STRUCTURE OF THE KELCH DOMAIN OF KEAP1
1568, 2z2pA, 0.5149, 4.51, 0.081, 293, 260, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE H270A VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS WITH QUINUPRISTIN
1569, 3uvkA, 0.5148, 4.45, 0.070, 299, 258, CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF MLL2
1570, 4kcbA, 0.5146, 4.58, 0.076, 300, 263, CRYSTAL STRUCTURE OF EXO-15-ALPHA-L-ARABINANASE FROM BOVINE RUMINAL METAGENOMIC LIBRARY
1571, 3ow8A, 0.5146, 4.49, 0.073, 293, 259, CRYSTAL STRUCTURE OF THE WD REPEAT-CONTAINING PROTEIN 61
1572, 5mqfF, 0.5145, 4.59, 0.073, 307, 261, CRYO-EM STRUCTURE OF A HUMAN SPLICEOSOME ACTIVATED FOR STEP 2 OF SPLICING (C* COMPLEX)
1573, 3e5zA, 0.5143, 4.31, 0.094, 287, 256, X-RAY STRUCTURE OF THE PUTATIVE GLUCONOLACTONASE IN PROTEIN FAMILY PF08450. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET DRR130.
1574, 5ndgID, 0.5141, 4.91, 0.082, 313, 268, struct.pdbx_descriptor              
1575, 2z2pB, 0.5141, 4.55, 0.065, 293, 261, CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE H270A VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS WITH QUINUPRISTIN
1576, 2ojhA, 0.5140, 3.88, 0.077, 269, 247, THE STRUCTURE OF PUTATIVE TOLB FROM AGROBACTERIUM TUMEFACIENS
1577, 5kwnA, 0.5138, 4.78, 0.037, 306, 267, THE WD DOMAIN OFARABIDOPSIS THALIANA E3 UBIQUITIN LIGASE COP1 IN COMPLEX WITH PEPTIDE FROM HY5
1578, 2vk7B, 0.5138, 5.56, 0.080, 448, 286, THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES
1579, 6az1g, 0.5134, 4.54, 0.066, 300, 257, CRYO-EM STRUCTURE OF THE SMALL SUBUNIT OF LEISHMANIA RIBOSOME BOUND TO PAROMOMYCIN
1580, 2fpbA, 0.5133, 4.27, 0.051, 299, 255, STRUCTURE OF STRICTOSIDINE SYNTHASE THE BIOSYNTHETIC ENTRY TO THE MONOTERPENOID INDOLE ALKALOID FAMILY
1581, 4g56B, 0.5129, 4.34, 0.058, 291, 257, CRYSTAL STRUCTURE OF FULL LENGTH PRMT5/MEP50 COMPLEXES FROM XENOPUS LAEVIS
1582, 4aowB, 0.5127, 4.73, 0.075, 301, 265, CRYSTAL STRUCTURE OF THE HUMAN RACK1 PROTEIN AT A RESOLUTION OF 2.45 ANGSTROM
1583, 3qedD, 0.5123, 4.73, 0.061, 297, 263, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1584, 5nuvA, 0.5122, 4.60, 0.057, 301, 262, STRUCTURE OF THE WD40-DOMAIN OF HUMAN ATG16L1
1585, 3e5zB, 0.5122, 4.34, 0.094, 287, 256, X-RAY STRUCTURE OF THE PUTATIVE GLUCONOLACTONASE IN PROTEIN FAMILY PF08450. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET DRR130.
1586, 3qedC, 0.5121, 4.62, 0.061, 295, 261, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1587, 2z2oD, 0.5121, 4.62, 0.061, 295, 261, CRYSTAL STRUCTURE OF APO VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS
1588, 1vyhP, 0.5120, 4.74, 0.087, 310, 264, PAF-AH HOLOENZYME: LIS1/ALFA2
1589, 1vyhC, 0.5119, 4.88, 0.090, 310, 266, PAF-AH HOLOENZYME: LIS1/ALFA2
1590, 3qedB, 0.5118, 4.78, 0.076, 297, 264, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1591, 3ow8B, 0.5116, 4.51, 0.070, 292, 258, CRYSTAL STRUCTURE OF THE WD REPEAT-CONTAINING PROTEIN 61
1592, 1vyhL, 0.5116, 4.48, 0.081, 310, 258, PAF-AH HOLOENZYME: LIS1/ALFA2
1593, 1vyhH, 0.5116, 4.68, 0.084, 310, 262, PAF-AH HOLOENZYME: LIS1/ALFA2
1594, 4v8mH, 0.5112, 4.45, 0.059, 314, 256, 
1595, 3ow8D, 0.5110, 4.51, 0.047, 300, 258, CRYSTAL STRUCTURE OF THE WD REPEAT-CONTAINING PROTEIN 61
1596, 3ow8C, 0.5110, 4.51, 0.047, 300, 258, CRYSTAL STRUCTURE OF THE WD REPEAT-CONTAINING PROTEIN 61
1597, 2fpbB, 0.5110, 4.31, 0.055, 299, 254, STRUCTURE OF STRICTOSIDINE SYNTHASE THE BIOSYNTHETIC ENTRY TO THE MONOTERPENOID INDOLE ALKALOID FAMILY
1598, 1vyhO, 0.5110, 4.77, 0.091, 310, 264, PAF-AH HOLOENZYME: LIS1/ALFA2
1599, 3qedA, 0.5109, 4.61, 0.062, 290, 260, THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-12- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES
1600, 1npeA, 0.5108, 3.65, 0.033, 263, 240, CRYSTAL STRUCTURE OF NIDOGEN/LAMININ COMPLEX
1601, 5zcsD, 0.5107, 5.07, 0.052, 317, 271, 4.9 ANGSTROM CRYO-EM STRUCTURE OF HUMAN MTOR COMPLEX 2
1602, 5zcsC, 0.5107, 5.07, 0.052, 317, 271, 4.9 ANGSTROM CRYO-EM STRUCTURE OF HUMAN MTOR COMPLEX 2
1603, 4aowC, 0.5105, 4.77, 0.064, 305, 264, CRYSTAL STRUCTURE OF THE HUMAN RACK1 PROTEIN AT A RESOLUTION OF 2.45 ANGSTROM
1604, 1vyhS, 0.5101, 4.72, 0.095, 310, 262, PAF-AH HOLOENZYME: LIS1/ALFA2
1605, 1trjA, 0.5100, 4.72, 0.080, 314, 261, HOMOLOGY MODEL OF YEAST RACK1 PROTEIN FITTED INTO 11.7A CRYO-EM MAP OF YEAST 80S RIBOSOME
1606, 6g18g, 0.5098, 4.81, 0.061, 313, 264, CRYO-EM STRUCTURE OF A LATE HUMAN PRE-40S RIBOSOMAL SUBUNIT - STATE C 
1607, 5oa1V, 0.5091, 4.02, 0.056, 288, 249, RNA POLYMERASE I PRE-INITIATION COMPLEX
1608, 6ckcB, 0.5087, 4.37, 0.074, 303, 257, STRUCTURE OF PRMT5:MEP50 IN COMPLEX WITH LLY-283; A POTENT AND SELECTIVE INHIBITOR OF PRMT5; WITH ANTITUMOR ACTIVITY 
1609, 5lksPB, 0.5085, 5.05, 0.072, 313, 265, 
1610, 2z2oC, 0.5079, 4.63, 0.078, 299, 257, CRYSTAL STRUCTURE OF APO VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS
1611, 4gqbB, 0.5078, 4.40, 0.074, 303, 257, CRYSTAL STRUCTURE OF THE HUMAN PRMT5:MEP50 COMPLEX
1612, 3jb9L, 0.5072, 4.45, 0.091, 293, 254, CRYO-EM STRUCTURE OF THE YEAST SPLICEOSOME AT 3.6 ANGSTROM RESOLUTION
1613, 4ch9A, 0.5067, 4.39, 0.071, 286, 253, CRYSTAL STRUCTURE OF THE HUMAN KLHL3 KELCH DOMAIN IN COMPLEX WITH A WNK4 PEPTIDE
1614, 2z2nA, 0.5058, 4.63, 0.070, 289, 258, CRYSTAL STRUCTURE OF SELENOMETHIONINE SUBSTITUTED VIRGINIAMYCIN B LYASE FROM STAPHYLOCOCCUS AUREUS
1615, 4v92IA, 0.5052, 5.20, 0.074, 315, 270, 
1616, 5flcH, 0.5051, 4.44, 0.059, 317, 253, ARCHITECTURE OF HUMAN MTOR COMPLEX 1 - 5.9 ANGSTROM RECONSTRUCTION
1617, 5flcD, 0.5051, 4.44, 0.059, 317, 253, ARCHITECTURE OF HUMAN MTOR COMPLEX 1 - 5.9 ANGSTROM RECONSTRUCTION
1618, 5fa5B, 0.5050, 4.43, 0.071, 301, 255, CRYSTAL STRUCTURE OF PRMT5:MEP50 IN COMPLEX WITH MTA AND H4 PEPTIDE
1619, 5oj3B, 0.5049, 5.00, 0.078, 322, 268, YCF48 FROM CYANIDIOSCHYZON MEROLAE 
1620, 5oj3A, 0.5044, 5.01, 0.078, 322, 268, YCF48 FROM CYANIDIOSCHYZON MEROLAE 
1621, 3frxD, 0.5044, 4.66, 0.078, 306, 258, CRYSTAL STRUCTURE OF THE YEAST ORTHOLOGUE OF RACK1 ASC1.
1622, 4jsvC, 0.5042, 4.42, 0.071, 317, 252, MTOR KINASE STRUCTURE MECHANISM AND REGULATION.
1623, 3frxB, 0.5041, 4.67, 0.085, 306, 258, CRYSTAL STRUCTURE OF THE YEAST ORTHOLOGUE OF RACK1 ASC1.
1624, 4jsvD, 0.5036, 4.47, 0.067, 317, 253, MTOR KINASE STRUCTURE MECHANISM AND REGULATION.
1625, 6bcxF, 0.5035, 4.51, 0.063, 317, 254, struct.pdbx_descriptor              
1626, 3frxA, 0.5035, 4.63, 0.082, 303, 257, CRYSTAL STRUCTURE OF THE YEAST ORTHOLOGUE OF RACK1 ASC1.
1627, 3frxC, 0.5027, 4.60, 0.082, 302, 256, CRYSTAL STRUCTURE OF THE YEAST ORTHOLOGUE OF RACK1 ASC1.
1628, 3kstA, 0.5018, 4.80, 0.068, 287, 263, CRYSTAL STRUCTURE OF ENDO-14-BETA-XYLANASE (NP_811807.1) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.70 A RESOLUTION
1629, 3rfhD, 0.5017, 4.38, 0.063, 307, 253, CRYSTAL STRUCTURE OF THE YEAST RACK1 DIMER IN SPACE GROUP P21
1630, 3rfhB, 0.5012, 4.40, 0.055, 290, 253, CRYSTAL STRUCTURE OF THE YEAST RACK1 DIMER IN SPACE GROUP P21
1631, 3kstB, 0.5012, 4.91, 0.064, 286, 265, CRYSTAL STRUCTURE OF ENDO-14-BETA-XYLANASE (NP_811807.1) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.70 A RESOLUTION
1632, 3rfhA, 0.5010, 4.45, 0.059, 291, 254, CRYSTAL STRUCTURE OF THE YEAST RACK1 DIMER IN SPACE GROUP P21
